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i 
Zusammenfassung 
Der Ras-Signaltransduktionsweg wird in Neuronen durch eine große Anzahl verschiedener Signale 
stimuliert. Hierzu gehören trophische Faktoren, Neurotransmitter und modulatorische Neuropeptide. 
GDP/GTP-Austauschfaktoren (GEFs) vermitteln die Aktivierung der kleinen Ras-GTPasen, indem sie den 
Austausch von GDP gegen GTP katalysieren, und hierbei ein Signalnetzwerk ermöglichen. In dieser Arbeit 
wurde ein neuer gehirnspezifischer Ras-GDP/GTP-Austauschfaktor, very-KIND (VKIND), strukturell und 
funktionell charakterisiert. VKIND gehört, zusammen mit der Nicht-Rezeptor-Tyrosinphosphatase Typ 13 
und dem Aktinnukleator Spir, zu der KIND-Proteinfamilie. Die Kinase Non-catalytic C-lobe Domain 
(KIND) ist strukturell verwandt mit der C-terminalen katalytischen Domäne (C-Lappen) der p21-aktivierten 
Proteinkinase (PAK). Der Offene Leserahmen aus 5229 Basenpaare des VKIND Gens wurde kloniert. 
Dieser kodiert für ein Protein aus 1742 Aminosäuren mit einem Molekulargewicht von 191 kD. Die 
Proteinstruktur des VKINDs ist hoch konserviert und kommt nur in Wirbeltieren und Stachelhäutern vor. 
Das Vorkommen von zwei KIND-Domänen in der aminotermianlen Region ist für dessen Namensgebung 
verantwortlich. Die KIND-Domäne fungiert als Protein-Interaktionsmodul ohne bisher bekannte 
katalytische Eigenschaften. Während die Funktion der KIND1-Domäne noch geklärt werden muss, bindet 
die KIND2-Domäne das Mikrotubuli-assoziertes Protein 2 (MAP2). Die zentrale Region des Proteins weist 
zwei hoch konservierte Cluster mit noch unbekannter Funktion auf, sowie ein Super-Helix-Motiv, coiled-
coil, welches ein potentielles Protein-Interaktionsmodul darstellt. In der carboxyterminalen Region weist 
VKIND ein Guaninnukleotid-Austauschfaktor für die Protein-Superfamilie der kleinen Ras GTPasen 
(RasGEF) auf, welches sich in direkter Nachbarschaft des N-terminalen Strukturmotivs RasGEFN befindet. 
Das VKIND RasGEF-Modul ist strukturell mit der katalytischen Domäne CDC25 aus S. cerevisiae 
verwandt. Die Aminosäurensequenz der VKIND RasGEF-Domäne weist mit einer Homologie von 23% 
eine enge Verwandtschaft zur RasGEF-Domäne für RapGTPasen auf. Jedoch unterscheiden sich diese durch 
zwei zusätzliche Insertionen in der VKIND RasGEF-Domäne. Die Erste aus 24 Aminosäureresten 
bestehende Insertion ist im N-terminalen Bereich der RasGEF-Domäne zwischen den Helices αA und αB 
des SOS1 RasGEF Moduls lokalisiert, während die Zweite aus elf Aminosäureresten bestehende Insertion 
im C-terminalen Bereich zwischen den Helices αJ und αK des SOS1 RasGEF Moduls lokalisiert ist. Die 
RasGEFN-Domäne spielt eine wichtige Rolle für die strukturelle und katalytische Integrität der GEF-
Domäne.  
Im Maus-Embryo und in der adulten Maus wird VKIND spezifisch im Nervensystem exprimiert. Während 
der Embryogenese findet eine starke VKIND-Expression in dem murinen Neuralrohr, dem Telencephalon, 
dem Retinal-Ganglion und dem Rhombencephalon statt. Für die adulte Maus ist dagegen eine starke 
Expression ausschließlich in der Purkinje- und der Körner-Zellschicht des Cerebellums charakteristisch. 
Studien der subzellulären Verteilung und Zeitraffer-Video-Analysen zeigten die graduelle Akkumulation 
des VKIND Proteins in freibeweglichen zytoplasmatischen Partikeln. Diese zirkulären Partikeln wuchsen 
hierbei bis zu einer Größe von 2 µm an und bewegten sich mit einer Geschwindigkeit von maximal 
12 µm/min. Dies deutet auf eine mögliche Rolle des VKINDs bei dem vesikulären Transport hin. 
In dieser Arbeit konnte gezeigt werden, dass die VKIND KIND1/KIND2-Region durch die p38 MAP-
Kinase phosphoryliert wird. Vor kurzem wurde von anderen Gruppen ein p38-induziertes 
Neuritenwachstum als Antwort auf einen hyperomotischen Schock untersucht. Im Zusammenhang mit dem 
inhibitorischen Effekt des VKINDs auf das Neuritenwachstum könnte dies zur weiteren Aufklärung des 
komplexen Ras-Signalweges und der neuronalen Physiologie beitragen.  
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Abstract 
In neurons the Ras signaling pathway is activated by a large number of various stimuli, including trophic 
factors, neurotransmitters and modulatory peptides. Guanine nucleotide exchange factors (GEFs) mediate 
the activation of Ras GTPases, by catalyzing the exchange of GDP for GTP, and facilitate signaling 
networks crosstalk. In this work, very-KIND (VKIND), a new brain specific RasGEF was structurally and 
functionally characterized. VKIND belongs to the KIND protein family along with the non-receptor tyrosine 
phosphatases type 13 and Spir actin nucleation factors. The kinase non-catalytic C-lobe domain (KIND) is 
similar to the C-terminal protein kinase catalytic fold (C-lobe) of the p21-activated kinase (PAK). The open 
reading frame (ORF) of the VKIND gene of 5229 base pairs was cloned. The VKIND ORF translates into a 
protein of 1742 amino acids residues with a size of 191 kD. The VKIND protein structure is highly 
conserved among species and at present the protein is found only in Vertebratae and Echinodermatae. The 
arrangement of two KIND domains at its amino-terminal region, KIND1 and KIND2, is depicted in its 
name. The KIND module functions as a molecular interaction structure that is deprived of any enzymatic 
activity. While the precise occupation of the KIND1 domain remains elusive, the KIND2 domain binds to 
the microtubules-associated protein 2 (MAP2). The protein central portion features two clusters of high 
conservation of yet unknown function as well as a coiled-coil motif with a putative multiple protein-protein 
interaction activity. At the carboxy-terminal region VKIND features a guanine nucleotide exchange factor 
for Ras-like small GTPases (RasGEF) with a structural RasGEFN motif attached at its N-terminal site. The 
VKIND RasGEF motif is structurally related to the yeast catalytic domain CDC25. The closest relation of 
the VKIND RasGEF domain with an average sequence identity of 23% is assigned to the RasGEF domains 
of exchange factors specific for Rap GTPases with two unique insertions: the first one of 24 amino acids in 
the N-terminal end of the domain (between helixes αA and αB of the SOS1 RasGEF module) and the second 
one of 11 amino acids in the C-terminal part (between, helixes αJ and αK of the Sos1 RasGEF module). The 
RasGEFN domain plays a critical role in sustaining the structural and catalytical integrity of the guanidine 
exchange factor.  
VKIND is specifically and highly expressed in the murine nervous system during embryonic development 
and adulthood. During embryogenesis VKIND expression is present in the murine neural tube, 
telencephalon, retinal ganglion cells, and rhombencephalon. In the adult murine brain VKIND expression is 
most prominent in the cerebellum, however exclusively restricted to the granular and Purkinje cell layers.  
Subcellular distribution studies and time-lapse analysis revealed the gradual accumulation of VKIND into 
highly motile circular particles which featured estimated maximum velocity of 12 µm/min. By merging the 
nascent structures progressively grew to estimated 2 µm in size suggesting a role for VKIND in the 
vesicular transport process.  
Furthermore, the KIND1/KIND2 region of the VKIND protein was found to be phosphorylated by the p38 
mitogen-activated protein kinase (MAPK), recently discovered to induce neurite outgrowth in response to 
hyperosmotic shock. In the light of VKIND negatively controlling neurite outgrowth, further elucidation of 
the complex Ras pathways may provide rewarding insights in the neuronal physiology.  
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1.1  The kinase non-catalytic C-lobe domain (KIND) 
The novel KIND domain was discovered in a sequence analysis of the Spir N-terminal region (Ciccarelli et 
al., 2003). The Drosophila melanogaster p150Spir has been first identified as an important regulator of the 
actin cytoskeleton, since Spir proteins contain a cluster of four acting binding WH2 (Wiskott-Aldrich 
homology region 2) domains (Otto et al., 2000; Wellington et al., 1999; Symons et al., 1996). Spir is highly 
conserved between species and represents a third class of actin nucleation factors along with Arp 2/3 and 
formin family proteins (Quinlan et al., 2005). Additionally, p150Spir was discovered to be the prime 
phosphorylation target of the Jun N-terminal kinase (Otto et al., 2000) that is involved in vesicle transport 
processes (Kerkhoff et al., 2001). In a PSI-BLAST search (Altschul et al., 1997) the first 350 residues of 
Dm p150Spir were found to match ~200 residues of two regions of the to that point still uncharacterized 
human protein KIAA1768 (BAB21859, presently designated very-KIND, Mees et al., 2005) (Ciccarelli et 
al., 2003). Residues 30-220 of the very-KIND (VKIND) protein matched consequently various catalytic 
domains of protein kinases, with best similarities to the p21-activated kinase (PAK, a serine threonine 
phosphotransferase) (Ciccarelli et al., 2003). 
Protein kinases represent one of the most abundant families in genomes of eukaryotes (Hunter, 1987; Rubin 
et al., 2000). The highly regulated protein kinases act as phosphotransferases on proteins modifying their 
activity. Comparative analysis of protein kinase sequences defined the boundaries of the eukaryotic protein 
kinase catalytic domain, ‘a kinase fold’, which consists of ~250-300 amino acid residues, revealing 12 
conserved subdomains without any large amino-acid insertions and harboring characteristic patterns of 
conserved residues (Hanks et al., 1988; Hanks, 2003). The function of the kinase domains imparting the 
catalytic activity comprises: 1) binding and orientation of the ATP (or GTP) phosphate donor complexed 
with divalent cation (typically Mg
2+
 or Mn
2+
); 2) binding and orientation of the targeted protein substrate; 
and 3) transmission of the γ-phosphate from ATP (or GTP) to the acceptor hydroxyl residue (Ser, Thr, or 
Tyr) (Hanks & Hunter, 1995). Twelve kinase domain residues are described as being invariant or nearly 
invariant throughout the superfamily and play essential roles in the enzyme function (Hanks & Hunter, 
1995). Moreover, the patterns of amino acid residues observed within subdomains VIB, VIII and IX were 
found to be particularly well conserved among the individual members of the distinct protein kinase families 
(Hanks & Hunter, 1995). The homologous nature of kinase domains triggers a folding into a similar 3-
dimensional structure communicating a phosphotransfer according to a similar mechanism (Hanks & 
Hunter, 1995). The general topology of a protein kinase catalytic core structure was described at first with 
the solution of the crystal structure of the mouse cAPK catalytic subunit (Knighton et al., 1991a; Knighton 
et al., 1991b). The kinase domain structure is bilobal with a deep cleft between the structurally independent 
lobes (Knighton et al., 1991a). The smaller lobe, including the N-terminal subdomains I-IV, is primarily 
involved with nucleotide binding and orienting (Hanks & Hunter, 1995). This structure has largely beta 
sheet architecture, which is an unusual nucleotide binding motif (Hanks & Hunter, 1995). The 
larger lobe, consisting of the C-terminal subdomains VIA-XI, is mainly involved in substrate 
binding and catalysis (Hanks & Hunter, 1995). Its predominant content is an α-helical 
structure with a single beta sheet at the domain interface (Hanks & Hunter, 1995). The 
joining linker region between the two lobes consists of the subdomain V residues (Hanks & 
Hunter, 1995). The deep cleft between the N- and C-lobe is recognized as the site initiating 
the phosphotransfer (Hanks & Hunter, 1995) (Fig. 1A). The majority of the invariant amino acids in the 
conserved catalytic structure are clustered at the sites of nucleotide binding and catalysis (Knighton et al., 
1991a).  
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Fig. 1  Illustration of the architectures of the protein kinase fold and the KIND domain. 
(A) The 3D structure p21-activated kinase 1 (PAK1) (Lei et al., 2000) is depicted as an example of the kinase structural fold. The 
activation (AL) and the catalytic (CL) loops in the C-lobe are labeled in green and blue, respectively. The 3D representation has been 
realized using the MolMol program (Koradi et al., 1996). Reproduced with permission from Ciccarelli et al. (2003). 
(B) Kinase non-catalytic C-lobe domain (KIND) 3D structure from the CDD (conserved domain database for interactive domain family 
analysis) (Marchler-Bauer et al., 2007), available at http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=48017. 
 
The Spir protein N-terminal sequence matches the entire C-lobe of the protein kinase catalytic core but the 
N-lobe and the linker region (Ciccarelli et al., 2003) (Fig. 1A). The consensus sequence and the secondary 
structure prediction are calculated based on the multiple alignment of the shown sequences, excluding the 
sequence of the protein kinases (Ciccarelli et al., 2003) (Fig. 2). The consensus sequence and the secondary 
structure prediction line up well to those determined for protein kinases (Ciccarelli et al., 2003) (Fig. 2). 
Nevertheless, the invariant amino acid residues assigned the catalytic kinase activity in the catalytic loop, 
Asp166 and Asn171 as referenced to cAPK in subdomain VIB, are not found in the N-terminal regions of the 
aligned proteins (Ciccarelli et al., 2003) (Fig. 2). Moreover, in the activation loop the invariant amino acid 
Asp184 (as referenced to cAPK) that is incorporated in the highly conserved DFG triplet in subdomain VII is 
also missing (Ciccarelli et al., 2003). The significant similarity and the structural context strongly imply that 
the analyzed regions and the protein kinase C-lobe subunit share a common ancestor. Since structures, 
however, essential for the enzymatic activity of the protein kinase activity (the N-lobe, along with the deep 
cleft between the two lobes, and the invariant catalytic residues) are excluded in the analyzed protein 
regions, the novel domain is supposably deprived of any catalytic activity (Ciccarelli et al., 2003). Based on 
the structural resemblance and absence of essential catalytic residues the analyzed new region was named 
KIND, for kinase non-catalytic C-lobe domain (Ciccarelli et al., 2003) (Fig. 1B and 2). 
Additional homologous enzymes and nonenzymes sharing high sequence identity but not sharing any 
similarity in function have been described (Todd et al., 2002). Functional variations have developed through 
incremental modifications of the catalytic or substrate binding sites (Todd et al., 2002). It is thought that 
multifunctional genes subjected to adaptive pressure may undergo gene duplication and divergence to 
provide for the independent specialization of each function (Todd et al., 2002). Two scenarios for evolution 
of functional variations are described: the nonenzymes have developed from enzyme precursors, or, 
conversely, the enzymes originate from noncatalytic ancestors (Todd et al., 2002). The direction of 
evolution is usually evident from the nature of the superfamily and its members, and by a phylogenetic 
analysis (Todd et al., 2002). Due to the loss of the N-lobe, linker region and residues that play a functional 
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Fig. 2 Multiple sequence alignment of KIND (kinase non-catalytic C-lobe domain)-containing proteins.  
The alignment has been built taking non redundant representatives of each family retrieved by the PSI–BLAST analysis (Altschul et al., 
1997). The sequences were aligned starting from the most similar ones and adding members of the other families. The final multiple 
alignment was manually refined. Sequences are indicated using the database accession number followed by the species. The starting and 
ending residues are reported before and after the corresponding sequence. The consensus in 70% of the sequences, not including the kinases, 
is reported below the alignment; h, l, p, t and – indicate hydrophobic, aliphatic, polar, turn-like and negative residues, respectively. Capital 
letters denote conserved amino acids. Hydrophobic residues are highlighted in blue, aliphatic residues in cyan, polar residues in green, 
negative residues in pink and other conserved residues in yellow. The two asparic residues in the protein kinase sequences involved in the 
catalytic function are in bold red type. The red boxes indicate the C-lobe subdomains (VIa–XI); following the classification reported by Hanks 
et al. (Hanks et al., 1988), the conserved and variable motifs are indicated with unbroken and broken boxes, respectively. The protein kinase 
C-lobe consensus is in red text. The secondary-structure prediction (Sec.Str.Pred.) is taken from the consensus of the alignment, not including 
the kinases (Rost et al., 1994) (upper case indicates elements predicted with expected average accuracy >82%; lower case text indicates 
elements predicted with expected average accuracy <82%). The secondary-structure elements of the p21-activated kinase 1 (PAK1) 3D 
structure (PDB code: 1F3M) (Lei et al., 2000) are shown as red cylinders (α helices, αD–αI) and red arrows (β strands, β7–β8); the catalytic 
loop is indicated with a blue line and the activation loop with a green line. This multiple sequence alignment (alignment number 
ALIGN_000545) has been deposited with the European Bioinformatics Institute 
(ftp://ftp.ebi.ac.uk/pub/databases/embl/align/ALIGN_000545). Abbreviations: Ce, Caenorhabditis elegans; Cs, Ciona savignyi; Dm, 
Drosophila melanogaster; Hs, Homo sapiens; Mm, Mus musculus; E, strands; H, helices. Reproduced with permission from Ciccarelli et al. 
(2003). 
 
catalytic role, the KIND domain appears to be a case of a nonenzyme within a superfamily that otherwise 
embodies protein kinases. Moreover, the kinase domain is apparently an ancient module, since its ancestor 
predates the divergence of Bacteria, Archaea and Eukaryotes (Leonard et al., 1998). In contrast, the KIND 
domain is present only in Metazoa, signifying that it is the ‘odd one out’ in the superfamily. Paired 
nonenzymes are found to retain a ligand binding capacity though the binding properties of their enzymatic 
precursors are likely to change (Todd et al., 2002). The PAK1 C-lobe communicates substrate recognition 
(Knighton et al., 1991a); association of the inhibitory switch (IS) hence blocking the deep cleft with the 
kinase inhibitor (KI) segment; and rearrangements to the inhibitory conformation of the activation loop, 
adopting multiple conformations (Lei et al., 2000; Lei et al., 2005). In addition, the same C-lobe surface is 
an interaction site for the smaller N-lobe and a phosphorylation target (Lei et al., 2000). Conclusively, these 
data advocate an interaction and/or regulatory potential for the KIND domain.  
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Fig. 3 Domain construction of the KIND family proteins. 
The domain nomenclature is according to the SMART database (Schultz et al., 1998). Hs Spir (CAD19439); Cs PEM-5 
(BAA36293); Hs PTP-BAS (Q12923), Xl FRIED (AAR97566), Mm very-KIND (CAE30489). Abbreviations: Hs, Homo 
sapiens; Cs, Ciona savignyi; Xl, Xenopus laevis; Mm, Mus musculus; B41, band 4.1 homologue domain; CC, coiled-coil; 
FYVE, Fab1, YOTB, Vac1, and EEA1; GEF, guanine nucleotide exchange factor for Ras-like small GTPases; GEFN, 
RasGEF N-terminal domain; JNK, c-Jun N-terminal kinase; KIND, kinase non-catalytic C-lobe domain; PDZ, domain 
present in PSD-95, Dil and Zo-1/2; PTPc, protein tyrosine catalytic domain; WH2, Wiskott-Aldrich syndrome homology 
region 2.  
 
In fact, recently we reported that the Spir family KIND domain inhibits the actin nucleation by Cappuccino 
(Capu) family formins (Quinlan et al., 2007) (Fig. 3). The highly conserved eukaryotic formin family is 
implicated in a wide range of cellular processes, including cytokinesis, cell polarization and embryonic 
development (Emmons et al., 1995; Zeller et al., 1999). The most highly conserved feature of formins is two 
contiguous located formin homology domains, FH1 and FH2 (Castrillon & Wasserman, 1994), that are 
engaged in actin assembly (Evangelista et al., 1997; Pruyne et al., 2002). The Drosophila protein 
Cappuccino is a subclass representative of actin nucleating formins (Higgs, 2005; Quinlan et al., 2007). 
While competing with actin filaments and microtubules the Drosophila and mammalian Spir KIND domain 
binds the formin homology 2 (FH2) domain of Cappuccino (or its mammalian homologue formin-2) at a 
ratio of 2:2 (two KIND monomers/one FH2 dimer), displaying an evolutionary conserved interaction 
(Quinlan et al., 2007). Furthermore, the interaction of the Spir KIND domain with Capu enhances the actin 
nucleation by Spir. Interestingly, the KIND domains of the protein VKIND (Mees et al., 2005) did not bind 
the Formin-2 FH2 domain, emphasizing the specificity of the interaction (Quinlan et al., 2007). These data 
disclose the first interaction and regulatory function properties of the novel KIND domain.  
The precise functional role of the KIND domains in the remaining proteins included in the KIND protein 
family (Fig. 3) is still to be elucidated. Nonetheless, Herrmann et al. (2003) reported that a region consisting 
of the long N-terminal splicing variant of protein tyrosine phosphatase (Mm PTP-BL/Hs PTP-BAS) 
harboring the KIND domain associates with the midbody and γ-tubulin at centrosomes during cytokinesis, 
suggesting a regulatory role (Herrmann et al., 2003). In tightly controlled protein tyrosin phosphatases 
(Mm PTP-BL and Xl FRIED, both similar in structure) the KIND module is located at the very N-terminal 
portion (Herrmann et al., 2003; Itoh et al., 2005) that is in direct vicinity to a FERM (acronym of four point 
one, Ezrin, Radaxin, and Moesin) domain, by which the phosphatases are directed to the cell cortical area 
and bind to a number of cell surface receptors as well as the actin cytoskeleton (Chishti et al., 1998; Pearson 
et al., 2000) (Fig. 3). In addition, FERM binding to 1-phosphatidylinositol-4,5-bisphosphate (PIP2) has been 
described (Hamada et al., 2000). Next to the FERM domain, numerous PDZ domains are positioned (five in 
Mm PTP-BL and six in Xl FRIED). PDZ (domain present in PSD-95, Dil and Zo-1/2) domains are able to 
interact selectively with internal sequences and the C-termini of their target proteins, along with 1-
c 
c 
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phosphatidylinositol phosphate (PIP) (Erdmann, 2003). Given the arrangement of the KIND domain in a 
neighborhood of anchoring and scaffolding domains in the non-receptor subtype protein tyrosine 
phosphatases, strongly implies its protein-protein interaction potential and can expand the perceptive of 
functional involvement of these PTPs.  
An appealing case is the modular structure of the guanidine exchange factor (GEF) VKIND as two 
homologous KIND domains are arranged in the N-terminal region in a tandem like fashion (Mees et al., 
2005). The novel eukaryotic protein bears a name attributed to the dual occurrence of two KIND domains 
(KIND1 and KIND2) in its structure. Recently, the binding competence of the second KIND domain to the 
microtubules-associated protein 2 (MAP2) has been shown (Huang et al., 2007). Ortholog genes coding for 
structural MAP2 are found only in Metazoa and are spliced in several alternative ways (Dehmelt & Halpain, 
2005), producing proteins that contain variable number of microtubule-binding repeats near the C-terminus 
(Lewis et al., 1988; Kalcheva et al., 1995). Each repeat is featuring a conserved KXGS phosphorylation site 
recognized by the cAMP-dependent protein kinase (PKA) (Ozer & Halpain, 2000) and the microtubule 
affinity regulating kinase (MARK) (Drewes et al., 1995). MAP2 also interacts directly with F-actin, through 
an F-actin binding site located inside the domain harboring the microtubule-binding repeats (Roger et al., 
2004). Further, each family member has an amino-terminal projection domain of varying size which 
contains a distinctive PKA regulatory subunit (RII) binding domain (Malmendal et al., 2003) that is 
anchoring PKA to microtubules (Harada et al., 2002). Mammalian MAP2 is predominantly expressed in 
neurons (Menezes & Luskin, 1994) and is shown to segregate into nascent dendrites following axonogenesis 
in developing cortical and hippocampal neuronal cultures (Matus, 1990). Furthermore, MAP2 induces 
microtubule flexural rigidity (Felgner et al., 1997), microtubule bundles (Lewis et al., 1989; Lewis & 
Cowan, 1990) and neurites in Neuro-2a neuroblastoma cells; whereas ability of MAP2 to stabilize 
microtubules is necessary but not sufficient for this effect (Dehmelt et al., 2003). Intriguingly, cytoplasmic 
JNK phosphorylation of MAP2 in neurons regulates the dendritic complexity and length (Bjorkblom et al., 
2005). Linking the neuronally expressed VKIND and MAP2 proteins via the KIND2 interaction domain 
further elucidates the mechanisms of controlled dendrite outgrow.  
 
1.2  The guanine nucleotide-binding proteins  
The outset of higher organisms required regulation of four essential processes of their origin: cell 
proliferation, cell differentiation, cell-cell communication and cell movement. The final construction of a 
spectacular complexity and specificity demands the precise gathering, processing, manipulating and 
transmission of a staggering amount of information. To ensure information flow specific receptors receive 
molecular signals and initiate cellular respond. The mechanism of long- and short-rangesignaling involves 
guanine nucleotide binding proteins (GTP-binding proteins or G proteins) that act as molecular switches. 
GTP-binding proteins fall into five main superfamilies: 1) heterotrimeric G proteins (α, β, γ subunits) 
(Marrari et al., 2007); 2) monomeric small 20 to 25-kD Ras-like GTPases (Park & Bi, 2007); 3) translation 
factors (EF-G, EF-Tu, IF-2, RF-3) (Avarsson, 1995); 4) translocation factors (SRP, SRP-R) (Egea et al., 
2005; Bange et al., 2007); and 5) large GTP-binding proteins (Dynamin, GBP, Mx) (Praefcke & McMahon, 
2004; Vestal, 2005; Haller et al., 2007). 
The Ras superfamily members, Ras GTPases, cycle between an OFF (GDP bound) and an ON (GTP 
bound) state, as transition into the active state is accelerated by guanine nucleotide exchange factors 
(GEFs). The VKIND protein studied in the course of this work represents a newly discovered Ras-specific 
GEF.  
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1.2.1  The Ras superfamily  
In the early 1960s four acute transforming retroviruses were isolated leading by 1983 to the identification of 
three human transforming genes (H-Ras, K-Ras, N-Ras) (Malumbres & Barbacid, 2003) which in turn 
became the founding members of the Ras (Rat sarcoma) superfamily. In present day over 150 human 
members build up the Ras superfamily (Ras related) of small guanosine triphosphatases (GTPases), with 
conserved orthologs present in Drosophila, C. elegans, S. cerevisiae, S. pombe, Dictyostelium and Plantae 
(Takai et al., 2001; Colicelli, 2004). This superfamily can be subclassified into five major branches: Ras, 
Rho, Rab, Ran and Arf on the basis of sequence and functional similarities (monomeric G proteins) 
(Wennerberg et al., 2005). The Ras family (36 members, e.g. H-Ras, K-Ras, N-Ras, M-Ras , R-Ras, TC21, 
Rheb, Rad, Gem, Rap1, Rap2, RalA and B) serves as signaling nodes responding to various extracellular 
stimuli and has critical roles in human oncogenesis (Vojtek & Der, 1998; Repasky et al., 2004; Wennerberg 
et al., 2005). Nevertheless, several Ras family proteins (Rerg, Noey2 and D-Ras) act rather as tumor 
suppressors (Colicelli, 2004). Like Ras, the Rho family (Ras homologues; 20 members, e.g. RhoA, Rac1, 
Cdc42, Rnd) regulatessignaling networks that mediate actin organization, cell cycle progression and gene 
expression (Etienne-Manneville & Hall, 2002). Initially described as Rho, Miro proteins appear to form 
their own subgroup, that instead of modifying the cytoskeleton oversees the integrity of mitochondria 
(Wennerberg & Der, 2004). The most numerous Rab family (Ras-like proteins in brain) of 61 members 
directs intracellular vesicular transport and protein trafficking along the endocytic and secretory pathways 
(Zerial & McBride, 2001). The single human Ran protein (Ras-like nuclear) defines a distinct subgroup and 
facilitates directed nucleocytoplasmic transport of RNA as well as proteins (Weis, 2003). Ran GDP/GTP 
cycling also controls mitotic spindle and nuclear envelope assembly along with DNA replication (Li et al., 
2003). The Arf family (ADP-ribosylation factor; 27 members, e.g. Arf1-6, Arl1-11, Sar) is involved in 
regulation of endocytosis, vesicular assembly and transport (Nie et al., 2003; Memon, 2004). Additionally, 
nine proteins (e.g. SRPRB, RabL2A, RabL3) remain ‘unclassified’ since neither structural nor functional 
data relates them to any of the major subfamilies (Wennerberg et al., 2005).  
 
1.2.2  Structure and regulation of Ras GTPases  
The groups of Sung-Ho Kim and Fred Wittinghofer provided the first high resolution crystal structures of 
Ras proteins in the late 1980s (de Vos et al., 1988; Pai et al., 1989) as well as the crystal structure of 
mutated Ras proteins soon after (Krengel et al., 1990; Tong et al., 1991). A single point mutation causes the 
functional differences between the normal human H-Ras and its oncogenic allele (Reddy et al., 1982), but 
almost no structural discrepancies. Transforming alleles encode GTPases with greatly reduced (at least 300-
fold) intrinsic enzymatic activity (Gibbs et al., 1984; Trahey & McCormick, 1987). Ras proteins become 
activated by releasing GDP and binding to GTP which is greatly accelerated by RasGEFs (by several orders 
of magnitude)  (Wolfman & Macara, 1990; Vetter & Wittinghofer, 2001). The intrinsic slow GTPase 
activity is then highly increased by a GTPases-activating protein (GAP) (Trahey et al., 1988) resulting in 
hydrolysis of GTP to GDP, inactivation of the Ras protein and signal transduction abolishment. The Ras 
proteins share a set of conserved GDP/GTP binding motif elements reading: G1, GXXXXGKS/T 
(phosphate binding site; interacts with the β- and γ-phosphates); G2, T (interacts with a Mg2+ ion); G3, 
DXXGQ/H/T; G4, T/NKXD (interacts with the nucleotide base); and G5, C/SAK/L/T (Saraste et al., 1990; 
Bourne et al., 1991). Together these motives assemble an universal 20-kD structural fold for GTP-binding 
proteins - G domain (Ras residues 5-166) - with a canonical switch mechanism operating the nucleotide 
binding and hydrolysis (Wittinghofer & Pai, 1991). The G domain architecture is a typical mixed six-
stranded β sheet and five α helices (de Vos et al., 1988). Conformational differences of the two nucleotide-
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bound states are usually subtle and correspond primarily to the designated switch I (Ras residues 32-38, L2-
β2-region) and switch II (Ras residues 59-67, β3/α2-region) regions (Milburn et al., 1990). In the 
triphosphate-bound form, two γ-phosphate oxygens interact via hydrogen bonds with the main chain NH 
groups of the invariant Thr35 and Gly60 Ras residues in the switch I and II, respectively (Vetter & 
Wittinghofer, 2001) (Fig. 4A). The glycine originates from the DXXG motif and the threonine is 
additionally involved in binding Mg
2+
 through its side chain (Vetter & Wittinghofer, 2001) (Fig. 4B). 
Remarkably, the trigger for the conformational change is presumably universal constituting a loaded spring 
mechanism which upon γ-phosphate release after GTP hydrolysis relaxes both switch regions into the GDP-
specific form (Vetter & Wittinghofer, 2001) (Fig. 4A).  
 
1.2.3  Lipid modification and membrane targeting  
In 1980 a key observation revealed the association of retroviral v-Ras proteins with the inner surface of the 
plasma membrane (Willingham et al., 1980), a crucial biochemical requirement for cellular transformation 
(Willumsen et al., 1984). The majority of Ras subfamily proteins bear a C-terminal CAAX tetrapeptide (C, 
cysteine; A, aliphatic; X, any amino acid) sequence (Cox & Der, 2002). The cytoplasmic farnesyltransferase 
transfers a farnesyl moiety from farnesyl pyrophosphate to the cysteine of all Ras isoforms (Reiss et al., 
1990). Subsequently, at the ER the AAX tripeptide is endoproteolyticly processed by the endopeptidase 
Rce1 (Ras and a factor converting enzyme) (Boyartchuk et al., 1997; Kim et al., 1999). The resulting C-
terminal isoprenylated cysteine is then methyl esterified (Zhang & Casey, 1996). In addition, for N-Ras a 
palmitoyl lipid moiety (or two moieties for H-Ras) is attached to cysteines adjacent to the farnesylated 
cysteine (Lobo et al., 2002; Smotrys & Linder, 2004). Palmitoylation constitutes a membrane-targeting 
sequence that dictates the interaction with various membrane compartments and the Ras proteins trafficking 
to the plasma membrane through the exocytic pathway (Apolloni et al., 2000; Wennerberg et al., 2005). The 
association of Ras with the plasma membrane has been observed to be stable (Niv et al., 2002). However, 
the distinct targeting of Ras isoforms to transient cholesterol-dependent assemblies (rafts) laterally 
segregated on the plasma membrane affects either stimulatory or inhibitory their responsiveness to 
extracellular signals (Eisenberg & Henis, 2008 and citations therein). ‘Lipid rafts’ are termed to be small 
cholesterol-enriched assemblies which are complexed with proteins (Hancock, 2006). H-Ras·GDP has 
higher affinity to rafts, whereas H-Ras·GTP is targeted preferentially to nonrafts (Rotblat et al., 2004). N-
Ras·GTP associates with raft-like domains (Roy et al., 2005), while K-Ras interacts mainly with 
cholesterol-insensitive clusters or microdomains, due to the absence of palmitoyl residues (Prior et al., 
2003).  
 
1.2.4  The RasGEFs’ engagement: driving out the nucleotide 
The connection between mitogens and Ras was first reported by Kamata and Fremisco as they traced the 
epidermal growth factor (EGF) to stimulate GTP binding activity of Ras proteins (Kamata & Feramisco, 
1984). The signaling pathways started clarifying as growth-factor receptors with  tyrosine kinase activity 
(RTK) essential for transformation were found (Smith et al., 1986). Furthermore, the mammalian adaptor 
protein, GRB2, was proved to connect activated phosphorylated tyrosine protein kinase receptors through its 
single SH2 domain to the RasGEF SOS (son of sevenless) through its two SH3 domains (McCormick, 1993) 
unveiling the mechanism by which external molecules signal through the plasma membrane. SOS on its part 
facilitates the conversion of Ras·GDP to Ras·GTP enabling Ras·GTP to bind to effector proteins and launch 
signaling events through them (Milburn et al., 1990). Human SOS1, a large multidomain protein of 1333 
residues, contains a central catalytic module (SOS
cat
, residues 550 to 1050), that is sufficient for the 
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nucleotide exchange activity (Chardin et al., 1993). The SOS
cat
 segment includes a core region of significant 
sequence similarity to CDC25, a Ras-specific GEF  from S. cerevisiae, named CDC25 domain (residues 750 
to 1050) (Broek et al., 1987; Boguski & McCormick, 1993). The canonical recognition sites for SH3 
domains (PXXP; P, proline; X, any amino acid) are located in the C-terminal region, whereas the REM (Ras 
exchanger motif) is upstream of the CDC25 domain, which is responsible for allosterical stabilization of 
SOS by Ras·GTP (Margarit et al., 2003). Upon binding to RAS·GDP, SOS displaces the switch I and opens 
the nucleotide binding site by the insertion of a helical hairpin (αH and αI) into the Ras active site (Boriack-
Sjodin et al., 1998). The αH helix introduces a hydrophobic side chain (Leu938), which blocks Mg
2+
 binding, 
as well as an acidic side chain (Glu942), which disturbs the nucleotide α-phosphate binding site (Boriack-
Sjodin et al., 1998). Furthermore, the switch II conformation is distorted by Ala59, Gly60 and Gln61 of Ras 
turned inwards the P loop (phosphate binding site), preventing the coordination of magnesium and 
phosphate (Boriack-Sjodin et al., 1998). Thus the Ras-GEF interaction does not impede the binding sites for 
the base and ribose of GTP or GDP, allowing nucleotide release and reloading (Boriack-Sjodin et al., 1998).  
 
 
Fig. 4 Diagram of the universal switch mechanism. 
(A) Switch I and II domains are bound to the γ-phosphate of the GTP via the main chain NH groups of the invariant Thr35 and Gly60 
residues, in what might be considered as a loaded spring mechanism. Release of the γ-phosphate after GTP hydrolysis relaxes the switch 
regions into a different conformation. 
(B) Graphic representation of the GEF action, viewing common mechanistic principles. The high-affinity binding of the guanine 
nucleotide is accredited to the interaction of the phosphates with the P loop and the Mg2+ ion. The Mg2+ ion is forced out of its position 
by residues of the GNBP main chain, i.e. the Ala59 (in Ras and Rac), or from residues of GEF. Residues of the P loop are disrupted, 
causing the reorientation of its lysine (Lys16) toward carboxylates from the switch II region, such as the highly conserved Glu62 or in case 
of Ras the invariant Asp57. In a push-and-pull mechanism, switch I is pushed out of its usual position, whereas switch II is pulled toward 
the nucleotide-binding site. Diagrams according to Vetter and Wittinghofer (Vetter & Wittinghofer, 2001). Abbreviations: GDP, 
guanosine diphosphate; GEF, guanosine nucleotide exchange factor; GNBPs, guanine nucleotide binding proteins; P, phosphor. 
 
In general, the common mechanistic principles of a GEF action on the GNBPs (guanine nucleotide binding 
proteins) is a postulated sequence of fast reversible reaction steps, that lead a binary protein-nucleotide 
complex through a trimeric GNBP-nucleotide-GEF complex to a binary stable protein nucleotide free 
complex (Vetter & Wittinghofer, 2001). In the process the magnesium ion is dislodged; switch I is pushed 
out of its normal position, while switch II is pulled toward the nucleotide binding site (the so called push-
and-pull mechanism); whereas structural disturbance of the P loop is imperative, resulting in a weak affinity 
of the GNBP for the nucleotide (Vetter & Wittinghofer, 2001) (Fig. 4B). This series of reactions is reversed 
when a nucleotide is rebound, predominantly GTP, since its intracellular concentration is 10 times higher 
than GDP, lowering the affinity of the GNBP for the GEF (Vetter & Wittinghofer, 2001). As catalysts, 
GEFs accelerate the formation of the equilibrium between GDP- and GTP-bound forms of the GNBPs 
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(Lenzen et al., 1998; Klebe et al., 1995). Moreover, the position of the equilibrium is defined by the relative 
affinities of GDP and GTP to the GNBP; the cytosolic nucleotide concentration; and the concentration of 
additional components, such as effectors, which incline the equilibrium toward the GTP-bound form (Vetter 
& Wittinghofer, 2001).   
 
1.2.5  The GEFs’ structural basis for activation skills  
Classification of GEFs into families is based on both sequence similarity and cognate small GTP-binding 
proteins (Cherfils & Chardin, 1999). The majority of GEFs are multidomain proteins comprising catalytic 
domains of 200-300 residues with one or several contiguous domains, involved in protein-protein or 
membrane interactions, promoting oligomerization, along with regions with yet unknown function (Cherfils 
& Chardin, 1999). Within a given subfamily, GEFs are conserved, as RasGEFs (GEFs for Ras proteins) 
contain a CDC25, Rho-GEFs a DH (dibble–homology), and Arf-GEFs a Sec7 domain, respectively (Vetter 
& Wittinghofer, 2001). However, in contrast to GNBPs themselves, the catalytic domains of distinct GEF 
classes are structurally unrelated, as determined by the crystal or NMR structures of representative GEFs of 
Ran (RCC1), Ras (SOS), various Arf-  and Rho-GTPases, as well as of EF-Tu (EF-Ts) (Vetter & 
Wittinghofer, 2001). Consequently, in spite of GEFs sharing very similar substrates (small GTP-binding 
proteins), their active sites display a divergence of both shape and sequence, thus a poor evidence of 
convergent evolution (Cherfils & Chardin, 1999). Unrelated guanine exchange factors, therefore, might have 
been acquired by diverging GTP-binding proteins, achieving responsiveness to novel types of signals 
(Cherfils & Chardin, 1999).  
Nevertheless, GEFs usually approach from different angles (Bos et al., 2007). They form extraordinarily 
large interfaces during complexion with the G proteins, recognizing most notably the switch II regions and 
in consequence executing an analogous solution to nucleotide expulsion and rebinding (Cherfils & Chardin, 
1999) (Fig4B). Intriguingly, exclusive to plants RopGEFs that do not exhibit any homology to animal 
RhoGEFs, also show common action in perturbing the interaction surface in the P loop and magnesium-
binding site (Thomas et al., 2007). Rop (Rho of plants) proteins belong to the superfamily of small G 
proteins (Rho family of Ras-related) and are vital regulators of growth, development and plant responses to 
various environmental stimuli (Berken et al., 2005).  
 
1.2.6  Rigid regulation of GEFs  
In some GEF proteins two different GEFs domains are combined or even GAP domains are introduced (Bos 
et al., 2007). For example, SOS1 and SOS2 join the DH-PH (dibble homology-pleckstrin homology) 
domain specific for Rac with the REM and CDC25 domains specific for Ras (Bos et al., 2007). Moreover, 
GEFs commonly outnumber the G proteins (Garcia-Mata & Burridge, 2007), raising the urge for tight 
activity regulation. Almost all GEFs are multidomain proteins, harboring lipid or protein interaction 
domains, allowing controlled localization signaling and scaffolding of protein complexes (Bos et al., 2007). 
Again, SOS is recruited to the plasma membrane by the GRB2 adaptor protein in a SH2-SH3-domain 
mediated manner (Aronheim et al., 1994), while the extracellular signal-regulated kinase (ERK) regulates 
this translocation to a specific cell compartment, since SOS phosphorylation results in its dissociation from 
GRB2 (negative feedback) (Waters et al., 1995). Scaffolding SOS with GRB2 ensures action on Ras, 
whereas action on Rac requires the binding of SOS to a complex of Abi1/E3B1, Eps8, and PI3K (Innocenti 
et al., 2003). However, the same region of SOS mediates the interactions with GRB2 and Abi1/E3B1, which 
are consequently mutually exclusive (Innocenti et al., 2002). Additional modifications of SOS activity are 
implemented by allosterical regulation by Ras·GTP, which binds to parts of REM (also named RasGEFN) 
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and CDC25 and induces a 10-fold increase in the catalytic activity (Margarit et al., 2003). Conversely, this 
allosteric site is blocked by the DH (RhoGEF) domain, allowing no stimulation of RasGEF activity by 
Ras·GTP (Sondermann et al., 2004). Further autoinhibition of SOS is displayed by the N-terminal PH 
domain which is blocking the Rac binding site of the DH domain (Sondermann et al., 2004). In addition, the 
C-terminal proline-rich region of SOS is playing an inhibitory role decreasing the RasGEF activity 
(Aronheim et al., 1994).  
Besides directed translocation, autoinhibition by flanking N- and C-terminal domains and allosteric 
feedback modifications, a number of GEFs are regulated by direct binding of second messengers (e.g. 
cAMP, Ca
2+
, diacylglycerol) and posttranslational modification (Bos et al., 2007). The RapGEFs Epac1 and 
Epac2 contain cyclic nucleotide-binding (CNB) domains (Bos, 2006) which cover the binding site for Rap 
(Rehmann et al., 2006). Members of the RasGRP (guanyl nucleotide-releasing protein) family are build up 
by an N-terminal REM and CDC25 domains adjacent to C-terminal C1 domain as well as a pair of EF-hands 
(Ebinu et al., 1998). RasGRPs activate Ras and/or Rap in vivo in response to increased Ca
2+
 and DAG 
(diacylglycerol) concentrations (Ebinu et al., 1998) (Fig. 5). The conformation of the autoinhibitory region 
adjacent to the DH domain of the RhoGEF Vav1, with a calponin homology (CH) domain and an acidic 
(Ac) region presenting conserved tyrosines (Turner & Billadeau, 2002), is altered by a phosphorylation of 
the Tyr174 which results in the liberation of the catalytic site (Aghazadeh et al., 2000; Llorca et al., 2005).  
 
 
Fig. 5  Schematic view of the RasGEF/Ras regulation. 
Extracellular signals, mediated by receptor tyrosine kinases (RTKs), adhesion molecules and second messengers stimulate RasGEFs (blue 
ovals) that activate Ras (green ovals). The SPROUTY and ACK protein families bind to GRB2 and impede the activation of SOS. CBL 
proteins also act as ubiquitin ligases for RTKs which results in an inactive CRB2. Numerous GAPs (brown ovals) downregulate Ras by 
catalyzing the GTP hydrolysis. Diagram according to Malumbres and Barbacid (Malumbres & Barbacid, 2003). Abbreviations: ACK, 
acetate kinase; CBL, Casitas B-lineage lymphoma; DAG, diacylglycerol; GAP, GTPase activating protein; GRB2, growth factor receptor-
bound protein 2; Inositol-P, inositol monophosphate; NF1, neurofibromin; PLCε, phospholipase Cepsilon; PKC, protein kinase C; RasGRP, 
guanyl nucleotide-releasing protein; Ras, rat sarcoma; SOS, Son of sevenless.  
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1.2.7  Ras effectors andsignaling cascades 
Small G-proteins bind to their downstream effectors and induce conformational changes in functional 
domains, acting as timed biological molecular switches (biotimers) which determine functioning periods of 
activation (or inactivation) (Takai et al., 2001) and therefore the signal transduction intervals. Proteins with 
high affinity to GTP-bound form of GTPases are termed effectors. The Raf kinase (rapidly growing 
fibrosarcoma) (Rapp et al., 1983) was the first discovered mammalian protein with a strong affinity to 
activated Ras (Ras·GTP) (Moodie et al., 1993).  
The growing family of Ras effectors congregates meanwhile more than 10 members (e.g. AF6, Nore1, 
PI3K, PKCδ, PLCε, RalGDS, Raf, Rin1, Tiam1) (Repasky et al., 2004) (Fig. 6). These are characterized by 
a common subdomain in their otherwise unrelated protein body, a putative Ras binding domain (RBD) with 
an uniform ubiquitin fold (ββαββαβ) (Herrmann, 2003). Ras·GTP directly binds to Raf and triggers 
activation leading to conformational changes, phosphorylation (by the members of the Src kinase family) 
and hetero-oligomerization (Van Aelst et al., 1993; Marais et al., 1995; Park et al., 1996; Garnett et al., 
2005) (Fig. 7). In consequence Raf is localized to the cytoplasmic surface of the plasma membrane (Leevers 
et al., 1994). In addition, Prohibitin and 14-3-3 proteins complex with Raf and in turn regulate Ras ability of 
Raf activation (Kyriakis, 2007). A further signal modulating factor, a kinase suppressor of Ras (KSR) has 
been identified to function downstream of Ras, which upon Ras activation translocates to the plasma 
membrane, binds to Raf and blocks Ras signaling as well as MEK (mitogen and extracellular regulated 
kinase) and MAPK (mitogen-activated protein kinase) activation (Therrien et al., 1995; Therrien et al., 
1996). Activated mammalian Raf proteins (c-Raf-1, A-Raf, B-Raf) subsequently phosphorylate and activate 
the soluble MEK (MAP kinase kinase 1 and 2) at the plasma membrane (Dent et al., 1992; Kyriakis et al., 
1992) which then phosphorylates and activates the cytosolic MAP kinase (ERK, extracellular signal-
regulated kinase) (Crews et al., 1992; Matsuda et al., 1992). As a result the active MAP kinases translocate 
to the nucleus and induce gene expression (Katz et al., 2007) (Fig. 7).  
 
 
Fig. 6 Active Ras effectors pathways. 
Ras·GTP interacts with various effectors thus triggerssignaling cascades and consequently directs numerous 
cellular processes. Derived from Malumbres and Barbacid (Malumbres & Barbacid, 2003). Abbreviations: AF6, 
ALL-1 fusion partner on chromosome 6; NORE1, N-Oct-3 responsive element 1; Rin1, Ras interference 1; PI3K, 
phosphatidylinositol 3-kinase; PKCδ, Protein kinase Cδ; PLCε, phospholipase Cepsilon; Raf, rapidly growing 
fibrosarcoma; RalGDS, Ral guanine nucleotide dissociation stimulator; Tiam1, T lymphoma invasion and 
metastasis protein 1.  
Anaid Bedrossian  I  Introduction 
 
13 
Ras isoform-specific cellular responses are attributed to distinct post-translational lipid modifications of the 
isoforms which are set within their divergent C-termini (Rocks et al., 2006). These membrane-anchors 
ultimately enforce localization to diverse subcellular compartments (Silvius, 2002; Hancock, 2003) as a base 
for distinctive local Ras signal transmissions that propagate characteristic local cellular responses (Mor & 
Philips, 2006). 
Notably, further spatial separation of protein kinases and phosphatases creates cellular gradients of 
phosphorylated (active) forms of MEK and ERK, with high-level concentrations in the periplasmic site near 
the phosphorylation location and low-level ones at a distance from the membrane (Kholodenko, 2003). 
Several mechanisms, such as endocytosis of phosphorylated MEK, cytoplasmic streaming, recruitment to 
scaffolds and molecular motors are involved in the transmission of phosphorylation signals further into the 
cell (Kranenburg et al., 1999; Agutter et al., 1995; Garrington & Johnson, 1999; Verhey & Rapoport, 2001). 
 
 
Fig. 7 Diagram of the Ras signaling cascade upon activation of RTKs and G- protein coupled receptors. 
The recruitment of the guanine exchange factor SOS into a close proximity to the membrane anchored Ras triggers the ERK cascade 
which induces gene expression. Activated GPCRs stimulate ERK cascades either via transactivation of the RTKs that involves distinct 
cell type dependent mediators (i.e. calcium, Pyk2 and PKC and Src-family kinases), or by parallel pathways engaging PI3Kγ, PKC, Rap1 
and B-Raf. Representation according to Kholodenko (Kholodenko, 2003) as well as Wetzker and Bohmer (Wetzker & Bohmer, 2003). 
The membrane plane is indicated. Abbreviations: ERK, extracellular signal-regulated kinase; GPCR, G-protein-coupled receptor; GRB2, 
growth factor receptor-bound protein 2; HB-EGF, heparin-binding EGF; MEK, mitogen and extracellular regulated kinase; MP, 
metalloproteinase; PKC, protein kinase C; PI3Kγ, phosphatidylinositol 3-kinase γ; Pyk2, proline-rich tyrosine kinase 2; Ras, rat sarcoma; 
Raf, rapidly growing fibrosarcoma; Rap, Ras-related protein; RTK, receptor tyrosine kinase; SHC, Src homologous and collagen-like; 
SOS, Son of sevenless; TGFα, transforming growth factor-α. 
 
Further major noncanonical Ras effector targets among the Ras signaling pathways are the 
phosphatidylinositol 3-kinase (PI3K) as well as Ral and Rac guanine nucleotide exchange factors (Ral-GDS 
and Tiam1) (Rodriguez-Viciana et al., 1994; Feig et al., 1996; Lambert et al., 2002). When active PI3K 
generates the second messenger PIP3 (phosphatidylinositol-3,4,5-triphosphate), which recruits PDK1 
(phosphatidylinositol-dependent kinase 1) and AKT (also PKB, protein kinase B) to the plasma membrane 
(Cully et al., 2006). AKT is being activated by PDK1 phosphorylation and is suggested a crucial role in 
modulating cell death and proliferation (Cully et al., 2006). RalGEFs play a fundamental role in human cell 
transformation, tumor cell growth and cell survival (Chien & White, 2003; Rangarajan et al., 2004) since 
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Ralsignaling is found to regulate endo- and exocytosis, actin cytoskeletal organization, cell migration as 
well as gene expression (Feinstein, 2005). The stimulated Tiam1 (T lymphoma invasion and metastasis 
protein 1) RacGEF activity in the Ras-Rac cross talk is implicated in Ras-induced skin tumorgenesis 
(Malliri et al., 2002).  
A next family of Ras effectors is represented by the RASSF (Ras association domain family) proteins that 
function as human tumor suppressors (Tommasi et al., 2002). The Rab5-GEF, Rin1 (Ras 
interaction/interference), facilitates Ras-regulated endocytosis (Tall et al., 2001). Activation of PLCε 
(phospholipase Cepsilon) by PDGF is mediated by Ras, has demonstrated a crucial role of PLCε in 
carcinomas progression (Bai et al., 2004). Moreover, AF6 (Afadin) and PKCδ (protein kinase Cδ) are 
implied in a variety of cellular processes, such as cell adhesion and transcription, respectively (Toker, 1998; 
Zhang et al., 2005).  
While a large number of Ras effectors performs a plethora of tasks in response to extracellular cell stimuli, 
some of the divergent signaling pathways conduct significant cross talk, which conclusively converges at a 
certain level and confers a specific phenotype (Rajalingam et al., 2007). The growth factor signal 
transduction by Ras alone can dispose most if not all of the different phenotypes in the recipient cell 
(Rajalingam et al., 2007). Thereby, oncogenic Ras is able to transform cells both in vitro and in vivo 
(Barbacid, 1987) and by overstimulation of several pathways contributes to neoplastic processes (Bar-Sagi 
& Hall, 2000; Downward, 2003).  
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2.1  Chemicals 
Materials Supplier, Ordering # 
( α-32P )dCTP (6000 Ci/mmol) Amersham, Chalfont St. Giles 
(UK) 
2-Propanol  Merck, Darmstadt 
DABCO (1,4-Diazabicyclo 
(2,2,2) Octane) 
Sigma, Munich, D27802 
3 MM-Paper  Schleicher & Schuell, Dasel  
3AT:3Amino1,2,4-triazol  Sigma, Munich  
6-well-plate Greiner, 657 160 
Acetic acid  AppliChem, Darmstadt 
Acetone  Merck, Darmstadt 
Acrylamide/Bisacrylamide 19:1 
and 37.5:1  
Bio-Rad, Munich, 1610120 and 
1610125 
Adenine  Sigma, Munich, A9126 
Agar select  Sigma, Munich, A5054 
Agarose Ultra pure  Life Technology, Belgium, 15510-
027  
Ammonium acetate  Merck, Darmstadt 
Ammonium persulfate  Sigma, Munich, A3678 
Ampicillin Sodium crystalline Sigma, Munich, A9518 
AraC/HCL Sigma, Munich, C6645 
ATP Sigma, Munich 
Bacto Tryptone  Life Technology, Belgium 
Bacto-Agar  Difco Laboratories, Detroit (USA) 
Bacto-Pepton  Difco Laboratories, Detroit (USA) 
Bandage Drugstore, Würzburg  
Basal Medium Eagle (BME) Sigma, Munich, B 1522 
Benzamidin  Sigma, Munich 
Boric acid   Sigma, Munich, B0252 
Bottle Top Filter  
0,22 µm  
Nalge Nunc International, 
Wiesbaden  
Bovine Serum Albumin (BSA) Sigma, Munich, A 9418 
Bromphenol Blue  Sigma, Munich  
BSA powder  Sigma, Munich, A4503 
Calcium chloride  Sigma, Munich  
Cell culture dishes Sarstedt, Nümbrecht-Rommelsdorf  
Cell culture flasks  Sarstedt, Nümbrecht-Rommelsdorf 
Chloramphenicol Sigma, Munich, C0378 
Chloroform  Merck, Darmstadt 
Coomassie Blue G Sigma, Munich 
Cytosine β-D-arabinofuranoside 
hydrochloride (AraC) 
Sigma, Munich, C6645 
D(+)-Glucose Monohydrate  Merck, Darmstadt 
Diethylpyrocarbonate (DEPC)  Sigma, Munich, D5758 
Dimethylformamide (DMF) Sigma, Munich 
Dimethylsulfoxide (DMSO) Sigma, Munich, D2650 
Dithiothreitole (DTT)  Sigma, Munich  
DNA labeling kit Roche, Penzberg 
dNTPs  peQLab, Erlangen  
Dried milk powder Nestlé  
Dulbecco´s Modified Eagle 
Medium (DMEM) 
Life Technology, Belgium, 31330-
038 
Duralon-UV-Membranes Stratagene, 420114 
ECL-hyperfilm  Amersham, Chalfont St. Giles 
(UK) 
EDTA Sigma, Munich, E5134 
Eppendorf combitips Eppendorf, Hamburg 
Eppendorf tubes  Eppendorf, Hamburg 
Ethanol, abs.  AppliChem, Darmstadt 
Ethidium bromide Life Technology, Belgium 
Fetal calf serum (FCS) PAN Systems, Nürnberg  
Formaldehyde  Sigma, Munich, F1635 
Gentamycin sulfate Sigma, Munich, G 1264 
Glutathione Sepharose® 4B 
Amersham, Chalfont St. Giles 
(UK), 17075601 
Glycerol  Sigma, Munich  
Glycine  Merck, Darmstadt 
Greiner  tubes  Greiner, Frickenhausen  
HEPES  Sigma, Munich  
Hoechst Stain Solution Sigma, H 6024 
Hydrochloric acid  Merck, Darmstadt  
Hyperfilm™ MP  
Amersham, Chalfont St. Giles 
(UK), RPN3103K 
Imidazole Sigma, Munich, I 0125 
Immersion oil  Leica, 11513859 
IPTG Sigma, Munich, I6758 
IPTG  Sigma, Munich 
Kanamycin  Sigma, Munich, K1377 
LB Broth Base  Sigma, Munich, L3022  
L-glutamine Sigma, Munich, G1251 
Lipofectamine™ Invitrogen, Karlsruhe, 18324012 
Lithium acetate Sigma, Munich 
Magnesium acetate  Sigma, Munich 
Magnesium chloride Merck, Munich, M2670 
Magnesium sulfate Sigma, Munich 
Methanol  Rühl AG  
MOPS acid  Sigma, Munich, M3183 
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Moviol 4-88 Calbiochem-Novabiochem, 475904 
NAP-10 columns 
Amersham, Chalfont St. Giles 
(UK), 17085401 
Oregon Green -conjugated 
Phalloidin 
Molecular Probes, O-7466 
Parafilm® M Brand GmbH, Wertheim  
PBS Dulbecco’s (10x) Molecular Probes, 14200083 
PBS Dulbecco’s (1x) Molecular Probes, 14190169 
PCR-Tubes 0,2ml Eppendorf, 0030 124.332 
PCR-Tubes 0,5ml Eppendorf, 0030 124.502 
Pepstatin Sigma, Munich 
peqGOLD RNAPureTM peQLab, Erlangen 
Phenol Red Sigma, P 5530 
Phenol:Chloroform: Iso-
amylalkohol 
AppliChem, Darmstadt 
Phenylalanine  Sigma, Munich  
Pipes Sigma, Munich, P6757 
PMSF Sigma, Munich 
Poly Screen PVDF transfer 
membrane  
NENTM Life Science Products, 
Cologne 
Poly-L-Lysine Sigma, Munich, P 2636 
Ponceau S  Sigma, Munich  
Potassium  acetate  Merck, Darmstadt  
Potassium chloride  Sigma, Munich, P4504 
Potassium hydrogen phosphate Merck, Darmstadt  
Potassium hydroxide  Merck, Darmstadt  
Protein G-Agarose  Boehringer, 1 243 233 
Protran Nitrocellulose transfer 
membrane  
Schleicher & Schell, Dassel  
QuickHyb Stratagene, 201220 
Random Prime L. Kit Roche, 1004760 
Rhodamine-conjugated   
Phalloidin 
Molecular Probes, R-415 
Salmon sperm DNA Stratagene, 201190 
SDS ultra pure  Sigma, Munich, L4390 
Sodium acetate Sigma, Munich 
Sodium chloride  Sigma, Munich, S3014 
 Sodium dehydrogenate 
phosphate  
Merck, Darmstadt  
Sodium fluoride  Sigma, Munich  
Sodium hydrogen carbonate Sigma, Munich 
Sodium hydroxide  Sigma, Munich  
Sodium pyrophosphate Sigma, Munich 
Sterile filter Millex-GS  Millipore, Schwalbach  
TEMED Sigma, Munich, T9281 
Tris Base  Sigma, Munich, T1503 
Triton X-100  Sigma, Munich 
Trizole Life Technology, Belgium 
Trypsin Sigma, Munich, T 9935 
Trypsin Inhibitor Sigma, Munich,T6522 
Trypsin-EDTA  Life Technology, Belgium 
Tween 20 Sigma, Munich, P1379 
Tyrosine Sigma, Munich 
Uracil Sigma, Munich 
Urea Molecular Probes,15505027 
Water Sigma, W 3500 
Whatman round filter  Whatman, Maidstone (USA) 
Xylencyanole blue Sigma, Munich 
Yeast extract  Life Technology, Belgium 
β-Mercaptoethanol  Sigma, Munich 
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2.2  Enzymes 
Enzyme  Supplier, Ordering # 
Calf Intestinal Phosphatase (CIP)  NEB, M0290 S 
DNase  Sigma, D 5025 
Endonucleases  NEB and MBI-Fermentas 
Klenow Fragment  Roche, 1008404 
Pfu DNA-Polymerase  Promega, M 774B 
Pfx DNA-Polymerase  Invitrogen, 12344-024 
RNase A  Roche, 109169 
T4 DNA ligase  NEB, M0202 
Taq DNA-Polymerase  peQLab, 01-1030 
 
2.3  Antibodies 
2.3.1  Primary antibodies 
Antibody / Antigen Species 
Dilution 
 for stain 
Dilution  
for WB 
Supplier, Ordering # 
Anti-GST / anti-GST goat monoclonal — 1:10000 Amersham, 27-4577-01 
Anti-mVKIND / anti-mVKIND rabbit polyclonal 1:1000 1:300 immunoGlobe 
Living colors A.v. / anti-EGFP rabbit monoclonal — 1:100 Clontech, 8367-1 
Myc 9E10 / anti-Myc mouse polyclonal 1:28.6 1:200 Santa Cruz, sc-40 
 
2.3.2  Secondary antibodies 
Antibody Species 
Dilution 
for stain 
Dilution 
for WB 
Supplier, Ordering # 
Anti-goat horseradish-peroxidase linked sheep polyclonal — 1:5000 Amersham, NA933 
Anti-mouse horseradish-peroxidase linked sheep polyclonal — 1:4000 Amersham, NA9310 
FITC-conjugated anti-mouse donkey polyclonal 1:250 — Dianova, 715-095-151 
TRITC-conjugated anti-mouse goat polyclonal 1:250 — Dianova, 715-025-151 
TRITC-conjugated anti-rabbit donkey polyclonal 1:250 — Dianova, 711-025-152 
 
2.4  Oligodeoxynucleotides 
All oligonucleotides were acquired from MWG BIOTECH of standard HPSF quality, diluted in MPH2O to 10 
pmol/µl and stored at -20°C. For detailed information see Appendix II. 
 
Primer Sequence 
5’-mVK-in situ 
5’ cg GGATCC GCC GCC GCC ATG GAG CAG AAG CTG ATC TCC GAG GAG 
GAC CTG CAG GCC ATG GAC CCA GCC TCC 3’ * 
3’-mVK-in situ 5’ gc TCTAGA C CAG GGA GTA GAT GTG AGC CTC 3’ * 
5’-mVK 5’ gc GGA TCC GAG AAG GGT CCT TAC TTC TTG 3‘ * 
3’-mVK 5’ cg GAA TTC CTA CTG GAA TGT GGC CTT CAT 3‘ * 
 * Underlined nucleotide bases mark endonuclease restriction sites. 
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2.5  Plasmids 
 
Plasmid Description Marker Supplier 
pBACe3.6  pUC-derived cloning plasmid used for preparing BAC libraries Chloramphenicol — 
pBluescript II high copy number ColE1–based phagemid cloning vector Ampicillin Stratagene 
pcDNA3 mammalian CMV promoter driven high–level constitutive expression vector Ampicillin 
Molecular 
Probes 
pcDNA3.1(V5- 
HiS)TOPO 
pcDNA3-derived mammalian constitutive expression vector Ampicillin Invitrogen 
pEGFP-C1 
mammalian CMV promoter driven EGFP C-terminally fusion protein 
expression, optimized to mammalian codon usage 
Kanamycin Clontech 
pGEX-6P-1 
vector for high–level expression of C–terminally GST–tagged proteins in 
bacteria 
Ampicillin Pharmacia 
pSport1 cloning pUC-derived phagemid cloning vector Ampicillin Invitrogen 
 
 
2.6  Organisms and cell lines 
2.6.1  Bacterial strains 
Strains Description Supplier/Reference 
E. coli Dh5α 
F–, ø80dlacZΔM15, Δ(lacZYA-argF)U169, deoR, recA1, endA1, 
hsdR17(rK–, mK+), phoA, supE44, λ–, thi-1, gyrA96, relA1 
Gibco BRL/ Hanahan, 1983 
Rosetta F- ompT hsdSB(rB
-mB
-) gal dcm pRARE2 (Camr) Novagen, #70953-3/Kane, 1995 
 
2.6.2  Eukaryotic cell lines 
Line Description Reference 
primary cells murine granular cells primary cerebellar mouse cells  
HeLa human cervical epithelial carcinoma cell line MSZ stock 
NIH 3T3 continuous immortalized mouse embryo fibroblast cell line 
America Type Culture Collection 
(ATCC) CRL-1711 
 
2.6.3  Mice  
Organism  Description Reference 
C57BL/6 mouse inbred strain, substrain 6 separated prior to 1937 Little, 1921 
CD1 albino outbred mouse strain Charles River, 1959 
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2.7  Analytical kits 
Analytical kits  Supplier, Ordering # 
ECL Western Blotting Detection  Amersham, RPN 2106 
NucleoTrap® Gel Extract Kit   Macherey Nagel, 636018 
One Step RT-PCR Kit  Qiagen, 10212 
pcDNA3.1(V5- HiS)TOPO TA Expression Kit  Invitrogen, K4900-01 
pegGOLD dNTP Set  peQLab, 20-2010 
Plasmid Giga Kit  Qiagen, 10191 
Plasmid Maxi Kit  Qiagen, 12163 
QIAquick PCR purification Kit  Qiagen, 28106 
RNA Isolation Kit   Stratagene, 200345 
 
2.8  Standards  
Standards  Supplier, Ordering # 
1 kb ladder for DNA  Invitrogen, 15615-024 
Kaleidoscope prestained standards  Bio-Rad, 1610324 
Precision Plus Protein dual color standards  Bio-Rad, 1610374 
Pre-stained Molecular Weight Standard Mixture for protein  Amersham, RPN 800 
 
2.9  Equipment 
Apparatus  Supplier  Apparatus  Supplier 
3100 Avant Sequencer  Applied Biosciences 
 Fluorescent 
Microscope 
 Leica DMIRBE 
Agarose electrophoresis gel 
chamber 
 Stratagene 
 
Freezer  Liebherr, Nunc 
Autoclave   Webeco  Ice maker  Scotsman 
Blotting chamber  Hoefer  Incubator  Heraeus, Memmert 
Cell freezing container  Nalgene  Photometer  Hitachi 
Centrifuges  Eppendorf, Sorvall, Heraeus  Pipettes  Eppendorf, Abimed 
Computer  Apple  Precision balance  Sartorius 
Contrast microscope  Fluovert FS, Leitz  Shaker  Bellco Biotechnology 
Counting chamber  Neubauer (improved)  Sterile bench  Heraeus 
Digital camera  Hamamatsu C4742-95  Thermocycler  Eppendorf, Perkin Elmer 
Digital chemical balance  Sartorius  UV crosslinker  Stratagene 
Film processor   Kodak     
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3.1  Molecular Biological Methods 
3.1.1 Separation of nucleic acids by gel electrophoresis 
3.1.1.1  Agarose gel electrophoresis 
Agarose gel electrophoresis is a technique used to separate DNA fragments based on their size. DNA is 
negatively charged in solution and is forced to migrate through an agarose gel to the positive pole by an 
electric field. Migration rate is inversely proportional to the logarithm of the number of base pairs. Longer 
molecules move more slowly due to their entrapment in the gel matrix. Gel agarose concentration is chosen 
to be appropriate for the size of DNA fragments. Concentration of 0.7%-agarose gels shows good resolution 
of large DNA molecules (up to 12 kb), whereas 2%-agarose gels are suitable for smaller molecules (down to 
0.2 kb). DNA can be visualized by illumination by UV light based on the incorporation of fluorescent dye 
(ethidium bromide) into the DNA helix. If the DNA was to be used for further cloning procedures only brief 
exposure to UV light was performed to minimize the risk of DNA damage. The agarose (% (w/v) = gel 
concentration) was dissolved by boiling in 0.5x TBE buffer (microwave). After cooling to 60°C ethidium 
bromide was added to a final concentration of 5 µg/ml. DNA-loading buffer was added to the DNA samples. 
Gels were run usually at 100 volts for 30-60 min. The agarose gel areas containing the DNA fragments of 
interest were excised and DNA was recovered from the gel by employing NucleoTrap® Gel Extract Kit 
(Macherey Nagel, →2.7). 
 
10x TBE buffer  DNA-loading buffer 
Tris-Base, pH 8.3 0.89 M  Tris-Base, pH 7.4 9 mM 
EDTA 25 mM  EDTA 0.45 mM 
Boric acid 0.89 M  Glycerin 46% (v/v) 
   SDS 0.2% (w/v) 
   Bromphenol blue 0.05% (w/v) 
 
 
3.1.1.2  Northern blot 
Northern blot is a method used to study gene expression. Isolated and purified total RNA from organs of an 
adult C57BL/6 mouse (→2.6.3) was separated by gel electrophoresis and transferred onto a Duralon UV 
membrane (Stratagene) by capillary action with a high salt solution. The following hybridization step 
allowed the detection of RNA with a radioactive labeled probe complementary for the RNA fragment in 
question. The specifically bound probe was visualized by autoradiography. For the gel, 1 g agarose was 
dissolved in 73.4 ml DEPC treated MPH2O by boiling (microwave). Solution was cooled to 50°C, next, 
16.6 ml 37% formaldehyde solution and 10 ml 10x formaldehyde gel running buffer (FGRB) were added. 
The gel was poured into the gel chamber under the chemical hood. The gel was pre-run for 5 min at RT and 
5 V/cm. 30 µg RNA were dissolved in 10 µl DEPC treated MPH2O. RNA sample buffer was added to a final 
volume of 20 µl and samples were incubated at 65°C for 15 min. Next, samples were chilled on ice, 
centrifuged for 5 s and complemented with 3 µl of a 1 µg/µl ethidium bromide stock solution. The gel was 
pre-run for 5 min at RT and 5 V/cm. Samples were loaded onto the gel and electrophoresis was carried out 
until the bromphenol blue line migrated approximately 8 cm. The gel was then soaked in 0.05 N NaOH for 
20 min and subsequently rinsed in DEPC treated MPH2O and further soaked in 20x SSC (3 M NaCl, 0.3 M 
Na-citrate) for 45 min. The gel containing the RNA of interest was blotted onto the Duralon membrane 
(Stratagene) by capillary force in 20x SSC for 6-18 h. Membrane was then briefly washed in 2x SSC and 
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placed under a UV crosslinker (Stratagene) with default settings. 1000 bp DNA probes were labeled with 
(α-32P)dCTP by DNA random primed labeling kit (Roche) following the manufacturer’s instructions. The 
radioactively labeled DNA fragment was hybridized employing QuickHyb solution (Stratagene). The 
QuickHyb solution was incubated for 20 min at 42°C. The roller oven was pre-heated to 65°C. The Duralon 
membrane containing the RNA and a grid filter were briefly dipped in DEPC treated MPH2O. The membrane 
was rolled onto the grid and placed into the roller bottle. 15 ml pre-warmed QuickHyb solution was added 
and the air bubbles were removed with a pipet. The blot was pre-hybridized for 30 min at 65°C. 0.6 ml 
QuickHyb solution and 30 ng (α-32P)dCTP labeled double stranded DNA were briefly boiled, complemented 
with 1000 µg salmon sperm DNA and added onto the membrane. Thereafter, hybridization was performed 
for 4 h at 65°C in a roller oven. The membrane was then washed twice with 2x SSC/0.1% SDS solution for 
15 min at RT. A further washing step was exercised twice with 0.1x SSC/0.1% SDS solution for 15 min at 
60°C. Finally, autoradiograms were prepared. 
 
10x FGRB  RNA sample buffer 
NaOAc 20,7 mM 
 
37% formaldehyde solution 18.9% (v/v) 
EDTA 2.6 mM 
 
formamide  66% (v/v) 
MOPS 50 mM 
 
10x FGRB 9.4% (v/v) 
 ad 500 ml DEPC treated MPH2O 
 
0.5 % bromphenol blue solution 5.7% (v/v) 
 adjust to pH 7.0 with 2N NaOH 
 
 Store at – 20° 
 
20X SSC 
NaCl 3 M 
NaCitrate 341 mM 
 add 1000 ml MPH2O 
 adjust pH to 7.0 with 1M HCl 
 
 
3.1.2  Isolation of nucleic acids from aqueous solutions 
3.1.2.1  Alcohol precipitation 
Ethanol precipitation is a rapid technique to concentrate DNA. A DNA precipitate is allowed to form in 
ethanol in the presence of moderate concentration of monovalent cations (0.1 volumes of 3M NaOAc). 
Initial precipitation was done with 2 to 2.5 volumes of ice cold absolute EtOH for 20 min at low temperature 
(-20°C). DNA was recovered by centrifugation at 15000 g for 20 min at RT. Next, the precipitate was 
redissolved in ice cold 70% ethanol, followed by a brief centrifugation eliminating the residual salt. After 
drying the pellet was resuspended in an appropriate buffer or MPH2O. Isopropanol can be used instead of 
ethanol. One volume isopropanol was added to the aqueous solution. Precipitation was achieved by mixing 
and incubation for 10 min at RT. DNA precipitate was collected by centrifugation at 15000 g for 10 min at 
RT. Isopropanol and salt were removed by subsequent wash with ice cold 70% ethanol.  
 
3.1.2.2  Isolation of plasmid DNA 
Isolation of plasmid DNA from bacterial cells was carried out by using Qiagen Plasmid Maxi Kit and 
Qiagen Plasmid Giga Kit following the manufacturer’s instructions (→2.7). 
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3.1.2.3  Isolation of total RNA 
To isolate total RNA, 50-100 mg tissue was homogenized in 1 ml peqGOLD RNAPure
TM 
using an 
UltraThurrax homogenizer. If a cell monolayer was treated, the supernatant was removed and cells were 
washed with PBS. 1 ml peqGOLD RNAPure
TM 
(peQLab) was applied to 10 cm
2
 and cells were gently 
resuspended by pipeting. Subsequently, samples were incubated for 5 min at RT. 0.2 ml chloroform (per 
1ml peqGOLD RNAPure
TM
) were added, samples were vortexed thoroughly for 15 s and incubated for 3-
10 min at RT. Following centrifugation at 12000 g for 5 min at RT the upper aqueous phase was separated 
(containing the RNA) and was mixed with 0.5 ml isopropanol in a fresh tube. After incubation for 5-15 min 
at RT, RNA was precipitated by centrifugation at 12000 g for 10 min at 4°C. The supernatant was discarded 
and pellet was washed twice with 1 ml 75% ethanol (12000 g, 10 min, 4°C) and briefly air-dried. Finally the 
pellet was dissolved in DEPC treated MPH2O by pipeting, photometrically examined (→3.1.2.5) and stored 
at -80°C.  
  
3.1.2.4  Gel DNA recovery  
Following gel electrophoresis analysis DNA fragments of interest were excised and recovered from the gel 
by using the NucleoTrap® Gel Extract Kit (Macherey Nagel, →2.7) following the manufacturer’s 
instructions.  
 
3.1.2.5  Quantification of nucleic acids by spectrophotometry 
ssDNA, dsDNA and RNA absorb light in ultraviolet range, most strongly in 254-260 nm range. The 
measurement at 260 nm allows a calculation of the dsDNA concentration. An OD260 of 1 corresponds to 
approximately 50 µg/ml of dsDNA. The ratio between measurements at 260 nm and 280 nm provides an 
estimate of the purity of the samples. Proteins absorb light at 280 nm. 
Formulas:  
C (double stranded DNA) = OD260 x factor of dilution x 50 [μg/ml]  
C (RNA and oligos) = OD260 x factor of dilution x 40 [μg/ml] 
1 µl DNA (or RNA) sample was dissolved in MPH2O (1:100) and photometrically examined (Hitachi). 
Nucleic acid concentration was calculated employing the formulas described above. 
 
3.1.3  Amplification of DNA by polymerase chain reaction 
3.1.3.1  PCR 
The polymerase chain reaction (PCR) is a powerful technique for oligonucleotide primer directed enzymatic 
amplification of a specific DNA sequence of interest. The PCR product is obtained from the DNA template 
in vitro applying a heat-stable DNA polymerase. An automated thermal cycler puts the reaction through 30 
or more cycles of denaturation of dsDNA, annealing of primers and polymerization. Denaturation separates 
the complementary strands and was carried out at 92 °C. Annealing temperature was calculated based on the 
primer sequence (Tm). Primers are single-stranded oligonucleotides complementary to the flanking areas of 
the targeted segment which serve as a starting point for DNA replication. During polymerization the enzyme 
catalyzes the synthesis of a new strand DNA. The optimal temperature varies according to the polymerase 
species. PCR products were visualized on an agarose gel (→3.1.1.1). 
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Taq PCR components (µl)  Pfu PCR components (µl)  Pfx PCR components (µl) 
Taq Pol buffer 10x 5  Pfu Pol buffer 10x 10  Pfx Pol buffer 10x 5 
MgCl2 (25 mM) 3  Plasmid DNA (~200 ng/µl) 1  Plasmid DNA (~200 ng/µl) 1 
Plasmid DNA (~200 ng/µl) 1  5’-Primer (10 pmol/µl) 2  5’-Primer (10 pmol/µl) 3 
5’-Primer (10 pmol/µl) 2  3’-Primer (10 pmol/µl) 2  3’-Primer (10 pmol/µl) 3 
3’-Primer (10 pmol/µl) 2  dNTPs (25 mM) 1  Pfx Pol (2.5 U/µl) 1 
dNTPs (10 mM) 1  Pfu Pol (3 U/µl) 1  MPH2O ad 50 
Taq (3 U/µl) 0.4  MPH2O ad 100  
MPH2O ad 50      
 
Standard 1-step PCR Program   Standard 2-step PCR Program 
# Step Temperature Time Cycle (s)  # Step Temperature Time Cycle(s) 
                          hot start                                     hot start 
1 Denaturating 92°C 2 min 1  1 Denaturation 92°C 2 min 1 
2 Denaturating 92°C 0.25 min   2 Denaturation 92°C 0.25 min  
 Annealing TmR 0.25 min 30   Annealing Tmr 0.25 min 2 
 Elongation 72°C 1 min*/kb    Elongation 72°C 1 min*/kb  
3 Completion 72°C 10 min 1  3 Denaturation 92°C 0.25 min  
4 Storage 15°C hold   Annealing TmR 0.25 min 30 
      Elongation 72°C 1 min*/kb  
     4 Completion 72°C 10 min 1 
     5 Storage 15°C hold 
 
*1 min per 1000 bp of DNA sequence of interest was calculated for the duration of the elongation step based 
on the average processivity of the specific polymerase.  
Taq Pol → 1 min/kb DNA sequence 
Pfu Pol → 2 min/kb DNA sequence 
Pfx Pol → 1 min/kb DNA sequence, operates at 68°C 
The basic melting temperature Tm of the primers was calculated with the formula:  
Tm= 2 x (aA +bT) + 4 x (cG +dG) [ °C], where a, b, c, and d are the numbers of bases A, T, G and C in the 
primer sequence, respectively. 
Tmr= Tm – 5 (or 4) [ °C], without taking into consideration the restriction endonuclease recognition site 
sequence (additional to the gene specific sequence)  
TmR= Tm – 5 (or 4) [ °C], calculating the entire primer, including the introduced endonuclease recognition 
site 
 
3.1.3.2  Primer design  
Primers were designed to be 21 base pairs in length with a melting temperature preferentially over 60°C. 
The minimum GC content was 50%. In case a restriction site was added to the primer 5’- or 3’-site 
additional bases were constructed to support the recognition by endonucleases. The primers terminate in one 
or more G or C bases at the 3’-end. All primers were synthesized by MWG BIOTECH of standard HPSF 
quality. 
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3.1.3.3  Reverse transcription polymerase chain reaction  
Reverse transcription polymerase chain reaction (RT-PCR) is the most sensitive technique for mRNA 
detection and quantification currently available. RT-PCR engages two sequential steps. First, single-
stranded RNA is reverse transcribed into complementary DNA (cDNA) by using total cellular RNA, a 
reverse transcriptase enzyme, a primer, dNTPs and an RNase inhibitor. Three types of primers can be used 
for a RT-Reaction: oligo (dT) primers, random primers and gene specific primers. And second, the resulting 
cDNA is used as template for PCR amplification of a gene of interest. RT-PCR can be carried out as one-
step RT-PCR in which all reaction components are mixed in one tube. Throughout the course of this work 
RT-PCR was performed using the Qiagen OneStep RT-PCR Kit (→2.7) with gene specific primers.  
 
RT-PCR components (µl) 
 
RT-PCR Program  
Qiagen buffer  5x 10 
 
# Step Temperature Time Cycle (s) 
RNA (~200 ng/ µl) 1 
 
1 Reverse Transcriptase 50°C 30  min 1 
5’-Primer (10 pmol/µl) 3 
 
 HotStarTaq activation 95°C 15 min 1 
3’-Primer (10 pmol/µl) 3 
 
2 Denaturating 92°C 0.25 min  
dNTPs (0.4 µM) 2 
 
 Annealing Tm 0.25 min 30 
Enzyme Mix 2 
 
 Elongation 72°C 1 min*/kb  
MPH2O ad 50 
 
3 Completion 72°C 10 min 1 
  
4 Storage 15°C hold 
 
3.1.3.4  Colony PCR 
Colony PCR is a rapid method for screening for positive bacteria clones on a plate subsequent to DNA 
cloning (→3.1.4). Gene specific primers of the desired sequence were used for a Taq-PCR reaction mix 
(→3.1.3.1). The reaction mix was aliquoted to 10 PCR tubes on ice. Single isolated bacteria colonies from a 
LB-plate were picked with an autoclaved toothpick into the PCR-tubes containing the mix. The tested 
colonies were transferred to a fresh LB-plate for further usage. Cell lysis was achieved by an additional 
initialization heating step at 95°C for 3 min in the thermocycler (Eppendorf) prior to the standard PCR-
program (→3.1.3.1). PCR-products were analyzed by agarose gel electrophoresis (→3.1.1.1). Cultures for 
positives clones were prepared for plasmid DNA isolation (→3.1.2.2). 
 
3.1.4  DNA Cloning  
DNA cloning is a technique for DNA fragments reproduction. A vector is required to carry the DNA 
fragment of interest into a host cell. All cloning vectors used in the course of this work were plasmids. 
Plasmids are small circular molecules of double stranded DNA derived from natural plasmids that occur in 
bacterial cells. A DNA fragment can be inserted into a plasmid if both, the circular plasmid and the source 
of DNA, have recognition sites for the same restriction endonuclease. The plasmid and the foreign DNA are 
cut by a restriction endonuclease producing intermediates with sticky and complementary ends. The new 
plasmid can be introduced into bacterial cells and produce many copies of the inserted DNA.  
 
3.1.4.1  Generating a DNA insert  
DNA inserts were generated by PCR (→3.1.3.1) or by releasing DNA fragments out of plasmids. PCR 
products were separated on an agarose gel and purified (→3.1.1.1). Subsequential incubation with 
restriction endonucleases produced blunt ends or single-stranded overhangs (cohesive ends also called sticky 
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ends) complementary to those in the vector. Primers were designed to provide a restriction site at each end 
of the PCR product (→3.1.3.2). In other cases the PCR products contained the cleavage site. Accurate 
digestion was verified by agarose gel electrophoresis, followed by purification of the digested products 
(→3.1.1.1).  
 
Preparative restriction double digestion (µl) U 
PCR cDNA product (~500 ng) 20  
10x  reaction buffer 3  
restriction endonuclease I variable 10-20 
restriction endonuclease II variable 10-20 
MPH2O ad 30  
 
The temperature of incubation, the choice of reaction buffer as well as the amount of units applied were 
dependent on the restriction endonuclease’s requirements. Duration of incubation was in most cases 
minimum 2 h. In case double digestion was not suitable, the cDNA was subjected to cleavage by one 
enzyme at a time, followed by gel electrophoresis and extraction (→3.1.1.1).  
 
3.1.4.2  Generating recombinant plasmid DNA 
Plasmid DNA was cleaved by corresponding restriction endonucleases which produced cohesive ends 
complementary to the insert DNA. After verification of a successful plasmid linearization and vector 
fragment integrity by gel electrophoresis (→3.1.1.1), the vector was purified using the NucleoTrap® Gel 
Extract Kit (Macherey Nagel, →2.7).  
 
Preparative restriction double digestion (µl) U 
plasmid DNA (~1µg) variable  
buffer 10x 3  
restriction endonuclease I variable 5-10 
restriction endonuclease II variable 5-10 
MPH2O ad 30  
 
The temperature of incubation and the choice of reaction buffer, as well as the amount of units applied were 
dependent on the restriction endonuclease’s requirements. Duration of the incubation was 0.5-1 h. In case a 
double digestion was not suitable DNA was subjected to cleavage by one enzyme at a time, followed by a 
gel electrophoresis and extraction (→3.1.1.1).  
 
3.1.4.3  Noncohesive ends cloning 
If not having compatible restriction sites for a cloning procedure at hand, a blunt (noncohesive end) cloning 
was performed. Also, provided a restriction endonuclease generated noncohesive ends upon restriction of an 
insert, a blunt end cloning was carried out. The insert and vector terminii were both blunted by using E. coli 
DNA polymerase I large fragment (Klenow fragment, Roche) according to the manufacturer’s instructions. 
Klenow has 5’-3’ polymerase and 3’-5’ exonuclease, but not 5’-3’ exonuclease activities. Next, the vector 
was dephosphorylated by using the calf intestinal phosphatase (CIP) to decrease the background of non-
recombinants that arise from self-ligation. CIP was also employed according to the manufacturer’s 
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instructions. Gel purification of the vector was performed to reduce the frequency of aberrant clones 
(→3.1.1.1). 
 
3.1.4.4  Deletion mutagenesis 
Specific deletions were introduced into cloned DNA using completely overlapping sense and antisense 
primers containing the mutation of interest. Mutagenic primers lacking the DNA sequences designated for 
deletion were employed for PCR amplification using pSport1-mVKINDfl construct as template and the 
Pfx DNA Polymerase (Invitrogen), according to the manufacturer’s conditions. Primers were extended for 
10 min at 68°C during which the desired mutations were incorporated and subsequently amplified. The PCR 
products obtained were two different linear DNA fragments, the parental template and the mutated DNA. 
Parental template DNA was subjected to degradation by DpnI digestion (30 U/50 µl PCR sample, for 1 h at 
37°C). Subsequently, DpnI endonuclease was heat inactivated for 15 min at 65°C. Mutant DNA was 
circularized by blunt end ligation, achieved by transforming competent E. coli Dh5α bacterial cells with 
DpnI-treated PCR sample (→3.1.4.5). Clones were tested by colony PCR (→3.1.3.4). 
 
3.1.4.5  Ligation 
Ligation is the process of joining linear DNA fragments together with a covalent bond. A phosphodiester 
bond between the 3’-hydroxyl termini and the 5’-phosphate is catalyzed by the T4 DNA ligase. The enzyme 
originates from the T4 bacteriophage and ligates DNA fragments having blunt and sticky ends annealed 
together. The optimal incubation temperature for T4 DNA ligase is 16°C. Following generation and 
purification of insert (→3.1.4.1) and vector (→3.1.4.2) DNA fragments, the fragments were eluted 
(→3.1.1.1) together in 1x T4 ligase buffer and supplemented with T4 DNA ligase (NEB). To maximize the 
yield, a ligation reaction was set in an estimated vector:insert molar ratio of 3:1. Following over night 
incubation at 16°C, the total reaction was used for transformation of competent cells (→3.1.4.6). 
  
Ligation (µl) U 
DNA fragments  19  
T4 DNA ligase 1 400 U/µl 
final volume 20  
 
 
3.1.4.6  Transformation and culturing of E. coli Dh5α bacterial cells 
Transformation of bacterial cells is achieved by an uptake of plasmid DNA. The procedure involves heat 
shocking and ice shocking alternately. Cells, which efficiently accept extra DNA, are known as competent 
cells. Competent cells are prepared by treatment with CaCl2 (Morrison, 1977). Plasmids holding an origin of 
replication recognized by the host cell DNA polymerase are being replicated along with the endogenous 
DNA. Moreover, plasmids expressing antibiotic resistance provide a way of identifying and isolating cells 
that have successfully incorporated the desired plasmid. 20 µl of a ligation reaction (→3.1.4.5) were added 
to 200 µl competent bacterial cells (E. coli Dh5α) previously thawed on ice, gently mixed and incubated on 
ice for further 40 min. Cells were heat shocked for 90 s at 42°C and chilled on ice for 2 min. 1 ml LB was 
added and the cells were incubated under shaking for 30-60 min at 37°C. Cells were collected by 
centrifugation at 3500 rpm for 3 min at RT. Supernatant was discarded and the cell pellet was dissolved in 
150 µl LB. Next, 50 µl and 100 µl were plated out on LB agar plates containing the appropriate antibiotic as 
selection marker and plates were incubated overnight at 37°C. Colonies of transformants were inoculated for 
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further investigation (→3.1.3.4) or plates were stored for several weeks at 4°C. For bacterial culture and 
subsequent plasmid purification, designated transformed E. coli Dh5α clones were shaken over night in LB 
broth supplemented with either 100 µg/ml ampicillin or 100 µg/ml kanamycin at 37°C. Later cells were 
pelleted and plasmid DNA was isolated employing the Plasmid Maxi Kit (Qiagen, →2.7). 
 
3.1.4.7  Sequencing 
Throughout the course of this work, DNA was sequenced by automated sequencing using the 3100 Avant 
Sequencer (Applied Biosystems), employing the Big Dye Terminator VII Cycle Sequencing Kit (Applied 
Biosystems). 
 
3.2  Protein Chemical Methods  
3.2.1  Electrophoretic separation of proteins 
Polyacrylamide gel electrophoresis (PAGE) is applied to separate protein mixtures based on their migration 
in solution in response to an electric field. The sample is run in a support matrix which separates the 
molecules by size and provides a record of the electrophoretic run. Proteins are amphoteric compounds, 
therefore their net charge is determined by the pH of the solution. The net charge is independent of its size, 
i.e. the charge is carried per unit mass. Under denaturing conditions the anionic detergent sodium dodecyl 
sulfate (SDS) disrupts the secondary and tertiary structure and binds to proteins quite specifically in a mass 
ratio of 1.4:1. Therefore SDS confers a negative charge to the polypeptides in proportion to their length 
(equal charge per unit length). 2-mercaptoethanol reduces disulphide bridges in proteins. During denaturing 
SDS-PAGE separation is achieved by polypeptide migration determined not by its intrinsic electrical charge, 
but by its molecular weight.  
 
3.2.1.1  SDS-PAGE 
Throughout the course of this work protein samples were subjected to SDS-PAGE using a discontinuous 
buffer system providing a good resolution. In a discontinuous system a non-restrictive large pore gel, called 
stacking gel, is layered on top of a separating gel, called a resolving gel. Each gel was made with a different 
buffer along with the tank buffer being different from the gel buffers. Prior to loading, protein samples were 
added 1x SDS-loading buffer and boiled for 5 min at 100°C. Protein sizes were analyzed using the pre-
stained Protein Ladder (Amersham, Bio-Rad) as molecular mass marker. Electrophoresis was performed at 
36 mA at RT until the BPB (bromphenol blue) dye reached the bottom of the gel. 
 
 Resolving gel Stacking gel 
 6% 10% 12%   
Acrylamide: 
Bisacrylamide 
(37.5:1) 
5.85 ml 9.3 ml 11.16 ml 
Acrylamide: 
Bisacrylamide 
(19:1) 
2.25ml 
3M Tris-HCl, pH 9 3.8 ml 3.8 ml 3.8 ml 1M Tris-HCl, pH 6.8 1.25 ml 
MPH2O 19.15 ml 15.7 ml 13.84 ml MPH2O 6.25 ml 
20% SDS 150 µl 150 µl 150 µl 20% SDS 50 µl 
TEMED 30 µl 30 µl 30 µl TEMED 15 µl 
10% APS 150 µl 150 µl 150 µl 10% APS 100 µl 
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10x Electrophoresis buffer  1x SDS-loading buffer 
Glycine 190 mM  Tris–HCl, pH 6.8 60 mM 
Tris base 25 mM  Glycerin 10% (v/v) 
SDS 0.1% (w/v)  SDS 3% (w/v) 
 pH 8,6  ß-Mercaptoethanol 5% (v/v) 
   Bromphenol blue 0.005% 
 
3.2.1.2  Electroblotting and immunodetection 
Proteins were transferred efficiently from a polyacrylamide gel (→3.2.1.1) to a nitrocellulose membrane by 
electroblotting (western blot) using a Sigma blotting tank. The transfer was carried out for 1.5 to 2 h at 
150 mA at RT in western transfer buffer. Protein transfer was verified by staining the nitrocellulose 
membrane with Ponceau S solution (Sigma). Nitrocellulose membrane was incubated in staining solution for 
1 min at RT. Rinsing with MPH2O for 5 min at RT with shaking reveals the protein distribution on the 
nitrocellulose membrane. Thereafter the membrane was destained twice with PBS-Tween (PBST) buffer for 
15 min at RT with shaking until staining faded away completely. For immunodetection the nitrocellulose 
membrane was blocked over night in blocking buffer at 4°C. After blocking the membrane was incubated in 
blocking buffer containing the corresponding primary antibody (→2.3.1) for 3 h at RT. Subsequently, the 
membrane was washed 3 times with PBST for 10 min at RT with shaking. Next, the membrane was 
incubated in PBST:blocking buffer 3:1 (v/v) containing the secondary HRP-linked antibody (→2.3.2) for 
45 min at RT followed by a second washing as described above. Finally, the exceed liquid was removed and 
the antibody coupled peroxidase was detected with an ECL reagent kit (enhanced chemoluminescence, 
Amersham) (→2.7). Signals were detected by autoradiography using an ECL-hyperfilm (Amersham). 
 
Western transfer buffer  Panceau S 
Glycine 190 mM  Panceau S 0.2% (w/v) 
Tris base 25 mM  Trichloroacetic acid 3% (w/v) 
Methanol 20% (v/v)  
 
PBS-Tween  Blocking buffer 
Tween 20 0.05% (v/v)  dried milk powder 5-10% (w/v) 
PBS, pH 7.4 1x  PBS-Tween 1x 
 
3.2.2  Recombinant protein expression in prokaryotes  
E. coli strain Rosetta (Novagen, →2.6.1) was transformed with the recombinant protein expression vector 
pGEX-6P-1, coding for N-terminally GST-fused proteins. The bacterial culture was grown in LB broth 
supplemented with 100 g/ml ampicillin and 34 g/ml chloramphenicol. The Rosetta strain contains a 
pRARE plasmid (cam
r
) coding for tRNAs of the rarely used codons Arg, Ile, Gly, Leu and Pro, enabling 
high protein expression yields (Novy et al., 2001). The recombinant protein transcription driven by a lacZ 
promotor was then induced with isopropyl-β-D-thiogalactopyranoside (IPTG). Initially, the recombinant 
host was grown over night to saturation in LB with shaking (180 rpm) at 37°C. Next, 5 l of LB broth were 
inoculated with the primary culture (10:1) and incubated with shaking (180 rpm) at 37°C to A600 of 0.6. 
Recombinant expression was then induced by 1 mM IPTG (to 0.1 mM) and cells were cultured over night 
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with shaking (120 rpm) at 21°C. Finally, cells were pelleted (Beckmann GSA, 10000 g, 10 min, 4°C), 
subsequently washed once with PBS and if required stored at -20°C. 
 
3.2.3  Glutathione based affinity chromatography  
Glutathione-S-transferase (GST) from Schistosoma japonicum is used as tag for proteins for expression and 
purification applications. GST is a 26 kD protein which binds to glutathione with high affinity and 
specificity. Recombinant proteins fused to GST can then be selectively purified based on its high affinity for 
immobilized glutathione (glutathione sepharose). Sepharose is a bead form of agarose. The binding occurs 
under nondenaturating conditions since GST loses its ability to bind glutathione sepharose when denatured. 
The cDNA of interest was cloned into pGEX-6P-1 and expressed as described in 3.2.2. In the course of this 
work purification was performed using the Amersham Pharmacia Glutathione Sepharose 4b resin according 
to the manufacturer’s batch purification protocol. To reduce protein degradation, the entire purification 
process was performed on ice. Recombinant host cells (Rosetta) were resuspended in TBST buffer and 
disrupted by sonification (6 x 15 s at 50%, and 1 x 20 s at 100%). Cell debris was cleared by centrifugation 
at 10000 g (Sorvall SS34) for 30 min at 4°C. The cleared lysate was incubated with Glutathione Sepharose 
4b (Amersham Pharmacia) (250 µl bead volume/10 ml cleared lysate), earlier washed 3x with TBST, for 2 h 
at 4°C under rotation. After 3 cycles of washing with 800 µl TBST bound protein was released from the 
slurry with 1000 µl elution buffer (2x 500 µl). Fractions were collected, stored at – 20°C. Aliquots of the 
fractions were analyzed by SDS-Page (→3.2.1.1). 
 
TBST  Elution Buffer 
Tris-HCl, pH 7.4 10 mM  Tris-HCl, pH 8.0 500 mM 
NaCl 150 mM  reduced glutathione  10 mM 
Tween 20 0.1% (v/v)  
 
 
3.2.4  Buffer exchange  
To extract the protein in question from a previously used buffer, protein samples were applied to Nap-10 
columns (Amersham). Prior to application, columns were equilibrated with 15 ml of the desired buffer 
(glycerin free). Subsequently, proteins were eluted into 1 ml desired buffer.  
 
3.3  Cell Biological Methods 
3.3.1  Cell culture 
3.3.1.1  NIH 3T3 and HeLa cells maintenance and passaging  
The mouse fibroblasts NIH 3T3 and human cervix carcinoma HeLa eukaryotic cells were grown in T75 
flasks in DMEM (Dulbecco's Modified Eagle Medium, Life Technology) in the presence of 10% FCS, 
penicillin (100 U/ml), streptomycin (100 U/ml) and L-Glutamine (200 mM). Cells were cultured in a 
humidified incubator at 37°C with 5% CO2 (Heraeus). In the course of this work NIH 3T3 and HeLa cell 
lines were passaged every 3 days upon reaching 80-90% confluence. Cells were washed with 5 ml PBS, 
thereafter 1 ml of Trypsin-EDTA (Life Technology) was added to detach the cells from the flask. Next, 4 ml 
DMEM were added and cells were brought into suspension. 1 ml cell suspension was presented to 9 ml 
DMEM in a fresh sterile T75 flask (Sarstedt). 
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3.3.1.2  Preparation of murine granule cells  
To extract murine granule cells, seven mouse cerebella were dissected from C57BL/6 mice (→2.6.3) at 
postnatal day 5 and the meninges were removed. Tissues were incubated in few drops of 37°C pre-heated 
solution 1, triturated with a sterile scalpel in the hood and washed in 10 ml of solution 1 (centrifugation at 
1200 rpm, Heraeus, for 3 min at RT). Supernatant was aspirated, 7 ml 37°C pre-heated solution 2 were 
added and tissues were incubated in a sterile 100 mm dish for 13 min at 37°C with 5% CO2 with occasional 
shacking. Following neutralization, achieved by 7 ml 37°C pre-heated solution 4, cells were pelleted by 
centrifugation at 1200 rpm for 3 min at RT. The supernatant was again aspirated and tissues were triturated 
in 2 ml 37°C pre-heated solution 3 by 25 strokes with a sterile pasteur pipet. After allowing to sediment for 
10 min, the supernatant was transferred to a fresh sterile 15 ml tube containing 3 ml 37°C pre-heated 
solution 5. 2 ml of 37°C pre-heated solution 3 were added to the sediment and it was dissociated with a 
pasteur pipet for a second time. Following afresh sedimentation period of 10 min, the supernatants were 
consolidated in the 15 ml tube and centrifuged at 1200 rpm for 10 min at RT. In the meanwhile the poly-
lysine solution was removed from the petri dishes and let to air-dry in the hood. The supernatant was 
discarded and cells were incubated in complete medium. Cerebellar granule cells were counted and seeded 
in 60 mm poly-lysine coated dishes at a density of 5x 10
6
 and incubated at 37°C with 5% CO2. For a 
cytostatic treatment of glial cells, 10 µl Ara-c/HCl were added on the following day. RNA of 5x 10
6
 granule 
cells was isolated at 0, 24, 48 and 96 h post preparation (→3.1.2.3). 
 
Krebs-Ringer 10x  Solution 1 
NaCl 1.2 M  Krebs-Ringer buffer 1x   
KCl 50 mM  BSA  0.3% (w/v) 
KH2PO4 12 mM  MgSO4 1,24 mM 
NaHCO3  0.25 M  
D-Glucose 0.14 M  
Phenol red a pinch  
 filter and store at – 20°  
 
 
Solution 2  Solution 3 
Solution 1   Krebs-Ringer buffer 1x  
Trypsin 0,025% (w/v)  DNase 0,008% (w/v) 
   Trypsin inhibitor 0,052% (w/v) 
   MgSO4 2,79 mM 
 
 
Solution 4  Solution 5  Complete medium 
Solution1 6,2% (v/v)  Krebs-Ringer buffer 1x   BME 1x  
Solution 3 93,75% (v/v)   MgSO4 2,48 mM  FCS 10% (v/v) 
   CaCl2 13,1 M  KCl 20 mM 
      Gentamycin sulphate 1x  
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3.3.1.3  Cell density 
To determine cell concentration of cultured cells, cells were resuspended and loaded onto a Fuchs-Rosenthal 
(Neubauer) counting chamber. On a phase contrast microscope (Fluovert FS, Leitz) particle count was 
performed in the middle corner square, consisting of 25 smaller squares. 
Cell number was calculated as follows:  
C (cell) = counted cells x dilution x 5000 [cells/ml] 
  
3.3.2  Transfection  
Transfection is the process of introducing nucleic acids into cells by non-viral methods, such as liposomes 
and calcium phosphate precipitation techniques. 
 
3.3.2.1  Transfection with Lipofectamine 
Eukaryotic cells were transfected with a liposome transfection method (Lipofectamine, Invitrogen). 
Synthetic cationic lipids are used to deliver nucleic acid into cells presumably through endocytosis. Cationic 
lipids at physiological pH build a unilamellar liposomal structure with a positive surface charge which 
associates with the negatively charged DNA. Thus a compaction of the nucleic acid in a liposome/nucleic 
acid complex is facilitated. Following association with the negatively charged cell membrane, the complex 
enters the cell and appears in endosomes. Later the exogenous DNA is relocated to the nucleus.  
One day prior to transfection cells were seeded in a 6-well plate at a cell density of 1x 10
5
. Complexes were 
prepared by adding high quality DNA (µg) to transfection reagent (µl) at a ratio of 1:6. Transfection was 
performed according to the manufacturer’s conditions for 4-5 h at 37°C with 5% CO2 (humidified 
incubator). Serum and antibiotics were not present during transfection.  
 
3.3.2.2  Transfection with calcium-phosphate coprecipitation 
Mixing DNA and calcium phosphate, and adding the mixture in a controlled manner to a buffered 
saline/phosphate solution generates a DNA-calcium phosphate coprecipitate. Coprecipitate particles form 
slowly at RT. Following dispersion onto cultured cells the coprecipitate adheres to the cell surface and is 
taken up by cells presumably via endocytosis or phagocytosis. Cells were plated in a 6-well plate (at 
Ø 35 mm) at a density of 1x 10
5
. 3-4 h prior to transfection cells were provided with fresh growth medium. 
In a tube A 9 µl CaCl2 (2M) was mixed with 5 µg DNA to a total volume of 75 µl. Solution A was added 
drop wise to solution B, holding 75 µl HBS (2x), until solution A was completely depleted. A fine 
precipitate was allowed to form for 30 min at RT. Subsequently, the precipitate was distributed drop wise 
onto the cells in a well of a 35 mm well dish. Transfection was performed overnight at 37°C with 5% CO2 in 
a humidified incubator (Heraeus). 
 
2x HBS  
NaCl 1.6 g 
KCl 0.074 g 
Na2HPO4x2H2O 0.027 g 
Glucose 0.2 g 
HEPES 1 g 
MPH2O ad 100 ml, adjust to pH 7.05 with NaOH 
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3.3.3  Immunocytochemistry 
Immunocytochemistry is a powerful technique for recognizing the location of endogenous or exogenously 
expressed proteins in cultured cells. It involves a first antibody which targets directly the antigen. In a 
subsequent step, a second antibody (anti IgG) with an attached fluorescent dye (fluorochrome) interacts with 
the first antibody, which improves the visualization. The procedure is carried out in fixed permeabilized 
cells on a cover slip. For immunological staining cells were seeded on glass cover slips (Ø 10 mm) in a  
6-well plate and transfected with the nucleic acid of interest by Lipofectamine (as described in 3.3.2). 24 h 
post transfection cells were washed 3x with PBS and fixed with 600 µl 3.7% paraformaldehyde (PFA) in 
PBS for 20 min at 4°C. Following 3x washing with PBS, cells were permeabilized with 600 µl 0.2% Triton 
X-100 in PBS for 3.5 min at RT and washed again 3x with PBS. For immunodetection, fixed cells were 
incubated in 50 µl 1% FCS/PBS (v/v) blocking solution in the presence of a suitable primary antibody for 
1 h at RT and then washed 3x with PBS. A second incubation in the presence of either TRITC-conjugated 
(red) or FITC-conjugated (green) secondary antibodies (dilution 1:250 in 50 µl 1 % FCS/PBS) along with 
either Oregon Green phalloidin or rhodamine phalloidin (dilution 1:20), respectively, was performed for 1 h 
at RT with exclusion of light. Fixed cells were washed 3x with PBS and rinsed in MPH2O. A drop of Moviol 
was placed on a microscope slide and the cover slip was gently positioned on top, allowing Moviol to spread 
beneath the cover slip and cover the cells. Moviol functions as a mounting medium with DABCO operating 
as a fluorescence stabilizer. Slides were air-dried overnight at RT with exclusion of light. Immunostains 
were stored at 4°C and examined on a fluorescent microscope. 
GFP-fusion proteins were detected by autofluorescence and filamentous actin by staining with conjugated 
phalloidin (1:20, Molecular Probes). Anti-mVKIND rabbit polyclonal antibody (anti-mVKIND serum/0.1% 
NaN3 (v/v), 1:1000, immunoGlobe, →2.3.1) was employed for immunodetection of the mouse VKIND 
protein. Myc-tagged proteins were detected with anti-Myc 9E10 (1 µg/ml, Santa Cruz, →2.3.1). TRITC-
conjugated goat anti-mouse antibody (1:250, Dianova, →2.3.2) and FITC-conjugated donkey anti-mouse 
antibody (1:250, Dianova, →2.3.2) were used as secondary antibodies. Cells were analyzed on a Leica 
DMIRBE fluorescence microscope (100x oil objective) and documented with a monochrome digital camera 
(Hamamatsu). Digital pictures were processed using Openlab software (Improvision). 
 
Moviol 
Glycol 20 ml 
Moviol  15 g 
0,2 M Tris-HCl pH 8,5 100 ml  
DABCO 3.5 g 
 
3.3.4  Time-lapse video live cell analysis 
Transfected NIH 3T3 cells transiently expressing EGFP-fused exogenous proteins were seeded on glass 
cover slips (Ø 25 mm) in DMEM (Dulbecco's Modified Eagle Medium, Life Technology) in the presence of 
10% FCS, penicillin (100 U/ml), streptomycin (100 U/ml) and L-Glutamine (200 mM). Upon visual 
evidence of high levels transient expression the cover slip was clamped in a cover slip chamber. Cells were 
overlaid with 37°C warm growth medium and immediately transferred to a fluorescent microscope (Leica) 
while being incubated at 37°C. Cells positive for EGFP fluorescence were selected and focused at 100x/1.30 
oil objective. Subsequently, a time-lapse fluorescent monitoring was initiated with images captured every 
30 s employing a digital camera (Hamamatsu). Images (1024x1022 pixels) were optimized and light 
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intensities were color-coded with Openlab imaging software (Improvision). Quick Time videos (.mov 
format) were generated using time series pictures. 
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The new protein module kinase non-catalytic C-lobe domain (KIND) was originally identified as a 
conserved domain represented in the N-terminal region of the Spir family actin organizers (Otto et al., 2000; 
Ciccarelli et al., 2003). Moreover, data base searches identified the KIND domain in a second distinct 
protein family represented by the non-receptor tyrosine phosphatase type 13 (PTP type 13, PTP-Bas, PTP-
BL) (Erdmann, 2003) and an additional protein sequence deduced from a human expressed sequence tag 
(EST) KIAA1768. In the course of this work a new representative of the KIND family, very-KIND 
(VKIND) (ortholog of the human EST clone KIAA1768), was cloned and characterized.  
 
4.1  Cloning  
In order to characterize the mouse ortholog of the human KIAA1768 EST clone (accession: NP_689856) the 
third member of the KIND family was cloned. Due to its two KIND domains it was designated very-KIND 
(VKIND). An open reading frame of 5229 base pairs (with a translational stop codon) (accession: AJ580324) 
was deduced from sequenced cDNA fragments, in analogy to the mouse KIAA1768 clone (accession: 
AK046817) and the partial sequence of a mouse gene which was predicted by automated computational 
analysis (accession: XM_133920). A cDNA fragment encompassing the complete coding region was 
generated by cloning six RT-PCR fragments, employing cerebellum RNA of an adult C57BL/6 mouse as 
template (→3.1.3.3, accession: AJ580324). The endonuclease single restrictions sites within the mVKIND’s 
coding sequence XhoI (base 1008), BstXI (base 2072), NheI (base 3174), XbaI (base 4044) were 
incorporated in the cloning process. The complete mouse VKIND cDNA (mVKINDfl) was assembled in the 
pSport1 cloning vector (Fig. 8) and inserted into the pcDNA3 expression vector at restriction sites HindIII 
(formerly blunted) and EcoRI (Tab. 1). The sequence was confirmed by DNA sequence analysis (→3.1.4.7). 
The vector pcDNA3 induces a high level mammalian expression from the CMV promoter. A Myc-epitope 
tag (amino acids 410-419 of c-Myc) was fused in frame to the amino-terminus (second codon) to allow 
efficient detection. The Myc tag as well as the HindIII restriction site was introduced in the forward primer 
5’-mKISN-XbaI/HindIII+Myc (→App. II). The expression of the mVKIND directed by the CMV promoter 
of the pcDNA3 vector was verified by SDS-PAGE and immunoblotting, employing the Myc 9E10 antibody 
(→3.2.1.1, 3.2.1.2). The employed cloning strategy is presented in Fig. 8.  
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Fig. 8  Cloning strategy, a step by step composition of the mVKINDfl cDNA.  
pcDNA3 expression vector consisting of 5.4 kb and pSport1 cloning vector consisting of 4.1 kb. Abbreviations: Ap r, Ampicillin; 
BGH pA, bovine growth hormone polyadenylation signal; CC, coiled-coil; f1 ori, filamentous phage origin of replication; GEF, 
guanine nucleotide exchange factor for Ras-like small GTPases; GEFN, RasGEF N-terminal domain; K1, KIND1; K2, KIND2; 
kb, kilobase; Myc, Myc tag; ori, origin; P CMV, human cytomegalovirus promotor; SP6, bacteriophage SP6 promotor; VK, 
mVKIND. 
pcDNA3-Myc-
mVKIND-aa2-
337 
pcDNA3-Myc-
mVKIND-aa2-
709 
pcDNA3-Myc-
mVKIND-aa2-
1204 
pcDNA3-Myc-
mVKIND-aa2-
1349 
pSport1-Myc-
mVKIND-aa2-
1349 
pSport1-
mVKIND-
aa1349-1742 
 f1 ori       Apr        P CMV      Myc         VK           K1          K2          CC        GEFN     GEF      BGH pA 
pcDNA3 
pSport1    ori          Apr         SP6        Myc         VK           K1          K2         CC       GEFN      GEF         lacI    
pSport1-Myc-
mVKINDfl 
pcDNA3-Myc-
mVKINDfl 
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Tab.1  provides data about the DNA constructs employed in the cloning of the mVKINDfl cDNA, including 
the deduced protein sequence, the primers, and the restriction sites used to insert the cDNAs into the 
pcDNA3 expression vector and the pSport1 cloning vector, respectively.  
 
Tab. 1  Overview of the mVKIND cloning constructs. Detailed construct records are illustrated in Appendix II 
Construct 
Coding 
Sequence 
 Protein 
Sequence of 
Insert 
Primer Restriction Site 5’/3’ 
pcDNA3-Myc-mVKIND-aa2-337 4-1013 bp aa2-337 
5’-mKISN-XbaI/HindIII+Myc 
3’-mKISN-afterXhoI 
HindIII/BamHI 
pcDNA3-Myc-mVKIND-aa2-709 4-2129 bp aa2-709 
5’-mVKIND-beforeXhoI 
3’-mVKIND-afterBstXI+BamHI 
HindIII/BamHI 
pcDNA3-Myc-mVKIND-aa2-1204 4-3614 bp aa2-1204 
5’-mVKIND-beforeBstXI 
3’-mVKIND-3-rev+KpnI 
HindIII/XhoI (blunt) 
pcDNA3-Myc-mVKIND-aa2-1349 4-4049 bp aa2-1349 
5’-vKIND-beforeNheI 
3’-vKIND-afterXbaI 
NheI/XbaI 
pSport-Myc-mVKIND-aa2-1349 
4-4049 bp aa2-1349 — HindIII/XbaI 
pSport-mVKIND-aa1349-1742 4044-5229 bp aa1349-1742 
5’-vKIND-beforeXbaI 
3’-vKIND-Ende+EcoRI 
XbaI/EcoRI 
pSport1-Myc-mVKINDfl 4-5229 bp aa2-1742 — HindIII/EcoRI 
pcDNA3-Myc-mVKINDfl 4-5229 bp aa2-1742 — HindIII (blunt)/EcoRI 
 
4.2  VKIND structural analysis 
The murine VKIND gene is located on the mouse chromosome 7 at location 139,746,507-139,791,278 
(transcript ID: ENSMUST00000084468) and contains 31 exons. The corresponding exon-intron gene map is 
pictured in Fig. 9A. The mRNA comprising the mVKIND protein counts 7320 base pairs and has a C-
terminal polyA site (accession: NM_177261) (Fig. 9B). An open reading frame of 5229 base pairs translates 
into 1742 amino acids residues (Fig. 9C, D). Since the sequence of the novel protein mVKIND was yet not 
characterized, it was submitted to an analysis with the Simple Modular Architecture Research Tool 
(SMART) for identification and annotation of protein domains (Schultz et al., 1998) (http://smart.embl-
heidelberg.de). SMART revealed two non-catalytic C-lobe domains (KIND) in the amino-terminus and a 
guanine nucleotide exchange factor for Ras-like small GTPases (RasGEF) in the carboxy-terminus, with a 
structural motif attached at its N-terminal (RasGEFN). Furthermore, COILS (version 2.2), a program that 
compares sequences to a database of known parallel two-stranded coiled-coils and derives a similarity score 
(Lupas et al., 1991) (http://www.ch.embnet.org/software/COILS_form.html) calculated a coiled-coil in the 
central portion of mVKIND (Fig. 9D). Amino acid residues 1123 thought 1151 were assigned a probability 
of forming coiled-coils greater than 99%, whereas residues 1121, 1122 and 1152 were assigned a probability 
greater than 90%.  
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Fig. 9  Structural array of the VKIND protein.  
(A) Genomic exon information, gene sequence length of 44.772 kb. (B) mVKIND transcript, Coding Sequence (CDS) spans bases 492 through 
5720. (C) Cloned mVKIND, with start codon (ATG) and stop codon (TAG at 5229 bp). (D) Array of structural domains in the mVKIND 
protein, comprising 1742 amino acid residues. The N-terminal half of the protein includes two KIND domains (kinase non-catalytic C-lobe 
domains); the central region contains a coiled-coil helix (CC); a guanine nucleotide exchange factor for Ras-like small GTPases (RasGEF) 
motif and a RasGEF N-terminal domain (RasGEFN) are located in the C-terminal part. 
 
4.3  Phylogenic analysis  
The mouse VKIND protein was a novel protein without established function and activity. To analyze 
putative orthologs, the mVKIND sequence was used as template for a tBLASTn homology search (Altschul 
et al., 1997) (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) within the completed fully sequenced genome 
databases of R. norvegigus (RGSC build 3.4), G. gallus (WASHUC build 2), F. rubripes (Fugu build 3.0), 
D. rerio (Zv6 build 2.1), S. purpuratus (BCM Spur 2.1), C. elegans (WS build 144) and D. melanogaster 
(BGDP build 5.1). Putative orthologs were found in Vertebratae and Echinodermatae, but not in Nematodae 
and Insectae. Next, a BLAST search was conducted at NCBI in EST non-mouse non-human database 
implying the mouse sequence as a query. The search yielded EST evidence in X. laevis, X. tropicalis, 
O. mykiss, D. rerio, P. marinus, P. lividus, G. gallus, T. guttata, R. norvegigus, B. taurus and 
M. fascicularis. 
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Fig. 10  mVKIND protein structure.  
Alignment of human (Homo sapiens, hs), mouse (Mus musculus, Mm), chicken (Gallus gallus, Gg) and fish (Fugu rubripes, 
Fr) VKIND protein sequences. The sequences of both KIND domains are underlined in pink, the sequence of the coiled-coil 
structure is underlined in yellow, the ones of the RasGEFN and RasGEF domains are underlined in blue and green, 
respectively. Coloured letters within the sequence denote conserved amino acids. Cysteines are shown in pink letters, charged 
amino acids in red, small amino acids in green and polar amino acids in blue. Negative residues are highlighted in red, 
aliphatic in yellow, positive residues in green, aromatic in cyan and hydrophobic in blue. 
Reproduced with permission from Mees et al. (2005). 
 
A sequence alignment of the human, mouse, chicken and fugu protein showed a high conservation within 
the predicted two KIND domains, the coiled-coil region, the RasGEFN and the RasGEF domains (Fig. 10). 
The alignment also reveals two clusters of high conservation in-between the second KIND and the 
RasGEFN domains of yet unknown functional and structural identities (aa-880-962 and aa1071-1115).  
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4.4  The VKIND RasGEF domain 
The Ras superfamily of small GTPases includes over 150 proteins (Colicelli, 2004). The five major 
subfamilies (Ras, Rho, Rab, Ran and Arf) are involved in cancer, cell cycle, regulation, differentiation, 
vesicle trafficking, nuclear transport, control of cell morphology and chemotaxis. While Ras superfamily 
proteins are structurally highly conserved, the GEF proteins which mediate the GDP-GTP exchange of small 
GTPases are distinct for each subfamily. The catalytic domain of exchange factors specific for Ras 
subfamily GTPases is homologous to the yeast RasGEF CDC25 (Broek et al., 1987). To investigate the 
specificity of the novel RasGEF domain, its sequence was aligned to representatives of other GEF domains 
for Ras subfamily GTPases, such as RapGEFs, RalGEFs and the H-RasGEFs. The alignment demonstrates 
 
 
Fig. 11  Alignment of VKIND RasGEF domain to representatives of other guanine exchange factor domains 
for GTPases of the Ras subfamily.  
The Rap GEFs are illustrated in red, the Ral GEFs in green and the H-Ras GEFs in blue. For each domain, the starting and ending 
residues are reported. The average percent sequence identity between the VKIND RasGEF domains and the RasGEF domains of the 
other families is 23% to RapGEFs, 20% to Ral GEFs and 19% to H-Ras GEFs. The residue color scheme is the same as represented 
in Fig. 10. The sequences have the following accession numbers: VKIND_Mm: CAE30489.2; VKIND_Hs: NP_689856.5; 
RGE5_Human: Q92565; RGE4_Human: Q8WZA2; RGE1_Q13905; RGL1_Mouse; Q60695; RGL2_Human: O15211; 
GNDS_RAT: Q03386; RasGRF2: NP_008840; SOS1_Mouse: Q62245. The VKIND sequence from Gallus gallus is a computional 
prediction and has not been released to the data bases. Reproduced with permission from Mees et al. (2005). 
 
that the VKIND RasGEF domain is a CDC25 like domain closest related to the RasGEF domains of 
exchange factors specific for Rap GTPases, such as the Epac, MR-GEF and RA-GEF (Fig. 11). The average 
sequence identity between the Rap specific RasGEF domains and the VKIND catalytic domain is 23%. 
Furthermore, the alignment revealed that the VKIND enzymatic domain has a unique structure. It features 
two insertions, first one of 24 amino acids in the N-terminal end of the domain (between helixes αA and αB 
of the SOS1 RasGEF module) and the second one of 11 amino acids in the C-terminal part (between helixes 
αJ and αK of the Sos1 RasGEF module) (Boriack-Sjodin et al., 1998).  
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4.5  The murine VKIND protein 
The murine VKIND protein consists of 1742 amino acids (Fig. 9D) with a calculated size of 191,204 Dalton 
(Da). To confirm accurate expression of the cloned Myc-epitope tagged full length mVKIND, the pcDNA3-
Myc-mVKINDfl construct was transiently expressed in NIH 3T3 mouse fibroblasts for 48 h (→3.3.2.1). 
Total cell lysates were examined by SDS-polyacrylamide gel electrophoresis and subsequent electroblotting 
(→3.2.1.1). Next, an immunodetection using a c-Myc antibody 9E10 (→3.2.1.2, 2.3.1) was performed. The 
transiently expressed mVKINDfl protein migrates with an apparent molecular weight of 205 kD (Fig. 12) 
which is in good agreement with the predicted size. 
 
Fig. 12  In vivo expression of the mVKIND protein. 
NIH 3T3 cells were lipostransfected with pcDNA3-Myc-VKINDfl expression plasmid. 
Total protein lysates were analysed by immunoblot using anti-Myc antibodies. mVKINDfl 
migrates with an apparent molecular weight of approximately 205 kD. Abbreviations: kD, 
kilo Dalton; Myc, Myc tag; mVKINDfl, murine very-KIND full length. 
 
4.6  Expression analysis 
The versatile complexity of Ras-subfamily functions is associated with a multitude of activating stimuli and 
the spatial and temporal segregation of the signaling pathways (Mitin et al., 2005; Rocks et al., 2006). To 
investigate the spatial expression of the VKIND gene in mammals a Northern blot analysis was performed. 
The appearance of mVKIND mRNA was investigated in various tissues of an adult C57BL/6 mouse 
(→2.6.3), such as colon, brain, cerebellum, spleen, thymus, testis, kidney, lung and ovary (Fig. 13). An 
(α32P)dCTP labeled 1 kb mVKIND cDNA probe (encoding amino acids 2-335) was applied (→3.1.1.2). 
The northern hybridization revealed a highly restricted gene expression pattern at which strong expression 
was only found in the brain, along with a very faint staining in the RNA isolated from ovary. The 
mouseVKIND mRNA migrates on the formaldehyde agarose gel much slower than the ribosomal RNA 28s 
subunit (4.7 kb). Its estimated size is 7-8 kb which is concordant with the published data (accession: 
NM_177261) (Fig. 9B).  
Fig. 13  mVKIND mRNA expression.  
The expression of the mVKIND gene in different 
tissues of an adult murine was analyzed by Northern 
hybridization. Total RNA preparations of the 
indicated tissues were separated on a formaldehyde-
agarose gel and blotted onto a Duralon UV 
membrane. The mVKIND mRNA was detected with 
an (a-32P)dCTP labelled murine VKIND cDNA 
fragment encoding amino acids 2-335. The size of 
the ribosomal RNAs 4.7 and 1.9 kb (4.7, 1.9 kb) are 
indicated. The migration of the VKIND mRNA is 
marked (very-KIND). As a loading control the 
ethidium bromide stained 28 and 18 s ribosomal 
RNAs are shown. Reproduced with permission from 
Mees et al. (2005).  
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4.7  Developmental time course of VKIND expression in mouse embryo 
Gene expression is being temporally and spatially regulated during mouse development (Zhao et al., 2002). 
To study the developmental time course of mVKIND expression, sagittal and transverse sections of perfused 
CD1 mouse embryo tissue were subjected to RNA in situ hybridizations. Paraffin sections were hybridized 
with a digoxigenin-labeled antisense riboprobes for mVKIND (codon 2-126, accession: AJ580324.2), mouse 
islet1 (codon 129-349, accession: AJ32765.1) and mouse doublecortin (codon 124-360, accession: 
NM_010025.2) generated from plasmid templates as described previously (Leimeister et al., 1998). cDNA 
fragments were amplified by RT-PCR (→3.1.3.3) from cerebellum total RNA of a C56BL/6 mouse 
(VKIND) and total RNA of a day 14.5 mouse embryo (islet1, doublecortin). Next, they were inserted into 
the pcDNA3 vector using restriction sites BamHI/XbaI (for mVKIND), and BamHI/EcoRI (for islet1 and 
doublecortin) (Tab. 2). The developing brain and the neural tube are found to be strongly stained. At E14.5 a 
high VKIND expression is detected in the mid- and hindbrain, whereas the expression in the forebrain is 
only weak. During development a shift of the main expression towards the telencephalon is observed at 
E17.5 (Fig 14A, B). The neural tube exhibits VKIND expression in the ventro-lateral part at E10.5 
(Fig. 14C) as well as in the dorsal part during later development (Fig. 14C, F, I). At E10.5 the expression 
pattern in the neural tube partially coincides with islet1, a post mitotic motoneurons marker within the 
neural tube (Fig. 14D) (Appel et al., 1995), and doublecortin, an early post mitotic migrating neurons 
marker (Fig. 14E) (Hannan et al., 1999). In contrast, VKIND is not detectable in the developing DRG (dorsal 
root ganglia) cells at E10.5 (Fig. 14C), while islet1 demonstrates a strong staining intensity (Fig. 14D). Still, 
at E12.5 few cells in the DRG stain positive for VKIND (Fig. 14F). At E14.5 the entire neural tube except 
for the marginal layer shows strong staining, but only in a speckled pattern (Fig. 14I). 
 
Tab. 2  Overview of the in situ plasmid templates. Detailed construct records are 
illustrated in Appendix II 
Construct 
Coding 
Sequence 
 Protein 
Sequence 
of Insert 
Primer 
Restriction Site 
5’/3’ 
pcDNA3-Doublecortin 370-1082 bp aa124-360 
BamHI-m-Doublecortin-CT-5’ 
m-Doublecortin-CT-EcoRI-3’ 
BamHI/EcoRI 
pcDNA3-Islet1 385-1050 bp aa129-350 
BamHI-m-Islet1-CT-5’ 
m-Islet1-CT-EcoRI-3’ 
BamHI/EcoRI 
 
In the developing eye at E17.5 the expression of VKIND mRNA (Fig. 15A) overlaps widely with the 
expression of islet1, a vertebrate ganglion cell layer marker (Fig. 15B), and doublecortin (Fig. 15C). At 
earlier stages of development and in post natal mice no staining for VKIND mRNA could be observed.  
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Fig. 14  Expression pattern of VKIND in the mouse embryo. 
(A) At E14.5 VKIND is detected mainly in the mid- and hind-brain and in the neural tube (marked by arrows). (B) At E17.5 the expression 
in the neural tube is maintained. Moreover, additional high expression in the telencephalon is observed. (C) In the neural tube VKIND 
expression is exhibited by E10.5 at the ventral edge and (F, E12.5; I, E14.5) spread out dorsaly at later stages. Comparative studies show the 
expression of the neuronal markers (D, G, K) islet1 and (E, H, L) doublecortin. Reproduced with permission from Mees et al. (2005). 
 
Fig. 15  Expression of the VKIND 
gene in the mouse embryonic eye. 
At E17.5 in the predominantly (A) VKIND 
stains the future neuronal cell layers similar 
to (B) islet1 and (C) doublecortin. Layers 
are defined according to (D) Haematoxylin–
Eosin (HE) staining. Reproduced with 
permission from Mees et al. (2005). 
 
 
E14.5 E17.5 
E10.5 
E12.5 
E14.5 
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4.8  VKIND gene expression in postnatal mouse brain 
Since the developing brain presents a strong staining for mVKIND mRNA, in situ hybridizations for 
mVKIND were performed in adult CD1 mouse perfused brain tissue. Paraffin sections were hybridized with 
a digoxigenin-labeled antisense riboprobe for mVKIND (codon 2-126, accession: AJ580324.2) generated 
from a plasmid template as described previously (Leimeister et al., 1998). For the construction of the 
plasmid template, a cDNA fragment (codon 2-126, accession: AJ580324.2) was amplified by RT-PCR 
(→3.1.3.3) from cerebellum RNA of a C56BL/6 mouse and inserted into the pcDNA3 vector using 
restriction sites BamHI and XbaI. The following primers were used: 5’-mVK-in situ and 3’-mVK-in situ 
(→2.4). In the adult mouse brain VKIND expression is most prominent in the cerebellum, however 
exclusively restricted to the granular and Purkinje cell layer (Fig. 16A, B). The branching white matter of 
the cerebellum and the molecular layer display no staining. Large cells throughout most of the cerebral 
cortex are stained positive for mVKIND mRNA in a punctuate pattern (Fig. 16C). 
 
Fig. 16  Expression 
pattern of the VKIND 
gene in the adult 
mouse brain. 
(A) Overview of the 
expression pattern. (B) In 
the adult brain mVKIND is 
expressed in the granular 
and Purkinje cell layer of 
the cerebellum (arrows) 
(Abr.: m, molecular layer; 
g, granular layer; wm, 
white matter) and most 
likely in (C) the neurons of 
the cerebral cortex. 
Reproduced with 
permission from Mees et 
al. (2005). 
 
 
Pursuing an establishment of primary murine cerebellar cell culture and a prospect of further VKIND study, 
seven five days old C57BL/6 mice were sacrificed and cerebellar tissue was preparated. Granular cells were 
cultured in complete medium in 60 mm poly-lysine coated dishes at 37°C with 5% CO2 (incubator). Glial 
cells were cytostaticly suppressed with Ara-c/HCL (→3.3.1.2). RNA of 5x 106 granule cells was isolated at 
24, 48 and 96 h post preparation. RT-PCR was performed employing 0.1 µg RNA isolated from granular, 
NIH 3T3 and mouse kidney cells as single-stranded RNA template (→3.1.2.3). The employed mVKIND 
gene specific primers were: 5’-mVK and 3’-mVK (→2.4). Primers were amplifying 880 base pairs mVKIND 
gene segment. Generated cDNA fragments were examined by agarose gel electrophoresis (→3.1.1.1). 
Anaid Bedrossian IV  Results 
 
48 
cDNA fragments of a precise length were synthesized from granular cells RNA (at 24, 48 and 96 h). 
Furthermore, no cDNA was transcribed from NIH 3T3 and mouse kidney cells RNA (Fig. 17), showing that 
the mVKIND gene is specially expressed in the granular cells. 
Fig. 17  mVKIND expression in post 
natal mice granular cells. 
Day five postnatal mice cerebella were 
preparated and granular cells RNA was 
isolated at 24, 48 and 96 h post preparation. 
RT-PCR was performed with primers 
specific for mVKIND. mVKIND cDNA was 
amplified from granular cells, but not from 
NIH 3T3 and mouse kidney total RNA. 
 
4.9  Transient expression analysis  
The VKIND protein harbors five structural domains with an unresolved function and activity. To monitor 
the protein expression, putative interactions as well as the cellular localization of the novel KIND family 
member in eukaryotic cells, mouse NIH 3T3 fibroblast cells were transfected with mammalian expression 
vectors carrying the mVKIND cDNA.  
4.9.1  EGFP fusion protein expression 
To explore the subcellular distribution of the novel RasGEF protein and gain insights of its function, high 
level constitutive expression plasmids were constructed, fusing distinct truncated mVKIND mutants to the 
enhanced green fluorescent protein (EGFP). In this manner, a direct detection of fusion proteins by EGFP 
fluorescence is possible. Tab. 3 provides information about the EGFP-tagged constructs: the length of the 
incorporated protein sequence, the primers, and the restriction sites used to insert the cDNAs into the 
pEGFP-C1 expression vector. NIH 3T3 cells were transiently transfected with pEGFP-C1-mVKIND-aa2-
355, pEGFP-C1-mVKIND-aa2-709, pEGFP-C1-mVKIND-aa2-1204 and pEGFP-C1-mVKINDfl 
(→3.3.2.1, 1 µg DNA each). 24 h post-transfection cells were fixed and subjected to visual fluorescent 
microscopy analysis (→3.3.3). All constructs were expressed at high amounts. Fig. 18A shows a schematic 
outline of the utilized clones. The cellular distribution of the negative control (non fused EGFP) is illustrated 
in Fig. 18B. EGFP-mVKIND-aa2-355 (Fig. 18C) is evenly spread in the cell cytoplasm and in the nucleus. 
 
Tab. 3  Overview of the EGFP-tagged constructs. Detailed construct records are illustrated in 
Appendix II 
Construct 
Coding 
Sequence 
 Protein 
Sequence 
of Insert 
Primer 
Restriction Site 
5’/3’ 
pEGFP-C1-mVKIND-aa2-355 4-1066 bp aa2-355 
5’-fr.I+BglII 
3’-fr.I-afterXhoI+EcoRI 
BglII/EcoRI 
pEGFP-C1-mVKIND-aa2-709 4-2129 bp aa2-709 
5’-mVKIND-beforeXhoI 
3’-mVKIND-afterBstXI+BamHI 
XhoI/BamHI 
pEGFP-C1-mVKIND-aa2-1204 4-1364 bp aa2-1204 — BamHI/XbaI 
pEGFP-C1-mVKINDfl 4-1742 bp aa2-1742 — SacI/KpnI 
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Fig. 18  Fluorescence analysis of exogenous EGFP-fused mVKIND in NIH 3T3 cells.  
(A) Structural array outline of utilized clones. (B) NIH 3T3 cells were lipotransfected with vectors 
directing the expression of EGPF alone or (C) EGFP-fused mVKIND codons 2-355, (D) codons 2-
709, (E) mVKIND condons 2-1204 and (F) mVKINDfl. Subcellular localization was detected by 
autofluorescence. Subcellular accumulation is marked by golden arrows. Images were analyzed with a 
fluorescence microscope and a 100x oil immersion objective. Abbreviations: CC, coiled-coil; EGFP, 
Enhanced Green Fluorescent Protein; GEF, guanine nucleotide exchange factor for Ras-like small 
GTPases; GEFN, RasGEF N-terminal domain; K1, KIND1; K2, KIND2; mVKINDfl, murine very-
KIND full length. 
 
EGFP-mVKIND-aa2-709 displays additionally a very slight perinuclear and lamellipodial accumulation 
(Fig. 18D). Interestingly EGFP-mVKIND-aa2-1204 induced the development of large circular structures 
(Fig. 18E). The incorporation of expressed protein into these entities is observed to be forceful. The fraction 
of expressed protein which is excluded from those structures and remains in the cytosol is negligible. No 
protein is detectable at the cell periphery. EGFP-mVKINDfl expression pattern resembles very much the 
one of EGFP-mVKIND-aa2-1204 (Fig. 18F). 
 
EGFP-mVKIND-aa2-355 EGFP-mVKIND-aa2-709 
EGFP-mVKIND-aa2-1204 EGFP-mVKINDfl 
EGFP 
A 
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4.9.2  Transient expression of C-terminally truncated mVKIND mutants coding for 
KIND1 domain and KIND1/KIND2 domains 
The KIND module has been identified as an interaction domain (Ciccarelli et al., 2003; Huang et al., 2007). 
To study the localization of the KIND1 and KIND2 domains and to confirm the expression patterns of the 
EGFP-fused clones (Fig. 18C and D), coding for the KIND1 domain and KIND1/KIND2 domains, 
respectively, their Myc-tagged equivalents (Tab. 1) were transfected into NIH 3T3 cells (→3.3.2.1, 
1 µg DNA each).  
 
A 
        
   
   
Fig. 19  NIH 3T3 cells transiently expressing Myc-tagged C-terminal truncation mutants mVKIND-aa2-337 and 
mVKIND-aa2-709. 
(A) Structural array outline of utilized clones. NIH 3T3 cells were lipotransfected with vectors directing the expression of (B) Myc-epitope 
tagged mVKIND codons 2-337 and (C) codons 2-709. Cells were fixed with paraformaldehyde and stained with Oregon Green phalloidin 
(green) for actin along with Myc 9E10/ TRITC-conjugated anti-mouse secondary antibody (red) for transiently overexpressed proteins. 
Subcellular accumulation is marked by arrows. The blue arrow in pane C marks a second transiently cDNA expressing cell. Images were 
analyzed with a fluorescence microscope and a 100x oil immersion objective. Abbreviations: K1, KIND1; K2, KIND2; mVKIND, murine 
very-KIND; Myc, Myc tag. 
 
24 h post-transfection cells were fixed and stained with a primary antibody directed against the Myc tag 
epitope (9E10), located at the N-terminus of the fusion proteins, followed by a TRITC-conjugated anti-
mouse secondary antibody to expose the exogenous proteins. F-actin was visualized with 2',7'-
difluorofluorescein (Oregon Green 488 dye)-conjugated phalloidin and subjected to fluorescent analysis 
Myc-mVKIND-aa2-337 merge 
Myc-mVKIND-aa2-709 Oregon Green Phalloidin merge 
Oregon Green Phalloidin 
B 
C 
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(→3.3.3). Both constructs were expressed at high amounts. Fig. 19A pictures a schematic outline of the 
utilized clones. Myc-mVKIND-aa2-337, harboring the KIND1 domain, is detected in the cytosol, faintly 
accumulated in the perinuclear region (Fig. 19B). Myc-mVKIND-aa2-337 is also spotted in actin based cell 
surface protrusions (golden arrow). Myc-mVKIND-aa2-709, coding for both KIND domains, is observed 
mostly in the cell cytoplasm and is also enriched along actin bundles at the cell edges (Fig. 19C, golden 
arrows). Increased staining is found at cell-cell contact interfaces (red arrow). These findings are in good 
agreement with the data provided by the distribution analysis of the counterpart EGPF-fusion proteins 
(→ 4.8.1). 
 
4.9.3  Transient expression of C-terminally truncated mVKIND mutants coding for 
Myc-mVKIND-aa2-1204, Myc-mVKIND-aa2-1234 and Myc-mVKIND-aa2-1349 
To investigate putative targeting properties of the protein region adjacent to the KIND1 and KIND2 
domains of the mouse VKIND protein, the Myc-tagged mVKIND-aa2-1204, mVKIND-aa2-1234 and 
mVKIND-aa2-1349 C-terminally truncated mutants (Tab. 1 and 4) were expressed into NIH 3T3 cells 
(→3.3.2.1). 24 h post-transfection cells were fixed and treated with a primary antibody directed against the 
Myc tag epitope (9E10), located at the N-term of the fusion proteins, followed by a TRITC-conjugated anti-
mouse secondary antibody to visualize the exogenous proteins. F-actin was stained with 2',7'-
difluorofluorescein (Oregon Green 488 dye)-conjugated phalloidin and subjected to fluorescent analysis 
(→3.3.3). Fig. 20A pictures a schematic outline of the transfected clones. Both Myc-tagged mVKIND-aa2-
1204 and mVKIND-aa2-1349 mutants were expressed at high amounts, whereas the mVKIND-aa2-1234 
expression was observed only in few cells. Myc-mVKIND-aa2-1204 is harboring both KIND domains, the 
adjacent region and the coiled-coil and its expression pattern (Fig. 20B) is in agreement with the expression 
pattern of its EGFP-tagged equivalent (Fig. 18E). This truncated mutant formed structures in the cytosol, 
with estimated width of up to 7.7 µm and length of up to 8.8 µm (golden arrow). Myc-mVKIND-aa2-1234 
was observed to be difficult to express, nevertheless it also formed closed structures of estimated dimension 
of up to 10 µm width and 5.5 µm length (golden arrow) (Fig. 20C). Myc-mVKIND-aa2-1349, 
encompassing both KIND domains, the coiled-coil and a portion of the GEFN motif, exhibited a high 
expression and is viewed in roundish entities in the cytosol, with an estimated diameter of 3 µm (Fig. 20D, 
red arrow). The golden arrow points the distribution of the mouse VKIND mutant in the NIH 3T3 cell 
extension. All three truncation mutants are excluded from the nucleus and the cell membrane.  
 
 
 
 
 
 
Tab. 4  Overview of the pcDNA3-mVKIND-aa2-1234 construct. Detailed construct records are 
illustrated in Appendix II 
Construct 
Coding 
Sequence 
 Protein 
sequence  
of Insert 
Primer 
Restriction Site 
5’/3’ 
pcDNA3-mVKIND-aa2-1234 4-3702 bp aa2-1234 
5´-mKISNXbaI/HindIII-Myc 
3´-ab3682bp+EcoRI 
HindIII/EcoRI 
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Fig. 20  NIH 3T3 cells transiently expressing Myc-tagged C-terminal truncation mutants mVKIND-aa2-1204, 
mVKIND-aa2-1234 and mVKIND-aa2-1349. 
(A) Structural array outline of utilized clones. NIH 3T3 cells were lipotransfected with vectors directing the expression of (B) Myc-epitope 
tagged mVKIND codons 2-1204, (C) codons 2-1234 and (D) codons 2-1349. Cells were fixed with paraformaldehyde and stained with 
Oregon Green phalloidin (green) for actin structures along with Myc 9E10/ TRITC-conjugated anti-mouse secondary antibody (red) for 
transiently overexpressed proteins. Subcellular accumulation is marked by arrows. Images were analysed with a fluorescence microscope 
and a 100x oil immersion objective. Abbreviations: CC, coiled-coil; GEFN, RasGEF N-terminal domain; K1, KIND1; K2, KIND2; 
mVKIND, murine very-KIND; Myc, Myc tag.  
 
Myc-mVKIND-aa2-1204 merge 
Myc-mVKIND-aa2-1234 Oregon Green Phalloidin merge 
Oregon Green Phalloidin 
Myc-mVKIND-aa2-1349 Oregon Green Phalloidin merge 
C 
B 
D 
 A 
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4.9.4  Transient expression of N-terminally truncated mVKIND mutants coding for 
Myc- mVKIND-aa456- 1742, Myc-mVKIND-614-1742 and Myc-mVKIND-aa2-1451-
1742 
To further explore the function of the KIND1 and the KIND2 domains of the mVKIND protein, N-terminal 
truncation mutants were constructed, depleted of either one or both KIND domains (Myc-mVKIND-aa456-
1742 and Myc-mVKIND-aa614-1742, respectively). To analyze the distribution of the guanine nucleotide 
exchange factor domain, an N-terminal truncation mutant was created, encompassing the cDNA of the 
RasGEF module only (Myc- mVKIND-aa2-1451-1742) (Tab. 5). NIH 3T3 cells were transfected with these 
constructs (→3.3.2.1) and fixed 24 h later. An immunostain was performed using a primary antibody 
directed against the Myc tag epitope (9E10), located at the N-term of the fusion proteins and a TRITC-
conjugated anti-mouse secondary antibody to identify exogenous proteins. F-actin was stained with 2',7'-
difluorofluorescein (Oregon Green 488 dye)-conjugated phalloidin and fluorescent images were taken 
(→3.3.3). Fig. 21A pictures a schematic outline of the transfected clones. Both Myc-tagged mVKIND-
aa456-1742 and mVKIND-aa614-1742 mutants were observed only in few cells and were expressed at low 
amounts, whereas the Myc-mVKIND-aa1451-1742 mutant displayed high expression. Myc-mVKIND-
aa456-1742 harbors the KIND2 domain, its adjacent region as well as the RasGEFN and RasGEF domains. 
It is expressed predominantly and evenly in the cell cytoplasm (Fig. 21B), alike the Myc-mVKIND-aa614-
1742 mutant which is depleted of the KIND2 domain (Fig. 21C). Myc-mVKIND-aa1451-1742 is detected 
throughout the cytosol and in the nucleus (Fig. 21D). It is also detected in bundles of actin in the cell 
membrane (golden arrows). 
 
 
 
 
 
 
 
 
 
 
 
 
Tab. 5  Overview of the N-terminally truncated constructs coding for Myc-mVKIND-aa456-1742, Myc-
mVKIND-614-1742 and Myc-mVKINDaa-1451-1742. Detailed construct records are illustrated in 
Appendix II 
Construct 
Coding 
Sequence 
 Protein 
Sequence  
of Insert 
Primer 
Restriction Site 
5’/3’ 
pcDNA3-Myc-mVKIND-aa456-1742 1366-5229 bp aa456-1742 
5´KpnI+Myc-ab1366   
3´-vKIND-Ende+EcoRI 
KpnI/EcoRI 
pcDNA3-Myc-mVKIND-aa614-1742 1840-5229 bp aa614-1742 
5´KpnI+Myc-ab1840 
3´-vKIND-Ende+EcoRI 
KpnI/EcoRI 
pcDNA3-Myc-mVKIND-aa1451-1742 4351-5229 bp aa1451-1742 
5´-Ras-GEF-BamHI+Myc 
3´-Ras-GEF-EcoRI 
BamHI/EcoRI 
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Fig. 21  NIH 3T3 cells transiently expressing Myc-tagged N-terminal truncation, mutants mVKIND-aa456-1742, mVKIND-aa614-
1742 and mVKIND-aa1451-1742. 
(A) Structural array outline of utilized clones. NIH 3T3 cells were lipotransfected with vectors directing the expression of (B) Myc-epitope 
tagged mVKIND codons 456-1742, (C) codons 614-1742 and (D) codons 1451-1742. Cells were fixed with paraformaldehyde and stained 
with Oregon Green phalloidin (green) for their actin structures along with Myc 9E10/ TRITC-conjugated anti-mouse secondary antibody 
(red) for transiently overexpressed proteins. Subcellular accumulation is marked by arrows. Images were analysed with a fluorescence 
microscope and a 100x oil immersion objective. Abbreviations: CC, coiled-coil; GEF, guanine nucleotide exchange factor for Ras-like small 
GTPases; GEFN, RasGEF N-terminal domain; K2, KIND2; mVKIND, murine very-KIND; Myc, Myc tag.  
Myc-mVKIND-aa456-1742 merge Oregon Green Phalloidin 
B 
Myc-mVKIND-aa614-1742 Oregon Green Phalloidin merge 
C 
Myc-mVKIND-aa1451-1742 Oregon Green Phalloidin merge 
D 
A 
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4.9.5  Transient expression mVKIND deletion mutants coding for Myc-mVKIND-
Δaa880-1235, Myc-mVKIND-Δaa880-948 and Myc-mVKIND-Δaa1059-1235 
The alignment of the VKIND protein (Fig. 10) revealed two regions which were highly conserved among 
the species human, mouse, chicken and fugu. Region 1 spans amino acid residues 880 through 948, while 
region 2 spans amino acid residues 1059 through 1235, also harboring the coiled-coil motif (aa1121-1152). 
Since coiled-coil helices are known as mediators of protein-protein interactions and as structures responsible 
for protein stability and specificity (Singh & Hitchcock-DeGregori, 2006), the potential function of Region 
1 and 2 were addressed here. Constructs coding for mVKIND depleted of Region 1 and Region 2, 
respectively were produced (Tab 6, →3.1.4.4) and transfected into NIH 3T3 cells (→3.3.2.1, 1 µg DNA 
each). Cells were fixed 24 h later and immunostained using a primary antibody directed against the Myc tag 
epitope (9E10), located at the N-terminal of the fusion proteins and a TRITC-conjugated anti-mouse 
secondary antibody to detect the exogenous proteins. F-actin was stained with 2',7'-difluorofluorescein 
(Oregon Green 488 dye)-conjugated phalloidin and cells were fluorescently scanned (→3.3.3). Fig. 22A 
pictures a schematic outline of the transfected clones. The mutants were successfully expressed at high 
amounts in only few cells. Myc-mVKIND-Δaa880-1235 which is depleted of both Region 1 and Region 2 is 
observed in the cytosol, forming structures of estimated diameter of 0.4 µm in a speckled manner 
(Fig. 22B). Moreover, mVKIND-Δaa880-1235 is not located in the nucleus and in the cell membrane. Its 
expression pattern matches the expression pattern of Myc-mVKIND-Δaa1059-1235 (depleted of Region 2, 
including the coiled-coil) (Fig. 22D). Myc-mVKIND-Δaa880-948 (harboring the Region 2 and the coiled-
coil) on the other hand formed globular structures of estimated diameter of up to 1 µm (Fig. 22C, golden 
arrow), while it is excluded from the nucleus and the plasma membrane. In addition the observed structures 
are not associated to actin filaments.  
 
Tab. 6  Overview of the Myc-tagged deletion mutants mVKIND-Δaa880-1235, Myc-KIND-
Δaa880-948, Myc-mVKIND-Δaa1059-1235. Detailed construct records are provided in 
Appendix II 
Construct 
Depleted Coding 
Sequence 
 Depleted Protein 
Sequence of Insert 
Primer 
pTopo-Myc-mVKIND-Δaa880-1235 2639-3705 bp aa880-1235 
5´-873-879+1236-1242 
3´-873-879+1236-1242 
pTopo-Myc-mVKIND-Δaa880-948 2639-2844 bp aa880-948 
5´-873-879+949-955 
3´-873-879+949-955 
pTopo-Myc-mVKIND-Δ1059-1235 3175-3705 bp aa1059-1235 
5´-1052-1058+1236-1242 
3´-1052-1058+1236-1242 
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Fig. 22  NIH 3T3 cells transiently expressing Myc-tagged deletion mutants mVKIND-Δaa880-1235, Myc-mVKIND-
Δaa880-948, Myc-mVKIND-Δaa1059-1235. 
(A) Structural array outline of the utilized clones. NIH 3T3 cells were lipotransfected with vectors directing the expression of (B) Myc-
epitope tagged mVKIND deleted codons 880-1235, (C) deleted codons 880-948 and (D) deleted codons 1059-1235. Cells were fixed with 
paraformaldehyde and stained with Oregon Green phalloidin (green) for their actin structures along with Myc 9E10/ TRITC-conjugated anti-
mouse secondary antibody (red) for transiently overexpressed proteins. Subcellular accumulation is marked by arrows. Images were analysed 
with a fluorescence microscope and a 100x oil immersion objective. Abbreviations: CC, coiled-coil; GEF, guanine nucleotide exchange 
factor for Ras-like small GTPases; GEFN, RasGEF N-terminal domain; K1, KIND1; K2, KIND2; mVKIND, murine very-KIND; Myc, Myc 
tag. 
Myc-mVKIND-Δaa880-1235 merge Oregon Green Phalloidin 
B 
Myc-mVKIND-Δaa880-948 Oregon Green Phalloidin merge 
C 
Myc-mVKIND-Δaa1059-1235 Oregon Green Phalloidin merge 
D 
A 
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4.9.6  Transient expression of mVKIND deletion mutants coding for Myc-mVKIND-
Δaa1238-1364 
To investigate the influence and significance of the GEFN domain (amino acid residues 1238 through 1364) 
on the distribution of the mVKIND, a mutant depleted of the GEFN domain was created (Tab. 7, →3.1.4.4) 
and transfected into NIH 3T3 cells (→3.3.2.1). 24 h post transfection cells were fixed and immunostained 
using a primary antibody directed against the Myc tag epitope (9E10), located at the N-term of the fusion 
protein and a TRITC-conjugated anti-mouse secondary antibody to mark the exogenous protein. F-actin was 
visualized with 2',7'-difluorofluorescein (Oregon Green 488 dye)-conjugated phalloidin and stains were 
subjected to fluorescent microscopy (→3.3.3). Fig. 23A pictures a schematic outline of the clone. The 
mutant was successfully expressed in only few cells at high amounts. It accumulated in circular structures 
and distributed uniformly throughout the cytosol, being excluded from the nucleus and the cell membrane 
(Fig. 23B). Cells crafted cytosolic circular structures at low rates. 
 
Tab. 7  Overview deletion mutant mVKIND-∆aa1238-1364 construct. Detailed construct 
records are provided in Appendix II 
Construct 
Depleted Coding 
Sequence 
≡ Depleted Protein 
Sequence of Insert 
Primer 
pTopo-Myc-mVKIND-∆aa1238-1364 3712-4092 bp aa1238-1364 
5´-withoutRasGEFN 
3´-withoutRasGEFN 
 
 
                                                                                                           
   
Fig. 23  NIH 3T3 cells transiently expressing Myc-tagged deletion mutant mVKIND-∆aa1238-1364. 
(A) Structural array outline of the utilized clone. NIH 3T3 cells were lipotransfected with a plasmid coding for (B) Myc-epitope tagged 
mVKIND deleted codons 1238-1364. Cells were fixed with paraformaldehyde and stained with Oregon Green phalloidin (green) for actin 
along with Myc 9E10/ TRITC-conjugated anti-mouse secondary antibody (red) for the transiently overexpressed protein. Images were 
analysed with a fluorescence microscope and a 100x oil immersion objective. Abbreviations: CC, coiled-coil; GEF, guanine nucleotide 
exchange factor for Ras-like small GTPases; GEFN, RasGEF N-terminal domain; K1, KIND1; K2, KIND2; mVKIND, murine very-KIND; 
Myc, Myc tag. 
 
Myc-mVKIND-Δaa1238-1364 merge Oregon Green Phalloidin 
A 
B 
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4.9.7  Transient expression of mVKINDfl 
Transiently expressed mVKINDfl in NIH 3T3 cells revealed the formation of distinguished circular 
structures which were dispersed throughout the cytosol (Fig. 18F). To address the influence of the liposomal 
transfection method with the Lipofectamine transfection reagent on the formation of these structures in NIH 
3T3 cells, Myc-mVKINDfl and EGFP-mVKINDfl (Tab. 1 and Tab. 3) (Fig. 24A) were expressed by 
calcium phosphate transient transfection (→3.3.2.2). NIH 3T3 cells expressing Myc-mVKINDfl were fixed 
and immunostained using a primary antibody directed against the Myc tag epitope (9E10) located at the N-
terminus of the Myc-fusion protein and a TRITC-conjugated anti-mouse secondary antibody to mark the 
exogenous protein 24 h post transfection. F-actin was visualized with 2',7'-difluorofluorescein (Oregon 
Green 488 dye)-conjugated phalloidin, whereas cells expressing EGFP-tagged mVKINDfl were fixed and F- 
actin was probed with tetramethylrhodamine-conjugated phalloidin. EGFP-mVKINDfl (Fig. 24B) as well as  
 
       A 
 
   
   
Fig. 24  NIH 3T3 cells transiently transfected with EGFP-mVKINDfl and Myc-mVKINDfl by DNA-calcium 
phosphate co-precipitation procedure. 
(A) Structural array outline of utilized clones. NIH 3T3 cells were transfected with calcium-phosphate coprecipitation of a plasmid coding for 
(B) EGFP-fused mVKINDfl and (C) Myc-epitope tagged mVKINDfl. Cells were fixed with paraformaldehyde and cells expressing EGFP-
fused mVKINDfl were probed with tetramethylrhodamine-conjugated phalloidin for F-actin, whereas cells expressing Myc-epitope tagged 
mVKINDfl were stained with Oregon Green phalloidin (green) for actin along with Myc 9E10/ TRITC-conjugated anti-mouse secondary 
antibody (red) for the transiently overexpressed protein. Images were analyzed with a fluorescence microscope and a 100x oil immersion 
objective. Golden arrow in pane C marks a second Myc-mVKINDfl expressing cell. Abbreviations: CC, coiled-coil; EGFP, Enhanced Green 
Fluorescent Protein; GEF, guanine nucleotide exchange factor for Ras-like small GTPases; GEFN, RasGEF N-terminal domain; K1, KIND1; 
K2, KIND2; mVKINDfl, murine very-KIND full length; Myc, Myc tag. 
B             EGFP-mVKINDfl Phalloidin Rhodamine merge 
C              Myc-mVKINDfl Oregon Green Phalloidin merge 
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Myc-mVKINDfl (Fig. 24C) was found expressed at high levels. The expressed protein is accumulated in 
circular structures in the cytosol and excluded from nucleus and the cell membrane. Moreover, the spherical 
entities were not associated to the actin filament network. These findings are in good agreement with the 
results presented in 4.8.1. 
 
4.9.8  Summary of the transient expression of mVKINDfl and mVKIND truncation 
mutants 
Summarized subcellular distribution of the transiently expressed mVKINDfl and its truncation mutants in 
mouse NIH 3T3 fibroblast cells is presented in Fig. 25, as previously presented in Fig. 18, 19, 20, 21, 22, 23 
and 24.  
UTILIZED TRUNCATION MUTANTS  SUBCELLULAR DISTRIBUTION 
 A 
mVKIND-aa2-337; uniform nuclear and cytoplasmic 
distribution, faint accumulation in the perinuclear region and in 
actin based cell surface protrusions 
 B 
mVKIND-aa2-709; uniform cytoplasmic distribution, slight 
perinuclear and lamellipodial accumulation, enriched along actin 
bundles at the cell edges 
 C mVKIND-aa2-1204; formed uniformly distributed circular 
cytoplasmic structures 
 D mVKIND-aa2-1234; formed uniformly distributed circular 
cytoplasmic structures 
 E mVKIND-aa2-1349; formed uniformly distributed circular 
cytoplasmic structures 
                  F mVKIND-aa456-1742; uniform cytoplasmic distribution 
                        G mVKIND-aa614-1742; uniform cytoplasmic distribution 
                                                       H mVKIND-aa1451-1742; uniform cytoplasmic distribution, 
enriched on actin bundles in the cell membrane 
 I mVKIND-Δaa880-1235; formed uniformly distributed circular 
cytoplasmic structures 
 J mVKIND-Δaa880-948; formed uniformly distributed circular 
cytoplasmic structures 
 K 
mVKIND-Δaa1059-1235; formed uniformly distributed circular 
cytoplasmic structures 
 L mVKIND-∆aa1238-1364; formed uniformly distributed circular 
cytoplasmic structures 
 M mVKINDfl; formed uniformly distributed circular cytoplasmic 
structures 
                                          
Fig. 25  Subcellular distribution of the transiently expressed mVKINDfl and its truncation mutants in mouse NIH 3T3 
fibroblast cells 
Detailed construct records are provided in Appendix II. Abbreviations: CC, coiled-coil; GEF, guanine nucleotide exchange factor for Ras-like 
small GTPases; GEFN, RasGEF N-terminal domain; K1, KIND1; K2, KIND2; mVKINDfl, murine very-KIND full length. 
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4.10  Live cell imaging of EGFP-mVKINDfl transfected cells 
Mouse fibroblast NIH 3T3 cells transiently expressing mVKINDfl revealed the occurrence of massive 
circular structures that ranged in size up to 10 µm in a period of 24 h (Fig. 18 and 24). To monitor the 
formation and evolution of these structures, NIH 3T3 cells were lipotransfected with plasmids coding for 
EGFP-mVKINDfl (Tab. 3). A subsequent microscopic time-lapse imaging was carried out.  
For the EGFP-mVKINDfl time lapse analysis, NIH 3T3 cells were plated on glass cover slips in growth 
medium in 35 mm-well plates. Cells were allowed to adhere for approximately 18 h and were subjected to 
Lipofectamine mediated EGFP-mVKINDfl transfection (→3.3.2.1, 1 µg DNA). 5 h post transfection, cells 
were provided with fresh growth medium. Detection of the fluorescent signal from EGFP-mVKINDfl 
required approximately 6 h. Upon visual evidence of high levels transient expression of the EGFP-fused 
mouse VKIND, a cover slip carrying positively transfected NIH 3T3 cells was clamped in a cover slip 
chamber. Cells were overlaid with warm growth medium (CO2 free, Gibco) and immediately transferred to a 
fluorescent microscope (Leica) while being incubated at 37°C. Cells positive for EGFP fluorescence were 
selected and focused with a 100x oil immersion objective. Subsequently, a time-lapse fluorescent 
monitoring was initiated with images captured every 30 s for 22 min employing a digital camera 
(Hamamatsu Orca). Images (1024x1022 pixels) were optimized and light intensities were color-coded with 
Openlab imaging software (Improvision). QuickTime videos (.mov format) were generated using time series 
pictures (→3.3.4). The time-lapse analysis revealed a series of events by which the EGFP-carrying particles 
in the NIH 3T3 cytoplasm are in motion, make contact and eventually fuse. Fig. 26A illustrates three 
structures estimated to be up to 0.3 µm in size (golden, red and blue arrows) at start. Fig. 26B shows the 
slight migration of these three structures 4.5 min later which ultimately results in the fusion of two 
structures, indicated by blue and red arrows (Fig. 26C, the resulting larger structure is indicated by red 
arrow). Fig. 26D and E demonstrate the subsequent contact and fusion of the two structures described above 
(upper cell, red rectangle). At the same time, the red rectangle in the lower cell points out two distinct 
entities which fuse within the following 12 min (Fig. 26, images E through H). In general, the nascent 
structures progressively grew over the time period of 21 min to significantly larger entities of approximately 
2 µm in size. Relocation of the structures throughout the cytoplasm was viewed to be in cases leading to 
particle fusion directed and highly dynamic. 
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4.11  mVKIND antibody 
For further characterization of the endogenous expression pattern of the mouse VKIND protein, an 
mVKIND polyclonal antibody was generated by rabbit immunization. A designated mVKIND peptide, 
encompassing amino acid residues 219 through 453 (poorly conserved), was fused to glutathione-S-
transferase (GST) (pGEX-6P-1-mVKIND-aa219-453, Tab. 8, Fig. 29B). Recombinant GST-mVKIND-
aa219-453 (Fig. 27A) protein was expressed in the E. coli host stain Rosetta (Novagen) (→3.2.2). The 
Rosetta strain contains a pRARE plasmid coding for all of the rarely used codons Arg, Ile, Gly, Leu and Pro, 
enabling high protein expression yields (Novy et al., 2001). The GST-fusion protein was affinity purified on 
Glutathione Sepharose 4b beads (Amersham) under nondegrading conditions following the manufacturer’s 
batch purification protocol. The buffer was exchanged by using NAP 10 columns to TBST buffer and 
supplemented with 20% glycerin (→3.2.3, 3.2.4). The immunization with the mVKIND antigen was 
performed by immunoGlobe and crude sera were stored at -20°C. A sample of the acquired anti-mVKIND 
serum was supplemented with 0.02% NaN3 (v/v) and examined by western blot techniques. Initially, NIH 
3T3 fibroblasts were lipotransfected with vectors coding for Myc-epitope tagged mVKIND-aa2-709, 
mVKIND-aa2-1204 and mVKINDfl (→3.3.2.1). Total cell lysates were separated by SDS-polyacrylamide 
gel electrophoresis (→3.1.1.1) and analyzed by immunoblotting with the preimmune serum (→3.2.1) 
(Fig. 27B), the anti-mVKIND serum (Fig. 27C) and the anti-Myc antibody 9E10 (Fig. 27D). The developed 
immunoblot showed a slight background signal with the preimmune serum, whereas the anti-mVKIND 
serum detected the transiently overexpressed mVKINDfl and its C-terminal truncation mutants. The 
mVKIND antiserum was further analyzed by western blot, employing C57BL/6 mouse tissue samples 
(→2.6.3). Total tissue lysates were separated by SDS-PAGE and subjected to immunodetection using the 
anti-mVKIND serum. The anti-mVKIND serum detected the endogenous mouse VKIND protein in the 
murine brain and cerebellum tissue samples, with an apparent molecular weight of approximately 200 kD 
(Fig. 28A and B, golden stars), along with an equal sized overexpressed exogenous Myc-tagged mVKINDfl 
(Fig. 28B, indicated by a red star). Next, the anti-mVKIND serum was tested by immunocytochemical 
analysis. NIH 3T3 mouse fibroblasts were transfested by lipofection with a vector coding for EGFP-
mVKINDfl (→3.3.2.1). At 24 h post transfection, cells were fixed and EGFP-mVKINDfl was visualized by 
autofluorescence and staining with the anti-mVKIND serum along with a tetramethylrhodamine 
isothiocyanat (TRITC)-conjugated secondary antibody (red) (→3.3.3). EGFP-mVKINDfl accumulated in 
circular structures which were detected by the anti-mVKIND serum, along with a strong nonspecific 
background (Fig. 29). 
 
Tab. 8  Overview of the pGEX-6P-1-mVKIND-aa219-453 construct. Detailed construct records 
are illustrated in Appendix II 
Construct 
Coding 
Sequence 
 Protein 
Sequence  
of Insert 
Primer 
Restriction Site 
5’/3’ 
pGEX-6P-1-mVKIND-aa219-453 655-1359 bp aa219-453 
5´-vKIND-BamHI-655bp 
3´-vKIND-1340bp-EcoRI 
BamHI/EcoRI 
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Fig. 27  Anti-mVKIND serum tested by western blotting. 
(A) Purified GST-mVKIND-aa219-453 with an apparent molecular weight of approximately 56 kD. (B) 
Western blots developed with preimmune rabbit serum (1:300), (C) anti-mVKIND serum (1:300) and 
(D) the Myc 9E10 antibody. Abbreviations: GST, glutathione-S-transferase; kD, kilo Dalton; VK, 
mVKIND; mVKINDfl, murine very-KIND full length; Myc, Myc tag.  
 
 
Fig. 28  WB mVKIND antiserum analysis, employing 
mouse tissue samples. 
(A) C57BL/6 mouse tissue total lysates of lung, colon, brain 
and ovary, along with (B) total tissue lysate of cerebellum and 
in HeLa cells exogenously overexpressed mVKINDfl were 
separated by SDS-PAGE and blotted onto nitrocellulose 
membrane. Immnunoblots were developed with anti-mVKIND 
serum (1:300). Stars indicate immunodetected endogenous 
mVKIND. Abbreviations: kD, kilo Dalton; mVKfl, murine 
very-KIND full length . 
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Fig. 29  mVKINDfl detection in NIH 3T3 cells transiently expressing EGFP-mVKINDfl with an anti-mVKIND 
serum  
(A) Structural array outline of the utilized clone. (B) Schematic overview of the GST-tagged mVKIND peptide used for generating a 
polyclonal antibody. (C) NIH 3T3 cells were lipotransfected with a vector directing the expression of EGFP-epitope tagged mVKINDfl. 
Cells were fixed with paraformaldehyde and stained with anti-mVKIND serum (1:1000)/ TRITC-conjugated anti-mouse secondary 
antibody (red) for the transiently overexpressed protein. Subcellular localization of the EGFP-epitope tagged mVKINDfl was detected by 
autofluorescence. Images were analyzed with a fluorescence microscope and a 100x oil immersion objective. Abbreviations: AG, antigen; 
CC, coiled-coil; EGFP, Enhanced Green Fluorescent Protein; GEF, guanine nucleotide exchange factor for Ras-like small GTPases; GEFN, 
RasGEF N-terminal domain; GST, glutathione-S-transferase; K1, KIND1; K2, KIND2; mVKINDfl, murine very-KIND full length; VK, 
mVKIND. 
 
4.12  Murine VKIND protein phosphorylation by the p38 MAPK 
Guanine nucleotide exchange factors (GEFs) are highly regulated (Mitin et al., 2005). To determine if the 
mouse VKIND is a possible phosphorylation target of mitogen activated kinases, the phosphorylation of the 
mVKIND was investigated. NIH 3T3 mouse fibroblasts were transfected with plasmids either coding for 
Myc-mVKIND-aa2-709 alone (Tab. 1, computational calculated molecular weight of 78.49 kD), or along 
with plasmids coding for mitogen-activated protein kinase kinase 6 (MKK6, constitutively active) as well as 
p38 mitogen-activated protein kinase (MAPK), respectively (→3.3.2.1, 0.7 µg pcDNA3-Myc-mVKIND-
aa2-709 in combination with 0.4 µg DNA of each kinase expressing construct). Additionally, Myc-
mVKIND-aa2-337 (Tab. 1, computational calculated molecular weight of 40.3 kD) was expressed in NIH 
3T3 alone, as well as cotransfected with MKK6 and p38 MAPK (→3.3.2.1, 0.7 µg pcDNA3-Myc-
mVKIND-aa2-337 in combination with 0.4 µg DNA of each kinase expressing construct). Total cell lysates 
C 
EGFP-mVKINDfl merge 
EGFP-mVKINDfl + 
anti-mVKIND serum 
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were subjected to SDS-PAGE and western blotting (→3.2.1), revealing an electrophoretic mobility shift of 
the C-terminal truncation mutant mVKIND-aa2-709, suggesting an in vivo p38 phosphorylation (Fig. 30B), 
whereas mVKIND amino acids 2-337 were not phosphorylated. 
 
 
                                                                                                  
Fig. 30  Electrophoretic mobility shift of the N-terminally truncated 
mVKIND-aa2-709 mutant. 
(A) Overview of structural array of mVKINDfl and the utilized clones. (B) The 
region encompassing the two KIND domains (aa2-709) of  the mVKIND protein is 
phosphorylated by p38 MAPK activity in vivo and in consequence migrates more 
slowly. NIH 3T3 cells were lipostrasfected with vectors coding for either Myc-
mVKIND-aa2-709 and Myc-mVKIND-aa2-337 alone or in combination with 
vectors directing the expresison of MKK6 and p38. Total protein lysats were 
analyzed by immunoblot with the Myc 9E10 antibody. Abbreviations: CC, coiled-
coil; GEF, guanine nucleotide exchange factor for Ras-like small GTPases; GEFN, 
RasGEF N-terminal domain; K1, KIND1; K2, KIND2; MKK6, mitogen-activated 
protein kinase kinase 6; mVKIND, murinevery-KIND; Myc, Myc tag; p38 MAPK, 
p38 mitogen-activated protein kinase; VK, mVKIND. 
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5.1 | Cloning and structure 
At present the kinase non-catalytic C-lobe domain is located at present in the N-terminal regions of three 
proteins: 1) the Spir family of actin organizers (Otto et al., 2000; Ciccarelli et al., 2003); 2) the non-receptor 
tyrosine phosphatases type 13 (PTP type 13) (Erdmann, 2003); and 3) the guanidine exchange factor of the 
Ras-like small guanosine GTPases (VKIND) (Mees et al., 2005) (Fig. 3). A cDNA coding for the mouse 
VKIND was generated by cloning six RT-PCR fragments (Fig. 8, Tab. 1), employing cerebellum RNA of an 
adult C57BL/6 mouse as template. An open reading frame of 5229 base pairs (Fig. 9C) (with the 
endogenous stop codon) was deduced from sequenced cDNA fragments and the assembling accuracy was 
confirmed by DNA sequence analysis as well as endonucleolytic cleavage. The open reading frame 
translates into 1742 amino acid residues (Fig. 9D). The precise expression of the cloned Myc-epitope tagged 
full length mVKIND was confirmed by transient expression in NIH 3T3 mouse fibroblasts. The 
computational calculated size of 191,204 kD coincided with the observed apparent molecular weight of 205 
kD (Fig. 12). 
The novel KIND domain comprises the entire C-lobe of the protein kinase catalytic fold of p21 activated 
kinases (PAKs) except the N-lobe and the linker region (Ciccarelli et al., 2003) (Fig. 1A). The absence of 
structures essential for enzymatic activity, i.e. the N-lobe, including the N-terminal subdomains I-IV 
primarily involved with nucleotide binding and orienting; the invariant Asp166 and Asn171 (as referenced to 
PAK) in C-lobe subdomain VIB, assigned with catalytic kinase activity; the invariant amino acid Asp184 (as 
referenced to PAK) in the activation loop that is incorporated in the highly conserved DFG triplet in the C-
lobe subdomain VII; and the deep cleft between the structurally independent lobes recognized as the site 
initiating the phosphotransfer supposably deprives the KIND domain of any catalytic capacity (Hanks & 
Hunter, 1995; Knighton et al., 1991a; Knighton et al., 1991b) (Fig. 2). Homologous enzymes and 
nonenzymes sharing high sequence identity but not performing any similar functions have been described 
(Todd et al., 2002). The KIND domain appears to be an adapted nonenzyme within a superfamily that 
otherwise embodies protein kinases. Given the kinase domain is apparently an ancient module which 
ancestor predates the divergence of Bacteria, Archaea and Eukaryotes (Leonard et al., 1998), whereas the 
KIND domain is present only in Metazoa substantiates the assumption. An interaction and/or regulatory 
potential for the KIND domain is advocated since paired nonenzymes retain a ligand binding capacity (Todd 
et al., 2002) and the PAK1 C-lobe communicates the substrate recognition (Knighton et al., 1991a). In fact, 
recently we reported that the Spir family KIND domain mediates the inhibition of actin nucleation by 
Cappuccino family formins (Quinlan et al., 2007). In an evolutionary conserved interaction the Drosophila 
and mammalian Spir KIND domains bind the formin homology 2 (FH2) domain of Cappuccino (or its 
mammalian homologue formin-2) at a ratio of 2:2 (two KIND monomers/one FH2 dimer) while competing 
with actin filaments and microtubules (Quinlan et al., 2007). Moreover, the interaction of the Spir KIND 
domain with Cappuccino enhances the actin nucleation by Spir. The KIND domains of the protein VKIND, 
however, did not bind the Formin-2 FH2 domain, emphasizing the specificity of the interaction (Quinlan et 
al., 2007). 
In the VKIND protein two homologous KIND domains are arranged in the N-terminal region in a tandem 
like fashion (Fig. 3 & Fig 9C, D). The nomination of the novel eukaryotic protein is attributed to the dual 
occurrence of two KIND domains (KIND1/2) in its structure. Recently, the interaction capacity of the 
KIND2 domain was demonstrated as it binds to the microtubules-associated protein 2 (Huang et al., 2007).  
While the precise purpose of the first KIND domain of the VKIND protein remains obscure, some roles can 
be hypothesized analyzing the protein composition. Remarkably, up to 80% of the eukaryotic genome 
account for multidomain proteins (Apic et al., 2001a; Han et al., 2007). In some occasions domains behave 
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in a cooperative manner, that is the folding of individual domains is influenced by its adjacent domains 
(Batey et al., 2005; Zhou et al., 2005). Still, in others domains fold independently (Scott et al., 2002; 
Robertsson et al., 2005). Notably, the Spir KIND domain does not form dimers (Quinlan et al., 2007). It can 
be assumed that the folding of one KIND domain of VKIND may have stabilizing effects on the folding of 
the neighboring domain by interdomain interactions, given the KIND domains are separated by a linker of 
239 amino acid residues (Fig. 9D). It has been shown that tandem domains attain stabilization while flanked 
by expanded non-native peptides (Randles et al., 2007). Additionally, specific interdomain interactions may 
have essential biological significance, since multidomain proteins were assigned new functions combining 
evolutionary old building entities rather than inventing new ones (Apic et al., 2001b). Special functional 
demands that appeared with the rising of Metazoa, such as complex signalling, cell adhesion along with 
regulatory mechanisms, were met by repeated domains of Metazoa-specific families (Apic et al., 2001b). 
The cooperativity aspect of the KIND domains in VKIND remains to be elucidated, yet there is an 
indication that the functional ability of the KIND2 domain might be enhanced in the presence of the KIND1 
domain (Huang et al., 2007). 
A coiled-coil helix was predicted in the central portion of mVKIND by COILS (version 2.2) (Lupas et al., 
1991) (Fig. 9D). The coiled-coil is a general and highly versatile assembly motif present in a wide range of 
structural and regulatory proteins (Lupas, 1996) that comprise estimated 2-8% of the genomic complement 
(Rose et al., 2005). The coiled-coil functional variety ranges from assembling of macromolecular complexes 
to molecular recognition (Lupas et al., 1991) indicating an essential biological activity. Short coiled-coils 
(up to 35 residues) are reported to be stable (Yu, 2002) and important for oligomerization (Hayward & 
Koronakis, 1999). Furthermore, short coiled-coils were found to be involved in mediating protein-protein 
interactions (Picking et al., 2001). The coiled-coil of the eukaryotic protein Coronin, involved in actin 
rearrangements, is essential for its dimerization and ability to bind F-actin (Asano et al., 2001). Indeed, the 
coiled-coil module is a prominent structural feature for many eukaryotic cytoskeletal proteins engaged in the 
association with and regulation of actin polymerization (e.g. α-Actinin, α-Catenin and VASP) (Delahay & 
Frankel, 2002). In the light of the ligands for coiled-coil interactions tending to be coiled-coil helices as well 
(Delahay & Frankel, 2002), there is a promising option for VKIND to interact with multiple partners (i.a. F-
actin) via its coiled-coils motif. Moreover, interaction between coiled-coils and non-coiled-coils structures 
have also been described (Nusrat et al., 2000). Phosphorylation events induce functional modification 
(stabilization or destabilization) of coiled-coil interactions (Szilak et al., 1997) and display a means of 
VKIND regulation in the context of subcellular environment.  
In the carboxy-terminus of VKIND a guanine nucleotide exchange factor for Ras-like small GTPases 
(RasGEF) with a structural motif attached at its N-terminal site (RasGEFN) was identified by SMART 
(Schultz et al., 1998) (Fig. 9). The Ras subfamily comprises 36 members (e.g. H-Ras, Rap1, Rap2, RalA and 
B) and regulates signalling knots in respond to various extracellular stimuli (Vojtek & Der, 1998; Repasky 
et al., 2004; Wennerberg et al., 2005). Ras subfamily GTPases employ GEFs that share a catalytic domain 
with homology to the yeast RasGEF CDC25 (Ehrhardt et al., 2002). Sequence alignment of the VKIND 
GEF domain with representatives of other GEF domains for Ras subfamily GTPases, such as RapGEFs, 
RalGEFs and the H-RasGEFs indicates that the VKIND RasGEF domain is a CDC25 like domain (Fig. 11). 
The closest relation of the VKIND RasGEF domain with average sequence identity of 23% is assigned to 
the RasGEF domains of exchange factors specific for Rap GTPases, such as the Epac, MR-GEF and RA-
GEF (Fig. 11). Notably, the alignment shows that the VKIND enzymatic domain has a unique structure. It 
features two insertions, the first one of 24 amino acids in the N-terminal end of the domain (between helixes 
αA and αB of the SOS1 RasGEF module) and the second one of 11 amino acids in the C-terminal part 
Anaid Bedrossian V | Discussion 
 
69 
(between, helixes αJ and αK of the Sos1 RasGEF module) (Boriack-Sjodin et al., 1998) (Fig. 11). 
Nonetheless, recently VKIND was reported to operate as a GEF for the Ras GTPase (Huang et al., 2007). 
The CDC25 homology domains of the Ras branch, however, have been shown to concurrently regulate the 
cycling of other Ras subfamily proteins (Mitin et al., 2005). Thus, addtional interaction partners of the 
VKIND RasGEF domain remain to be investigated.  
To present knowledge the RasGEFN domain is mutual to all but one RasGEFs (Quilliam et al., 2002; Bos et 
al., 2007). The exceptional one is a dual specificity exchange factor for H-RAS and Rap 1A, PLCE1 (1-
phosphatidylinositol-4,5-bisphosphate phosphodiesterase epsilon-1) (accession: Q9P212). In SOS RasGEFN 
interacts with one edge of a helical hairpin (helices αH and αI) that projects from the main body of the 
CDC25 domain and is thereby loosely hinged to the core of the catalytic domain (Margarit et al., 2003). The 
helical hairpin is responsible for the displacement of the Switch 1 segment of Ras during the guanine 
nucleotide exchange reaction (Margarit et al., 2003). Interaction between the RasGEFN domain and the 
helical hairpin is critical for SOS function, since disruption of this interface reduces nucleotide exchange 
activity severely (Hall et al., 2001) even though Ras and SOS interact entirely via the CDC25 domain 
(Sondermann et al., 2004). Remarkably, in SOS the GEFN and GEF domains form an allosteric binding site 
for Ras·GTP (Margarit et al., 2003). Upon binding of Ras·GTP to this distal site the Ras exchange activity is 
increased to maximal levels revealing a positive feedback loop (Margarit et al., 2003). Additionally, it has 
been shown that Ras·GDP binds with lower affinity to the GEFN-GEF interface and sets an intermediate 
level of SOS activity (Sondermann et al., 2004). Yet SOS nucleotide exchange activity is masked until so 
far undescribed signals trigger the displacement of the DH-PH unit as the DH domain operates as a 
autoinhibition element (Sondermann et al., 2004). It has been proposed that the GEFN-GEF interface might 
be intrinsically unstable thus causing changes at the GEF active site and can be stabilized by Ras·GTP or 
Ras·GDP (Sondermann et al., 2004). While the Ras distal allosteric site is not conserved among other 
RasGEFs (Margarit et al., 2003) these findings indicate the significance of the interface between the GEFN 
and GEF domains for the proper GEF function of VKIND.  
The structure of the VKIND protein is highly conserved among species. Sequence analysis of the human, 
mouse, chicken and fugu protein showed a high conservation within the predicted two KIND domains, the 
coiled-coil region, the RasGEFN and the RasGEF domains (Fig. 10). Moreover, the phylogenic analysis 
yielded a distribution of the VKIND gene only in Vertebratae and Echinodermatae (S. purpuratus and 
P. lividus). Echinodermatae, like Chordatae, are Deuterostomia and thought to share a common ancestor and 
to be the most closely related of the major phyla to the Chordatae. Intriguingly, about 70% of sea urchin 
genes have a human counterpart compared for example to just 40% of fruit fly genes (Sodergren et al., 
2006a; Sodergren et al., 2006b). Though invertebrate sea urchins exhibit a radically different morphological 
design from humans and other Vertebratae, basic similarities are displayed by their embryonic development. 
Notably, receptor tyrosine kinases for growth factors and over 90% of sea urchin small GTPases are 
expressed during their embryogenesis suggesting a comparable complexity of signaling through GTPases 
between sea urchins and Vertebratae (Sodergren et al., 2006b). Analysis of the sea urchin genome also 
revealed genes involved in constructing neurons, transmitting signals and axon guidance (Sodergren et al., 
2006b). In the light of sea urchins bearing genes associated with taste, smell, hearing, balance and visual 
perception even without possessing eyes and ears (Sodergren et al., 2006b), it is credible that the ancient 
gene VKIND was assigned an important role in processing of sensory information and development.  
 
5.2 | mVKIND Antibody 
The mVKIND polyclonal antibody was produced by a rabbit immunization employing a peptide 
encompassing amino acid residues 219 through 453. The protein region selection was based on its poor 
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conservation (Fig. 10), therefore higher specificity was predicted. When tested by western blotting the 
VKIND antibody was able to detect the exogenous and endogenous VKIND protein with a slight 
background signal (Fig. 26 & 27).  
When tested by immunocytochemical analysis in NIH 3T3 mouse fibroblasts the VKIND antibody exhibited 
a strong nonspecific background suggesting further affinity purification procedures (Fig. 28). 
 
5.3 | mVKIND expression  
The highly restricted spatial expression pattern of the mammalian VKIND gene was revealed by a northern 
blot analysis. VKIND was not detected in adult murine tissues of the digestive, excretory, immune, male 
reproductive and respiration systems (Fig. 13). On the other hand, strong expression was found in the 
murine nervous system along with a low expression in the female reproductive system (Fig. 13). The mouse 
VKIND mRNA was found to possess the size of the published VKINDfl mRNA length (Fig. 9A). The 
northern blot analysis may also feature an indication of a second VKIND isoform (at the level of ~3 kb). 
The VKIND gene expression in the brain and the neural tube was also confirmed during mouse 
embryogenesis by in situ hybridizations. At E14.5 a high VKIND expression was located in the mid- and 
hindbrain with just weak expression in the forebrain (Fig. 14A). In the time course there was a shift of the 
main expression towards the telencephalon at E17.5 (Fig. 14A, B). At E10.5 (Fig. 14C), an even earlier 
VKIND expression was traceable in the murine neural tube in the ventro-lateral part, where motoneurons are 
already positioned, and it was later prolonged to the dorsal part (Fig. 14C, F, I). Particularly, at E10.5 the 
VKIND expression pattern in the neural tube coincided in part with markers for post mitotic motoneurons 
within the neural tube and early post mitotic migrating neurons (Fig. 14D, E). VKIND expression in the 
developing DRG was detectable not before E12.5 (Fig. 14C), while by E14.5 VKIND expression was 
distributed throughout the entire neural tube except for the marginal layer, but only in a speckled pattern 
(Fig. 14I). The speckled pattern is indicative of a cell type specific and probably neuronal expression 
pattern.  
In the developing vertebrate eye the expression of VKIND was restricted to the future neuronal cell layers 
and to the fetal stage E17.5 (Fig. 15A, B, C). Notably, the most specific expression of mVKIND in the 
retinal ganglion cells correlates with the high enrichment of rodent MAP2 mRNA in dendritic regions of the 
retina (Cristofanilli et al., 2004). A relation between the abolished VKIND expression past E17.5 and the 
differential expression of distinct MAP2 isoforms both during development and adulthood (Dehmelt & 
Halpain, 2005) remains to be determined.  
Intriguingly, in the adult mouse brain VKIND expression is most prominent in the cerebellum (Fig. 16A, B), 
however exclusively restricted to the granular and Purkinje cell layers indicating a very specific expression 
pattern (Fig. 16B, C). In addition, mVKIND was identified in cultured primary cerebellar cells of postnatal 
mice (Fig. 17).  
During embryonic development, VKIND may play a role in the delicately synchronized neuronal 
proliferation, migration and differentiation required for the construction of functional synaptic circuits in the 
mammalian cerebral cortex (Weimer & Anton, 2006). Granule cells precursors tour a complex migration 
route: they arise from the dorsal hindbrain rhombic lip and during embryonic development stream across the 
outer surface of the cerebellum founding the external germinal layer (E13-14 in mice) (Wingate, 2001; 
Porcionatto, 2006). After birth during the first two weeks of age EGL cells undergo extensive proliferation, 
move inward along Bergmann glia and establish contacts with the Purkinje cells (Wechsler-Reya, 2003; 
Porcionatto, 2006). Differentiating granule cells continue inward migration through the molecular layer and 
past the Purkinje cell bodies to their very last destination, the internal granule layer (Wechsler-Reya, 2003) 
where they make synapses with mossy fibers and Golgi cell axons (Ito, 1997). On the other hand, Purkinje 
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cell progenitors arise via radial migration from the neuroepithelium between E13 and E17 (Alvarez Otero et 
al., 1993).  
Ras subfamily GTPases participate in every aspect of the orchestration of granule cell precursor 
proliferation, cell-cycle exit and differentiation, migration, axon extension and synapse formation (Pascual-
Castroviejo et al., 1994) all of which are influenced by dynamic rearrangements of the neural cytoskeleton 
(Weimer & Anton, 2006). Likewise, the expression of extracellular guidance factors, such as Netrin 1, and 
of their respective receptors (e.g. DCC and α6β4 integrin) is strictly regulated in time and space during the 
early cerebellar development (Cirulli & Yebra, 2007). Netrin 1 exerts a chemorepulsive effect on the axonal 
outgrowth and migration of granule cells (Alcantara et al., 2000). The DCC/α6β4 integrin intracellular 
signalling response incorporates the Ras and AKT signaling pathways which are engaged in the control of 
cell migration and cell proliferation (Cirulli & Yebra, 2007). Conclusively, the expression pattern of the 
mVKIND protein during embryogenesis suggests its possible participation in the Ras GTPases regulated 
network of neuronal migration, process outgrowth (also retraction) along with nuclear translocation to 
ensure their correct positioning in the cerebellar cortex, eye and neural tube.  
 
5.4 | Transient expression  
Subcellular distribution of high level constitutively expressed mVKIND protein was explored by EGFP-
fused and Myc-epitope-tagged mVKINDfl and various C-terminal truncation mutants in NIH 3T3 mouse 
fibroblasts.  
The KIND1 domain evenly distributed in the cell cytoplasm and in the nucleus, indicating no specific 
localization (both EGFP- and Myc-fused) (Fig. 18C & 19B). Additionally, the KIND1 domain was detected 
in actin based cell surface protrusions (Fig. 19B). The expression of KIND1/KIND2 domains displayed 
perinuclear and lamellipodial accumulation (both EGFP- and Myc-fused) (Fig. 18D & 19C). In addition, 
KIND1/KIND2 was observed at cell-cell contact interfaces (Fig. 19C). Intriguingly, mVKINDfl induced the 
development of large circular structures in the cytosol (both EGFP- and Myc-fused) (Fig. 18F & 24B, C). 
Likewise, the deletion mutants ΔGEFN/ΔGEF induced partially circular entities (Fig. 20B, C, D). The 
incorporation of expressed protein into these structures was observed to be forceful with a negligible 
fraction of transiently expressed protein remaining unbound in the cytosol and no detectable protein at the 
cell periphery (Fig. 18, 20 & 24). The overlapping expression pattern of EGFP- and Myc-tagged truncation 
mutants, suggests no distributional influence of the employed molecular tags (Fig. 24B, C). Moreover, the 
transfection method (with respect to transfection reagents) had no effect on the potential of mVKINDfl to 
form distinguished circular structures (Fig. 24B, C). 
The mVKIND-aa2-1204 (Fig. 20B) and mVKIND-aa2-1349 (Fig. 20D) truncation mutants were expressed 
at high amounts, whereas the mVKIND-aa2-1234 (Fig. 20C) expression was observed only in few cells, 
indicating a probable instability of the protein product. These truncation mutants formed closed structures of 
estimated dimension of up to 10 µm width and 7.7 µm length dispersed in the cytosol and cell extensions 
(Fig. 20B, C, D). The truncation mutants exhibited no targeting to the nucleus and cell membrane. 
Conclusively, the data suggest the putative redundant role of GEFN and GEF domains and the fundamental 
involvement of the KIND1, KIND2, the adjacent two clusters of high conservation and the coiled-coil for 
the induction of the cytosolic circular structures as well as protein targeting.  
The N-terminal truncation mutants mVKIND-aa456-1742 (Fig. 21B) and mVKIND-aa614-1742 (Fig. 21C) 
displayed a feasible protein instability in contrast to the mVKIND-aa1451-1742 (Fig. 21D). The mVKIND-
aa456-1742 and mVKIND-aa614-1742 mutants distributed predominantly and evenly in the cell cytoplasm 
(Fig. 21B, C), whereas mVKIND-aa1451-1742 showed an additional nuclear and cell membrane 
distribution (Fig. 21D). The results advocate the crucial function of the KIND1 and KIND2 domains for the 
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construction of the cytosolic circular entities in combination with the central region of the VKIND domain. 
In addition, the key contribution of the KIND1 and KIND2 domains for the VKIND protein stability and 
targeting were revealed.  
The VKIND includes two regions which are highly conserved among species. Selective depletions of either 
region 1 (aa880-948), region 2 (aa1059-1235, also harboring the coiled-coil motif) or the coiled-coil motif 
(aa1059-1235) influenced the expression level (to a low intensity) of the deletion mutants and reduced the 
size of the cytosolic spherical structures (0.4 µm-1 µm) (Fig. 22B, C, D). The findings propose an 
implication of the coiled-coil helix for protein stability. Nevertheless, concave structures were formed, 
implying a possible role for these regions in mediating protein-protein interactions or/and oligomerization. 
This is supported also by the finding that the mVKIND truncation mutant ΔGEFN crafted cytosolic circular 
structures of a larger size (Fig. 23B). Compromised structural stability of this truncation mutant was evident.  
The formation and evolution of the circular structures was studied by a time-lapse fluorescent monitoring of 
transiently expressed EGFP-fused mVKINDfl in NIH 3T3 mouse fibroblasts. A time-lapse analysis revealed 
a series of events by which the EGFP-carrying particles in the cytoplasm were in motion, made contact and 
eventually fused (Fig. 25). In the course of time the nascent structures progressively grew from up to 0.3 µm 
to significantly larger entities of approximately 2 µm in size. Notably, in cases leading to particle fusion, the 
relocation of the structures throughout the cytoplasm was directed and highly dynamic. 
Punctuate distribution of VKIND has been recently concomitantly shown in dendrites of cerebellar granule 
cells (Huang et al., 2007). VKIND is proposed to be targeted to MTs via KIND2 domain interactions with 
MAP2 and influence the development of dendritic arborization with regard to both extension and branching 
(Huang et al., 2007). Thus VKIND is engaged in neurites differentiation which involves selective 
stimulation and inhibition of process outgrowth as well as the dynamic elaboration of the dendritic arbor 
(Cline, 2001). Neurite elongation requires assembly of tubulin into microtubules, whereas the propensity for 
branching is influenced by the stability of both the actin and microtubule cytoskeletons (Kiddie et al., 2005). 
Destabilization of the microtubule bundles within the terminal neurite area promotes branching (Kobayashi 
& Mundel, 1998) that in turn is regulated by the brain microtubule associated proteins (Dehmelt & Halpain, 
2005). Unphosphorylated MAP2 promotes and stabilizes microtubule assembly and bundling (Audesirk et 
al., 1997). VKIND has been reported to induce MAP2 phosphorylation by the Ras pathway downstream 
effectors ERK and JNK1 (Huang et al., 2007). During neuronal differentiation cytoplasmic JNK1 was found 
to be a dominant regulator of the dendritic shape (Bjorkblom et al., 2005) by means of phosphorylating and 
modifying the MAP2 affinity for microtubules (Ozer & Halpain, 2000).  
Furthermore, tubulin produced in the soma is delivered to the growth cone by diffusion as well as active 
transport (Kobayashi & Mundel, 1998). Also, neurons regulate the extent of their neurites by modifying the 
tubulin production at the soma relative to the active transport fraction  (Graham et al., 2006). Additionally, 
MAP2 mRNA, packed in complex macromolecular ribonucleoparticles, is specifically transported to 
dendrites along microtubules at an average velocity of 4-8 µm/min (Huang et al., 2003). Targeted transport 
of multiple mRNAs and proteins to dendrites, those modulating synaptic plasticity along with others that 
play more common roles in cellular metabolism, is crucial for the functions of the highly polarized neuronal 
cells (Zhong et al., 2006). Furthermore, MAP2 proteins are employed in the kinesin- and dynein-dependent 
intracellular organelle transport along microtubules (Hagiwara et al., 1994). Taken together, these findings 
imply a role for VKIND in organelle transport given the association and accumulation of VKIND to motile 
cytosolic particles.  A possible correlation between VKIND and distant dendritic transport of RNA granules 
or/and membranous structures needs to be further investigated.  
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5.5 | mVKIND protein phosphorylation by the p38 MAPK 
The p38 MAPK in combination with constitutively active MKK6 was able to phosphorylate in vivo 
exogenous truncation mutant mVKIND-aa2-709. An electrophoretic mobility shift of the C-terminal 
truncation mutant mVKIND-aa2-337 was not observed suggesting a possible p38 phosphorylation target 
sequence within the linker region between the KIND1 and KIND2 domains or/and the KIND2 domain. The 
p38 MAP kinase was found to induce neurite outgrowth in response to hyperosmotic shock by activation of 
CREB (Kano et al., 2007). These findings are indicative for a potential counter play of the p38 pathway as a 
positive acting factor in dendrite growth upon VKIND which negatively controls dendrite growth (Huang et 
al., 2007). 
 
5.6 | Outlook 
The further exploration of the mVKIND protein has the potential to be a rewarding venture. Since the 
interaction and regulatory functions of several KIND domains is determined (Quinlan et al., 2007; Huang et 
al., 2007) while the precise purpose of the VKIND KIND1 domain remains obscure, its interaction partners 
may be identified by a yeast two-hybrid screening. The confirmed expression of the VKIND gene in brain 
tissue (Mees et al., 2005) suggests the further study of VKIND in neuronal cells. The localization of the 
subcellular distribution of endogenous mVKIND in cultured mouse hippocampal and cerebellar cells with 
the anti-VKIND antibody may reveal the role of VKIND during various stages of neuronal morphological 
differentiation. To study the effects of VKIND on neuronal morphogenesis, mouse hippocampal neurons 
also may be infected with adenoviral vectors encoding the mVKINDfl and its truncation mutants. 
Furthermore, establishing stable VKIND expressing cell lines may reveal the VKIND signal transduction 
pathway. Also, the putative effect of the Nerve Growth Factor (NGF) on VKIND activity and dendritic 
growth can be addressed in cultured neuronal cells by NGF stimulation. Moreover, the effect of the in vivo 
p38 phosphorylation of VKIND on dendritic growth may be determined by exposing neuronal VKIND 
expressing cells to specific inhibitors of MKK6. Since the VKIND catalytic RasGEF domain is a CDC25 
like domain closest related to the RasGEF domains of exchange factors specific for Rap GTPases (Mees et 
al., 2005), its catalytic activity towards Rap and other representatives of the Ras subfamily GTPases can be 
investigated by performing in vitro and in vivo GEF assays. In addition, the VKIND gene function can be 
studied by a phenotypic characterization of a transgenic knock-in mouse model. 
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Appendix I | mVKIND Sequence 
Mus musculus mRNA for very-KIND protein sequence (VKIND gene); accession: AJ580324. 
1/1                                     31/11                                    
atg cag gcc atg gac cca gcc tcc cgg ggc ttc tac gag gaa gat ggc aag gac ttg ggc  
M   Q   A   M   D   P   A   S   R   G   F   Y   E   E   D   G   K   D   L   G    
61/21                                   91/31                                    
ttc tac gac ttc gag ccg ctc ccc acc ctg ccg gag gat gag gaa aat gtg tct ctg gct 
F   Y   D   F   E   P   L   P   T   L   P   E   D   E   E   N   V   S   L   A    
121/41                                  151/51                                   
gac atc ctc tcc ctg cgg gac aga ggc ctc agt gag cag gag gcc tgg gct gtg tgc cta 
D   I   L   S   L   R   D   R   G   L   S   E   Q   E   A   W   A   V   C   L    
181/61                                  211/71                                   
gag tgc agc ctg tcc atg cgg agt gtc gcc cac gca gcc atc ttc cag acc ctg tgc atc  
E   C   S   L   S   M   R   S   V   A   H   A   A   I   F   Q   T   L   C   I    
241/81                                  271/91                                   
aca cca gac acc ttg gcc ttc aac acc agt gga aac gtg tgc ttc atg gaa cag ctc agt 
T   P   D   T   L   A   F   N   T   S   G   N   V   C   F   M   E   Q   L   S    
301/101                                 331/111                                  
gat gac ccc gag ggt gcc ttt gta ccc cca gag ttt gac ctg aca gga aac acc ttt gag  
D   D   P   E   G   A   F   V   P   P   E   F   D   L   T   G   N   T   F   E    
361/121                                 391/131                                  
gct cac atc tac tcc ctg ggg gcc aca ctg aag gct gcc ctg gag tat gtc cca gaa cca 
A   H   I   Y   S   L   G   A   T   L   K   A   A   L   E   Y   V   P   E   P    
421/141                                 451/151                                  
gag ctg gag ccc aag ctg agc aca gac ctg gag gga ctg ctg agc cag atg cag gca gaa  
E   L   E   P   K   L   S   T   D   L   E   G   L   L   S   Q   M   Q   A   E    
481/161                                 511/171                                  
gac ccc aga gag cgg ccg gac ctg gcg agc atc ata gca ctg tgt gag gag aag atg cag 
D   P   R   E   R   P   D   L   A   S   I   I   A   L   C   E   E   K   M   Q    
541/181                                 571/191                                  
cct gtg tcc tca tgc cgc ctg tgc cgc agt ctc tca gcc att gga aga agg gtg ctc tcc  
P   V   S   S   C   R   L   C   R   S   L   S   A   I   G   R   R   V   L   S    
601/201                                 631/211                                  
att gag tcc ttc gga gca ttc cag gag ctc agc gag aac aca tgg agg gga agg cct gct 
I   E   S   F   G   A   F   Q   E   L   S   E   N   T   W   R   G   R   P   A    
661/221                                 691/231                                  
cca aga aac gtg ggg ccc aag aag atg cca gga gac ctc agc act gac cca gag gca ctg  
P   R   N   V   G   P   K   K   M   P   G   D   L   S   T   D   P   E   A   L    
721/241                                 751/251                                  
ttc cca tca aag ggc cta ctc cag cct cct gct tcc agg gat gcc gag cag gag gct ggg 
F   P   S   K   G   L   L   Q   P   P   A   S   R   D   A   E   Q   E   A   G    
781/261                                 811/271                                  
cag agg ccc aga gcc cca tcc ccc aaa cca ctg ctg tca gcc cct gtg aga aat ggt gag  
Q   R   P   R   A   P   S   P   K   P   L   L   S   A   P   V   R   N   G   E    
841/281                                 871/291                                  
aac cca gga cag gaa ggg ctg gct gac ctt gtc ctg gat gcc agg tgc ccc ctg ggc gag 
N   P   G   Q   E   G   L   A   D   L   V   L   D   A   R   C   P   L   G   E    
901/301                                 931/311                                  
ctg gac aga gac aac ctc agg cga agc cgg ctg aaa aag gct cag acg ttt ccc agg cta  
L   D   R   D   N   L   R   R   S   R   L   K   K   A   Q   T   F   P   R   L    
961/321                                 991/331                                  
ctg cag gaa agc aca gag acc agc acc ctc tgc ctg tca ctg aac ggc tcg aga aac cag 
L   Q   E   S   T   E   T   S   T   L   C   L   S   L   N   G   S   R   N   Q    
1021/341                                1051/351                                 
ctg gcc ata tct gag ttc ttt ccc cca gac cct agg aag ctc ttc ctg gaa ggg aaa aat  
L   A   I   S   E   F   F   P   P   D   P   R   K   L   F   L   E   G   K   N    
1081/361                                1111/371                                 
ggc ctt tct ggt ttc aaa aca cag tcc aaa agc aga ctg tgg cca gag cag gag cct gga 
G   L   S   G   F   K   T   Q   S   K   S   R   L   W   P   E   Q   E   P   G    
1141/381                                1171/391                                 
gtc cag ttg gat aag aca cca ggt gca ggc cgc aac cca cac agg agt cca ggg gcc tcg  
V   Q   L   D   K   T   P   G   A   G   R   N   P   H   R   S   P   G   A   S    
1201/401                                1231/411                                 
ggg caa cta gag gct tca tct cct agc cag gga tct gta gag tac aaa cct tca ccc agc 
G   Q   L   E   A   S   S   P   S   Q   G   S   V   E   Y   K   P   S   P   S    
1261/421                                1291/431                                 
cct gta gac gct gga gat tca gac cat gaa ggc cac ata cct agg agt gaa gag aag att  
P   V   D   A   G   D   S   D   H   E   G   H   I   P   R   S   E   E   K   I    
1321/441                                1351/451                                 
cca gaa gaa tcc aga caa cct gga agc aca gcc act gaa cag agc ctg tcc ctg aag gac 
P   E   E   S   R   Q   P   G   S   T   A   T   E   Q   S   L   S   L   K   D    
1381/461                                1411/471                                 
ctt ctg tct aag cta ggc cgg ccc ttc agg gag tac gag ctg tgg gca ctg tgc ctc tcc  
L   L   S   K   L   G   R   P   F   R   E   Y   E   L   W   A   L   C   L   S    
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1441/481                                1471/491                                 
tgc ctt agc act ctg cag aca cac aag gag cac cca gct cac ctg tgc ctg gac aac gtg 
C   L   S   T   L   Q   T   H   K   E   H   P   A   H   L   C   L   D   N   V    
1501/501                                1531/511                                 
ttg gtg gcc gag gac ggg aca gtg ttc ttc gga ccg ccc cct gcc aat ggc gcc tac aac  
L   V   A   E   D   G   T   V   F   F   G   P   P   P   A   N   G   A   Y   N    
1561/521                                1591/531                                 
tca ctc ttc ttg gct ccc gaa gtg tca gaa gag aag ctg gtg aca gag aag gcc tct gtg 
S   L   F   L   A   P   E   V   S   E   E   K   L   V   T   E   K   A   S   V    
1621/541                                1651/551                                 
tac tgt gtg gct gcg gtt ctg tgg aca gca gcc aag ttc agc gta ccc cga gac cac aaa  
Y   C   V   A   A   V   L   W   T   A   A   K   F   S   V   P   R   D   H   K    
1681/561                                1711/571                                 
ctg gcc ctg cca cgt aga ctc aaa aca ctc ctt ctg gac atg gcc aga cgc cat gcc tca 
L   A   L   P   R   R   L   K   T   L   L   L   D   M   A   R   R   H   A   S    
1741/581                                1771/591                                 
gaa cgg cca tct gca gcc gag gcc atc aag gtg tgc agc agc tac ctc ctt cag cga ggc  
E   R   P   S   A   A   E   A   I   K   V   C   S   S   Y   L   L   Q   R   G    
1801/601                                1831/611                                 
atg gac agc agc aag att cta gcc cac ctg cgg gca tcc acc tgc aag gtt cac cca gag 
M   D   S   S   K   I   L   A   H   L   R   A   S   T   C   K   V   H   P   E    
1861/621                                1891/631                                 
gag gag acc atc ggc ctc cag aac gcc ttc tca gtg gtt gaa ctg aaa tcc acc acg gca  
E   E   T   I   G   L   Q   N   A   F   S   V   V   E   L   K   S   T   T   A    
1921/641                                1951/651                                 
cct gct cct gag agt agt ccc ggc ttc ctg cag gtc agc aat gat acc aag ctg gtc gct 
P   A   P   E   S   S   P   G   F   L   Q   V   S   N   D   T   K   L   V   A    
1981/661                                2011/671                                 
gtc cca ggg cct gtg cct ggt ctg ccc ccc tgc tgc aaa gaa gcc tgt gag ctg cca gca  
V   P   G   P   V   P   G   L   P   P   C   C   K   E   A   C   E   L   P   A    
2041/681                                2071/691                                 
gcc ttc acc tct gag gcc act cac ttt aag ccc ata gtc ctg gct cag gac gca agt gtt 
A   F   T   S   E   A   T   H   F   K   P   I   V   L   A   Q   D   A   S   V    
2101/701                                2131/711                                 
acc aga gac cag ctt gcc ttg ccc tca gag tca aat gag aaa ccc aaa gag gga agt ggt  
T   R   D   Q   L   A   L   P   S   E   S   N   E   K   P   K   E   G   S   G    
2161/721                                2191/731                                 
cat ctg gac agg gag gga aca aga aag cag gca gcc ctg gag ctt gtt gag gcc act gac 
H   L   D   R   E   G   T   R   K   Q   A   A   L   E   L   V   E   A   T   D    
2221/741                                2251/751                                 
cta aag atg tcc aac cag ctg tca cct ggt cca gag ctg cag gga gca act cca gac cct  
L   K   M   S   N   Q   L   S   P   G   P   E   L   Q   G   A   T   P   D   P    
2281/761                                2311/771                                 
gat ggt gac tca ggg tcc ccc agc tca gcc acg gaa tgt tcc tgc ccc cat ggc cct gct 
D   G   D   S   G   S   P   S   S   A   T   E   C   S   C   P   H   G   P   A    
2341/781                                2371/791                                 
ctg gtc acc cag caa aaa gga aca tca ggg aca ccc agc tct cct gcc tct tcc ctg ccc  
L   V   T   Q   Q   K   G   T   S   G   T   P   S   S   P   A   S   S   L   P    
2401/801                                2431/811                                 
cct gag cac agg cca gat ggt gag gga cca cta ggc acc act gtg ctc cca ggg ccc acc 
P   E   H   R   P   D   G   E   G   P   L   G   T   T   V   L   P   G   P   T    
2461/821                                2491/831                                 
tca gcc agc cag ggc tct cga cac cca tgt aag cca ccc agg ggt agg gct gca gcg agt  
S   A   S   Q   G   S   R   H   P   C   K   P   P   R   G   R   A   A   A   S    
2521/841                                2551/851                                 
cca agc agc cct agg ggc tcg gat ggt cat cct gag aag cct cgg cca gca gac cgc aag 
P   S   S   P   R   G   S   D   G   H   P   E   K   P   R   P   A   D   R   K    
2581/861                                2611/871                                 
ctc tgt cca tcc agt gta gat acc tca tcc ccc cct aag atg aca gcc tgc ccc tcg ctt  
L   C   P   S   S   V   D   T   S   S   P   P   K   M   T   A   C   P   S   L    
2641/881                                2671/891                                 
cag gaa gcc atg cgc ctc atc cag gag gaa ttt gcc ttt gat ggc tac atg gac aac ggg 
Q   E   A   M   R   L   I   Q   E   E   F   A   F   D   G   Y   M   D   N   G    
2701/901                                2731/911                                 
cta gag gca ctg atc atg ggg gag tat att tac gcc ttg aaa gac ctc acc ttc gcc acc  
L   E   A   L   I   M   G   E   Y   I   Y   A   L   K   D   L   T   F   A   T    
2761/921                                2791/931                                 
ttc tgt ggt gcc ata tct gag aag ttt tgt gac cta tac tgg gat gag cag ctg cta aag 
F   C   G   A   I   S   E   K   F   C   D   L   Y   W   D   E   Q   L   L   K    
2821/941                                2851/951                                 
aac ctc ttc aag gtg gtc aat ggg cca gcc tca ccc tct gag agc act aat gag gag cct  
N   L   F   K   V   V   N   G   P   A   S   P   S   E   S   T   N   E   E   P    
2881/961                                2911/971                                 
gga tcc cag cca gaa cac tca ccc agc aga tgc tca ctg tcc agc aaa agg cct tcc ctg 
G   S   Q   P   E   H   S   P   S   R   C   S   L   S   S   K   R   P   S   L    
2941/981                                2971/991                                 
cat gga ctc ggc aag gag aag cca gcc acg acc tgg ggc agc ggg gga ccc tgc tcc ccc  
H   G   L   G   K   E   K   P   A   T   T   W   G   S   G   G   P   C   S   P    
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3001/1001                               3031/1011                                
aca gca cta tca gat ata gac tcc gac acg ctc tct cag gga aac ttt gag gtt gga ttt 
T   A   L   S   D   I   D   S   D   T   L   S   Q   G   N   F   E   V   G   F    
3061/1021                               3091/1031                                
cgg tct cag aag tca ata aaa gtc acg cga gag caa caa cca gag gcc gaa gtg ggt ggg  
R   S   Q   K   S   I   K   V   T   R   E   Q   Q   P   E   A   E   V   G   G    
3121/1041                               3151/1051                                
cag cca ggt cca agc cag gac tca acc agc cat gcc tcg gac aca gtg gcc cgg cta gct 
Q   P   G   P   S   Q   D   S   T   S   H   A   S   D   T   V   A   R   L   A    
3181/1061                               3211/1071                                
aga tct gag gac ggt ggc cca gct ggg tct cca ggg gca tct gat ttc cag aac tgc agc  
R   S   E   D   G   G   P   A   G   S   P   G   A   S   D   F   Q   N   C   S    
3241/1081                               3271/1091                                
cct ggc tgg tcc agt gcc ttc tat gag gct gac tgc ttt gga gcc gat gtc tac aac tac 
P   G   W   S   S   A   F   Y   E   A   D   C   F   G   A   D   V   Y   N   Y    
3301/1101                               3331/1111                                
gtg aag gat ctg gag agg cag aag gcc aac ggg cac aca gaa ctg gaa gcc cag agt cca  
V   K   D   L   E   R   Q   K   A   N   G   H   T   E   L   E   A   Q   S   P    
3361/1121                               3391/1131                                
gag ctg gag cag cag ctc atg ata gag aag agg aac tac agg aag acc ctg aag ttt tac 
E   L   E   Q   Q   L   M   I   E   K   R   N   Y   R   K   T   L   K   F   Y    
3421/1141                               3451/1151                                
cag aaa ctc tta cag aag gaa aaa cgg aac aaa ggc tct gag gtc agg acc atg ttg tct  
Q   K   L   L   Q   K   E   K   R   N   K   G   S   E   V   R   T   M   L   S    
3481/1161                               3511/1171                                
aaa ctt cga gga cag ctg gat gaa atg aag tcc aag gtg cag ttc ctg agc ctg gtc aag 
K   L   R   G   Q   L   D   E   M   K   S   K   V   Q   F   L   S   L   V   K    
3541/1181                               3571/1191                                
aag tac ctc cag gtc atg tat gca gaa cgc tgg ggg ctg gag ccc tgt gct ctg ccg gtg  
K   Y   L   Q   V   M   Y   A   E   R   W   G   L   E   P   C   A   L   P   V    
3601/1201                               3631/1211                                
att gtg aac atc gca gca gcc ccc ttt gac aca ctg gat ttc agc ccc ctg gat gag tct 
I   V   N   I   A   A   A   P   F   D   T   L   D   F   S   P   L   D   E   S    
3661/1221                               3691/1231                                
tct tcc ctc atc ttc tac aat gtc aac aag cac cca ggc agc ggc cga cag aag aag gct  
S   S   L   I   F   Y   N   V   N   K   H   P   G   S   G   R   Q   K   K   A    
3721/1241                               3751/1251                                
cgc atc cta cag gct ggt aca cca ctg ggg ctc atg gcc tac ctc tac tcc agt gat gct 
R   I   L   Q   A   G   T   P   L   G   L   M   A   Y   L   Y   S   S   D   A    
3781/1261                               3811/1271                                
ttc ctc gag ggc tac gtg cag cag ttt ctc tac act ttc cgg tac ttt tgc aca ccg cac  
F   L   E   G   Y   V   Q   Q   F   L   Y   T   F   R   Y   F   C   T   P   H    
3841/1281                               3871/1291                                
gac ttc ctg cac ttc ctc ctg gac cgc atc agc agc act tta tcc agg gct cac cag gat 
D   F   L   H   F   L   L   D   R   I   S   S   T   L   S   R   A   H   Q   D    
3901/1301                               3931/1311                                
cct acc tcg act ttt gcc aag atc tac agg cga agc ctc tgc gtc ctg cag gcc tgg gtg  
P   T   S   T   F   A   K   I   Y   R   R   S   L   C   V   L   Q   A   W   V    
3961/1321                               3991/1331                                
gaa gac tgc tac acc gtg gac ttc ata agg aac gcg ggg ctg ctg gga cag ctg gag gac 
E   D   C   Y   T   V   D   F   I   R   N   A   G   L   L   G   Q   L   E   D    
4021/1341                               4051/1351                                
ttc atc tct tcc aag atc cta cct cta gat ggc act gcc gag cac ctg ctg gcc ctc tta  
F   I   S   S   K   I   L   P   L   D   G   T   A   E   H   L   L   A   L   L    
4081/1361                               4111/1371                                
gag gtg ggc act gag cgg cgg gct gac agt gcc tct cga ggt gca gac ctg gag gac cct 
E   V   G   T   E   R   R   A   D   S   A   S   R   G   A   D   L   E   D   P    
4141/1381                               4171/1391                                
aag gag gca gag gag gac acc aga ccc ttt aat gcc ctc tgc aag agg ttc tca gag gat  
K   E   A   E   E   D   T   R   P   F   N   A   L   C   K   R   F   S   E   D    
4201/1401                               4231/1411                                
ggc atc acc cgg aag agc ttc tct tgg aga ctg cct cgg ggc aac ggg cta gtg ctg cca 
G   I   T   R   K   S   F   S   W   R   L   P   R   G   N   G   L   V   L   P    
4261/1421                               4291/1431                                
cat cat aag gag cgc cag tac acc att gca tcc gcc ctg cct aag ccc tgc ttc ttc gaa  
H   H   K   E   R   Q   Y   T   I   A   S   A   L   P   K   P   C   F   F   E    
4321/1441                               4351/1451                                
gac ttc tat ggc ccc tat gcc aaa gcc agt gag aag ggt cct tac ttc ttg aca gag tac 
D   F   Y   G   P   Y   A   K   A   S   E   K   G   P   Y   F   L   T   E   Y    
4381/1461                               4411/1471                                
agc acc aac cag ctc ttc act cag cta aca cta ctg cag cag gaa ttg ttt caa aag tgc  
S   T   N   Q   L   F   T   Q   L   T   L   L   Q   Q   E   L   F   Q   K   C    
4441/1481                               4471/1491                                
cac cct gtc cac ttc cta aat tca cga gcc ctg ggt gtc atg gac aaa agt gca gcc att 
H   P   V   H   F   L   N   S   R   A   L   G   V   M   D   K   S   A   A   I    
4501/1501                               4531/1511                                
ccc aaa gcc agc tct tct gag tct ctt tct gcc aaa acc tgc agc ctc ttc cta ccc aat  
P   K   A   S   S   S   E   S   L   S   A   K   T   C   S   L   F   L   P   N    
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4561/1521                               4591/1531                                
tac gtc cag gac aaa tat ctg cta cag ctt tta aga aac gca gat gat gtc agt acc tgg 
Y   V   Q   D   K   Y   L   L   Q   L   L   R   N   A   D   D   V   S   T   W    
4621/1541                               4651/1551                                
gtg gct gct gaa att gtg acc agt cat acc tcc aag ctt cag gtg aac ttg ctg tcc aaa  
V   A   A   E   I   V   T   S   H   T   S   K   L   Q   V   N   L   L   S   K    
4681/1561                               4711/1571                                
ttc ctg ctg att gca aaa tct tgc tac gaa cag agg aac ttt gca acg gcc atg caa atc 
F   L   L   I   A   K   S   C   Y   E   Q   R   N   F   A   T   A   M   Q   I    
4741/1581                               4771/1591                                
ctg ggc ggg ctg gag cac ctg gct gtg agg cag tcc cct gct tgg aga atc ctg cct gcg  
L   G   G   L   E   H   L   A   V   R   Q   S   P   A   W   R   I   L   P   A    
4801/1601                               4831/1611                                
aag att gct gag gtc atg gaa gag ctg aaa gct gtg gag gta ttc ctg aag agt gac agc 
K   I   A   E   V   M   E   E   L   K   A   V   E   V   F   L   K   S   D   S    
4861/1621                               4891/1631                                
ctg tgt ctg atg gaa gga agg cgc ttc cgg gcc cag cct act cta ccc tcc gcc cac ctg  
L   C   L   M   E   G   R   R   F   R   A   Q   P   T   L   P   S   A   H   L    
4921/1641                               4951/1651                                
ctg gcc atg cac atc cag cag ctg gag aca gga ggt ttc acc atg act aat gga gcc cat 
L   A   M   H   I   Q   Q   L   E   T   G   G   F   T   M   T   N   G   A   H    
4981/1661                               5011/1671                                
aga tgg agc aaa ctg aga aac atc gcc aag gtg gca agc cag gtg cac gcg ttc caa gag  
R   W   S   K   L   R   N   I   A   K   V   A   S   Q   V   H   A   F   Q   E    
5041/1681                               5071/1691                                
aac ccg tac aca ttc agc ccg gac ccc aag cta cag gcc cac ctc aag cag agg atc gcc 
N   P   Y   T   F   S   P   D   P   K   L   Q   A   H   L   K   Q   R   I   A    
5101/1701                               5131/1711                                
cgc ttt agc ggc gct gat gtc tcc att tta gca gct gat aac agg gcc aac ttc cac cag  
R   F   S   G   A   D   V   S   I   L   A   A   D   N   R   A   N   F   H   Q    
5161/1721                               5191/1731                                
atc cca gga gag aaa cac tca cgg aag atc caa gac aag ctg agg aga atg aag gct aca 
I   P   G   E   K   H   S   R   K   I   Q   D   K   L   R   R   M   K   A   T    
5221/1741                                
ttc cag tag 
F   Q   *   
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pcDNA3-Myc-mVKIND-aa2-337 
RT-PCR: template mouse cerebellum total RNA 
  primer 
5´-mKISN-XbaI/HindIII+Myc                        Myc → 
             XbaI         HindIII        Transl Ini       M      E     Q      K      L       I      S      E       E      D              
  5´- gc TCT AGA AAG CTT GCC GCC GCC ATG GAG CAG AAG CTG ATC TCC GAG GAG GAC  
 
   L      Q     A      M      D      P      A       S 
 CTG CAG GCC ATG GAC CCA GCC TCC – 3´ 
          VKIND 2. Codon                           codon 8 
           start 4 bp                                      24 bp 
  
 
3´-mKISN-afterXhoI 
                                       P      D       P      R      K       L     F 
 
coding sequence          5´- CCA GAC CCT AGG AAG CTC TTC - 3´ 
      start 1045 bp                                     1066 bp 
      codon 349                                      codon 355 
  
primer sequence 5´- GAA GAG CTT CCT AGG GTC TGG - 3´ 
  
Cloning: 
1st step: RT-PCR-fragment (  1 kb ) (purified) digested with XbaI/XhoI and cloned into pcDNA3, linearised by 
XbaI/XhoI, named pcDNA3-Myc-mVKIND-aa2-337(a) 
2nd step: inverting the fragment, pcDNA3-Myc-mVKIND-aa2-337(a) linearised by HindIII/BamHI and cloned 
into pcDNA3, linearised by HindIII/BamHI, named pcDNA3-Myc-mVKIND-aa2-337 
 
pcDNA3-Myc-mVKIND-aa2-709 
RT-PCR: template mouse cerebellum total RNA 
                   primer 5´-mVKIND-beforeXhoI 
              S       T      L      C       L      S         
  5´- CC AGC ACC CTC TGC CTG TCA C - 3´ 
       start 980 bp                                       1000 bp 
       codon 328                                   codon 332 
   
  3´-mVKIND-afterBstXI+BamHI 
                                          Q      L       A      L       P      S             BamHI 
  coding sequence         5´- C CAG CTT GCC TTG CCC TCA GA GGA TCC cg- 3´ 
      start 2109 bp                                      2129 bp   
          codon 704                            codon 709 
  
primer sequence 5´- cg GGA TCC TCT GAG GGC AAG GCA AGC TGG- 3´ 
   
Cloning:  
1st step: RT-PCR-fragment (  1.1 kb ) (purified) digested with XhoI/BamHI and cloned into pcDNA3-Myc-
mVKIND-aa2-337(a), linearised by XhoI/BamHI, named pcDNA3-Myc-mVKIND-aa2-709(a) 
2nd step:  inverting the fragment, pcDNA3-Myc-mVKIND-aa2-709(a) linearised by HindIII/BamHI and cloned 
into pcDNA3, linearised by HindIII/BamHI, named pcDNA3-Myc-mVKIND-aa2-709 
 
pcDNA3-Myc-mVKIND-aa2-1204 
RT-PCR: template mouse cerebellum total RNA 
                   primer 5´-mVKIND-beforeBstXI 
       E        L      P      A       A      F     T 
  5´- GAG CTG CCA GCA GCC TTC ACC - 3´ 
       start 2029 bp                                      2049 bp 
       codon 677                                      codon 683 
   
  3´-mVKIND-3-rev+KpnI 
                                             P       V       I       V      N      I                KpnI 
  coding sequence        5´- G CCG GTG ATT GTG AAC ATC GC  GGT ACC ccg- 3´ 
      start 3594 bp                                      3614 bp 
           codon 1199                          codon 1204 
  
primer sequence 5´- ccg GGT ACC GCG ATG TTC ACA ATC ACC GGC- 3´ 
   
Cloning:  
1st step: RT-PCR-fragment (  1.5 kb ) (purified) digested with BstXI/KpnIand cloned into  
pcDNA3-Myc-aa2-709, linearised by  BstXI/KpnI, named pcDNA3-Myc-mVKIND-aa2-1204(a) 
2nd step: inverting the fragment, pcDNA3-Myc-mVKIND-aa2-1204(a) linearised by KpnI, and pcDNA3 
linearsied by XhoI, both treated with Klenow pcDNA3-Myc-mVKIND-aa2-1204(a) (KpnI/Klenow) digested with 
HindIII and cloned into pcDNA3 (XhoI/Klenow), digested with HindIII,  
named pcDNA3-Myc-mVKIND-aa2-1204 
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pcDNA3-Myc-mVKIND-2-1234 
 
 
pcDNA3-Myc-mVKIND-aa2-1349 
RT-PCR: template mouse cerebellum total RNA 
                   primer 5´-vKIND-before NheI 
        D      S       T      S      H      A      S 
  5´- GAC TCA ACC AGC CAT GCC TCG - 3´ 
       start 3139 bp                                     3135 bp 
       codon 1047                                    codon 1053 
   
  3´-vKIND-after XbaI 
                                               A      L      L      E      V       G      T 
  coding sequence         5´- GCC CTC TTA GAG GTG GGC ACT - 3´ 
       start 4072 bp                                    4092 bpP 
       codon 1358                                   codon 1364 
  
primer sequence 5´- AGT GCC CAC CTC TAA GAG GGC - 3´ 
   
Cloning:  
PCR-fragment (  1kb, codon 1047-1364) digested with NheI/XbaI, and cloned into pcDNA3-Myc-mVKIND-aa2-
1204,digested with NheI/XbaI, dephosphorylated by CIP, named pcDNA3-Myc-mVKIND-aa2-1349 
 
pSport1-Myc-mVKIND-aa2-1349 
Cloning:  
Insert: pcDNA3-Myc-mVKIND-aa2-1349 digested with HindIII/XbaI and cloned into Vector pSport1, digested 
with HindIII/XbaI, named pSport1-Myc-mVKIND-aa2-1349 
 
pSport1-mVKIND-aa1349-1742 
RT-PCR: template mouse cerebellum total RNA 
                   primer 5´-vKIND-before XbaI 
        G       L      L      G       Q      L       E      
  5´- GGG CTG CTG GGA CAG CTG GAG - 3´ 
       start 3997 bp                                     4017 bp 
       codon 1333                                     codon 1339 
   
  3´-vKIND-Ende+EcoRI 
                                               M      K      A       T      F      Q    stop     EcoRI 
  coding sequence        5´- ATG AAG GCC ACA TTC CAG TAG GAA TTC cg - 3´ 
      start 5209 bp                                               5229 bp 
      codon 1737                                             codon 1743 
  
primer sequence 5´- cg GAA TTC CTA CTG GAA TGT GGC CTT CAT - 3´ 
   
Cloning:  
PCR fragment (≈ 1.2 kb, codon 1333-1742) digested with XbaI/EcoRI and cloned into pSport1, digested with 
XbaI/EcoRI, named pSport1-mVKIND-aa1349-1742 
 
pSport1-Myc-mVKINDfl 
Cloning:  Insert: pSport1-mVKIND-aa1349-1742 digested with XbaI/EcoRI and cloned into Vector pSport1-Myc-
mVKIND-aa2-1349 digested with XbaI/EcoRI, named pSport1-Myc-mVKINDfl 
 
PCR: template pcDNA3:Myc-VKINDfl 
                   primer 5´-mKISNXbaI/HindIII-Myc                           Myc → 
             XbaI          HindIII           Transl Ini    M      E      Q     K      L       I       S      E       E       D           
   5´- gc TCT AGA AAG CTT GCC GCC GCC  ATG GAG CAG AAG CTG ATC TCC GAG GAG GAC  
    L     Q      A      M     D       P      A       S 
  CTG CAG GCC ATG GAC CCA GCC TCC – 3´ 
          VKIND 2. Codon 
            start 4 bp                                      24 bp 
   
  3´-ab3682bp+EcoRI  
                                              V      N      K      H      P       G      S       EcoRI 
  coding sequence 5´-GTC AAC AAG CAC CCA GGC AGC GAA TTC cg - 3´ 
     start 3682                                          end 3702 bp 
     codon 1228                                    codon 1234 
            
primer sequence 5´- cg GAA TTC  GCT GCC TGG GTG CTT GTT GAC - 3´ 
   
Cloning:  
PCR-fragment ( ≈ 3.7 kb, codon2-1234) digested with HindIII/EcoRI cloned into pcDNA3 linearised by 
HindIII/EcoRI, named pcDNA3-Myc-mVKIND-aa2-1234 
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pcDNA3-Myc-mVKINDfl 
Cloning:  
Insert: pSport1-Myc-mVKINDfl linearised by SnaBI, Vector pcDNA3 linearised by HindIII, both treated with 
Klenow; 
Insert: pSport1-Myc-mVKINDfl (SnaBI/Klenow) digested by EcoRI and cloned into Vector pcDNA3 
(HindIII/Klenow), digested by EcoRI, named pcDNA3-Myc-mVKINDfl 
 
pcDNA3-Doublecortin 
RT-PCR: template day 14.5 mouse embryo total RNA (C57BL/6) 
                   primer BamHI-m-Doublecortin-CT-5´ 
             BamHI     S        Y         V        C        S         S         D 
  5´- GC GGATCC AGC TAT GTC TGC TCC TCA GAC - 3´ 
                              start 370 bp                                      390 bp 
   
  m-Doublecortin-CT-EcoRI-3´ 
                                          S      L      G       D     S      M    stop    EcoRI      
  coding sequence      5´- TCA CTT GGC GAT TCC ATG TGA GAA TTC gc - 3´ 
       start 1063 bp                                 1082 bp   
  
primer sequence 5´- GC GAA TTC TCA CAT GGA ATC GCC AAG TGA - 3´ 
  
Cloning:  
PCR-fragment (712 bp, codon 124-360) digested with BamHI/EcoRI  into pcDNA3 linearised by BamHI/EcoRI, 
named pcDNA3-Doublecortin 
 
pcDNA3-Islet1 
RT-PCR: template day 14.5 mouse embryo total RNA (C57BL/6) 
                   primer BamHI-m-Islet1-CT-5´ 
             BamH I     C     R       A      D      H      D     V    
  5´- GC GGATCC TGC CGT GCA GAC CAC GAT GTG – 3´ 
                               start 385 bp                                      405 bp   
   
         m-Islet1-CT-EcoRI-3´ 
                                         A       S       P      I       E      A     stop    EcoRI     
                 coding sequence        5´- GCC AGT CCT ATT GAG GCA TGA GAATTC GC – 3´ 
      start 1030 bp                                    1050 bp      
  
primer sequence 5´- GC GAATTC TCA TGC CTC AAT AGG ACT GGC – 3´ 
  
Cloning:  
PCR-fragment (661 bp, codon 129-350 ) digested with BamHI/EcoRI, cloned into pcDNA3 linearised by 
BamHI/EcoRI, named pcDNA3-Islet1 
 
pEGFP-C1-mVKIND-aa2-355 
PCR: template pcDNA3-Myc-mVKIND-aa2-1204 
                   primer 5´-fr.I+BglII 
          BglII           Q        A     M     D       P      A      S 
  5´- ga AGA TCT CAG GCC ATG GAC CCA GCC TCC – 3´ 
                              start 4 bp                                          24 bp 
                              codon 2                                          codon 8 
   
  3´-frI.-afterXhoI+EcoRI 
                                               P      D       P      R      K       L     F         EcoRI 
  coding sequence       5´- CCA GAC CCT AGG AAG CTC TTC GAA TTC cg– 3´ 
       start 1045 bp                                    1066 bp 
       codon 349                                     codon 355 
  
primer sequence 5´- cg GAA TTC GAA GAG CTT CCT AGG GTC TGG – 3´ 
   
Cloning:  
PCR-fragment (  1 kb, codon 2-355) digested with BglII/EcoRI cloned into pEGFP-C1 linearised by BglII/EcoRI,  
named pEGFP-C1-mVKIND-aa2-355 
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pEGFP-C1-mVKIND-aa2-709 
PCR: template pcDNA3-Myc-mVKIND-aa2-1204 
                   primer 5´-vKIND-beforeXhoI 
              S       T      L      C       L      S 
  5´- CC AGC ACC CTC TGC CTG TCA C - 3´ 
       start 980 bp                                       1000 bp 
              codon 32                              codon 332 
   
  3´-vKIND-afterBstXI+BamHI 
                                                Q       L      A       L      P      S            BamHI 
  coding sequence   5´- C CAG CTT GCC TTG CCC TCA GA GGA TCC cg- 3´ 
      start 2109 bp                                     2129 bp 
          codon 704                            codon 709 
  
primer sequence 5´- cg GGA TTC TCT GAG GGC AAG GCA AGC TGG- 3´ 
   
Cloning:  
PCR-fragment (  1.1 kb) digested with XhoI/BamHI into pEGFP-C1-mVKIND-aa2-355 linearised by 
XhoI/BamHI, named pEGFP-C1-mVKIND-aa2-709 
 
pEGFP-C1-mVKIND-aa2-1204 
Cloning:  
Insert: pcDNA3-Myc-mVKIND-aa2-1204 digested with BamHI/XbaI and cloned intoVector pEGFP-C1-
mVKIND-aa2-709 linearised by BamHI/XbaI,named pEGFP-C1-mVKIND-aa2-1204 
 
pEGFP-C1-mVKINDfl 
Cloning:  
Insert: pSport1-Myc-mVKINDfl digested with SacI/KpnI and cloned into Vector pEGFP-C1-mVKIND-aa2-355 
digested by SacI/KpnI, named pEGFP-C1-mVKINDfl 
 
pcDNA3-Myc-mVKIND-456-1742 
PCR: template pcDNA3-Myc-mVKINDfl 
                   primer 5´KpnI+Myc-ab1366                         Myc → 
             KpnI           Transl Ini          M      E     Q      K      L       I       S      E         
   5´- gg GGT ACC GCC GCC GCC  ATG GAG CAG AAG CTG ATC TCC GAG  
     E       D      L      L      S      L      K       D     L      L 
  GAG GAC CTG CTG TCC CTG AAG GAC CTT CTG– 3´ 
                              start1366 bp                                                    1386 bp 
                              codon 456                                                    codon 462    
   
  3´-vKIND-Ende+EcoRI 
                                                M     K       A      T      F      Q    stop    EcoRI 
  coding  sequence        5´- ATG AAG GCT ACA TTC CAG TAG GAA TTC cg – 3´ 
      start 5209 bp                                     5229 bp    
      codon 1737                                    codon 1743 
  
primer sequence 5´- cg GAA TTC CTA CTG GAA TGT GGC CTT CAT – 3´ 
   
Cloning:  
PCR-fragment (  4.0 kb, codon 456-1742) digested with KpnI/EcoRI and cloned into pcDNA3 linearised by 
KpnI/EcoRI, named pcDNA3-Myc-mVKIND-aa456-1742 
 
pcDNA3-Myc-mVKIND-aa614-1742 
PCR: template pcDNA3-Myc-mVKINDfl 
                   primer 5´KpnI+Myc-ab1840                        Myc → 
             KpnI           Transl Ini          M      E      Q      K      L      I       S      E         
   5´- gg GGT ACC GCC GCC GCC  ATG GAG CAG AAG CTG ATC TCC GAG  
     E      D       L      T      C     K       V     H      P       E 
  GAG GAC CTG ACC TGC AAG GTT CAC CCA GAG– 3´ 
                             start 1840 bp                                    1860 bp 
                             codon 614                                      codon 620 
   
  3´-vKIND-Ende+EcoRI 
                                              M     K      A       T      F     Q     stop    EcoRI 
  coding sequence         5´- ATG AAG GCC ACA TTC CAG TAG GAA TTC cg – 3´ 
      start 5209 bp                                     5229 bp 
      codon 1737                                    codon 1743 
  
primer sequence 5´- cg GAA TTC CTA CTG GAA TGT GGC CTT CAT – 3´ 
   
Cloning:  
PCR-fragment (  3.4 kb, codon 614-620 ) digested with KpnI/EcoRI and cloned into pcDNA3 linearised by 
KpnI/EcoRI,  
named pcDNA3-Myc-mVKIND-aa614-1742 
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pcDNA3-Myc-mVKIND-aa1451-1742 
RT-PCR: template mouse cerebellum total RNA 
                   primer 5´-Ras-GEF-BamHI+Myc               Myc →  
             BamHI         Transl Ini        M      E       Q    K       L      I       S      E         
  5´- gc GGA TCC GCC GCC GCC  ATG GAG CAG AAG CTG ATC TCC GAG  
     E       D      L      E      K      G      P      Y      F      L 
  GAG GAC CTG GAG AAG GGT CCT TAC TTC TTG– 3´ 
                              start 4351 bp                                   4371 bp    
                              codon 1451                                  codon 1457 
   
  3´-Ras-GEF-EcoRI 
                                                  M      K      A      T       F      Q    stop   EcoRI 
  coding  sequence       5´- ATG AAG GCC ACA TTC CAG TAG GAA TTC cg - 3´ 
      start 5209                                         5229 bp 
      codon 1737                                     codon 1743 
  
primer sequence 5´- cg GAA TTC CTA CTG GAA TGT GGC CTT CAT - 3´ 
   
Cloning:  
 RT-PCR-fragment (  880 bp, codon 1451-1742) (purified) digested with BamHI/EcoRI and cloned into pcDNA3, 
linearised by BamHI/EcoRI, named pcDNA3-Myc-mVKIND-aa1451-1742 
 
pSport1-mVKIND-∆aa880-1235 
PCR: template pSport1-Myc-mVKINDfl 
                   primer 5´-873-879+1236-1242 
        K      M     T       A      C      P       S      R       Q      K      K      A       R      I 
  5´- AAG ATG ACA GCC TGC CCC TGC CGA CAG AAG AAG GCT CGC ATC -3´ 
       start 2617 bp                    end 2638 bp start  3706 bp                   end 3726 bp 
       codon 873                            codon 879  codon  1236                         codon 1242 
   
  3´-873-879+1236-1242 
                                       K      M      T      A      C       P      S      R       Q      K      K       A      R      I 
  coding sequence      5´- AAG ATG ACA GCC TGC CCC TGC CGA CAG AAG AAG GCT CGC ATC - 3´ 
      start 2617 bp                  end  2638 bp  start  3706 bp                 end 3726 bp 
      codon 873                            codon 879  codon  1236                       codon 1242 
  
  primer sequence   5´- GAT GCG AGC CTT CTT CTG TCG GCA GGG GCA GGC TGT CAT CTT - 3´ 
    
Cloning:  PCR fragment (≈ 8.3 kb) digested with DpnI followed by bacterial transformation 
 
pTopo-mVKIND-∆aa880-1235 
PCR: template pSport1-mVKIND-∆aa880-1235 
                   primer 5´-Topo4delMut 
                  HindIII         Transl Ini      Myc →  
  5´- CACC AAG CTT GCC GCC GCC ATG GAG-3´ 
   
  3´-Topo4delMut+E 
                                                                                stop  EcoRI 
  coding  sequence        5´- atg aag gct aca ttc cag tag GAA TTC - 3´ 
      start 5209 bp     end  5229 bp    
      codon 1737                     codon 1743 
  
  primer sequence 5´- GAA TTC cta ctg gaa tgt agc ctt cat - 3´ 
    
Cloning:  PCR fragment (≈ 4.2 kb) cloned into pcDNA3.1D/V5-His-Topo, named pTopo-mVKIND-∆aa880-1235 
 
pSport1-mVKIND-∆aa880-948 
PCR: template pSport1-Myc-mVKINDfl 
                   primer 5´-873-879+949-955 
        K      M     T       A      C      P       S      P      A       S       P      S      E      S 
  5´- AAG ATG ACA GCC TGC CCC TCG CCA GCC TCA CCC TCT GAG AGC -3´ 
       start 2617 bp                  end  2638 bp start  2845 bp                   end 2865 bp 
      codon 873                             codon 879  codon  949                           codon 955 
   
  3´-873-879+949-955 
                                       K       M     T       A      C       P      S       P      A      S       P      S      E      S 
  coding  sequence       5´- AAG ATG ACA GCC TGC CCC TCG CCA GCC TCA CCC TCT GAG AGC - 3´ 
      start 2617 bp                  end  2638 bp start  2845 bp                   end 2865 bp 
      codon 873                            codon 879  codon  949                           codon 955 
  
  primer sequence 5´- GCT CTC AGA GGG TGA GGC TGG CGA GGG GCA GGC TGT CAT CTT - 3´ 
    
Cloning:  PCR fragment (≈ 9.2 kb) digested with DpnI followed by bacterial transformation 
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pTopo-mVKIND-∆aa880-948 
PCR: template pSport1- mVKIND-∆aa880-948 
                   primer 5´-Topo4delMut 
                        HindIII              TI       Myc →  
  5´- CACC AAG CTT GCC GCC GCC ATG GAG-3´ 
   
  3´-Topo4delMut+E 
                                                                          stop  EcoRI 
  coding sequence         5´- atg aag gct aca ttc cag tag GAA TTC - 3´ 
      start 5209 bp                   5229 bp    
      codon                             codon 1743 
  
  primer sequence 5´- GAA TTC cta ctg gaa tgt agc ctt cat - 3´ 
    
Cloning:  PCR fragment (≈ 5 kb) cloned into pcDNA3.1D/V5-His-Topo, named pTopo:mVKIND-∆aa880-948 
 
pSport-1-mVKIND-∆aa1059-1235 
PCR: template pSport1-Myc-mVKINDfl 
                   primer 5´-1052-1058+1236-1242 
        A       S      D      T      V       A       R      R      Q      K       K      A      R      I 
  5´- GCC TCG GAC ACA GTG GCC CGG CGA CAG AAG AAG GCT CGC ATC -3´ 
       start 3154 bp                   end  3174 bp start  3706 bp                   end 3726 bp 
       codon 1052                         codon 1058 codon  1236                        codon 1242 
   
  3´-1052-1058+1236-1242 
                                       A      S      D       T     V       A       R       R      Q       K      K      A      R       I 
  coding sequence     5´- GCC TCG GAC ACA GTG GCC CGG CGA CAG AAG AAG GCT CGC ATC - 3´ 
 start 3154 bp                        end 3174 bp  start 3706 bp                   end 3726 bp 
 codon 1052                              codon1058  codon 1236                         codon 1242 
  
  primer sequence 5´- GAT GCG AGC CTT CTT CTG TCG CCG GGC CAC TGT GTC CGA GGC- 3´ 
    
Cloning:  PCR fragment (≈ 8.9 kb) digested with DpnI followed by bacterial transformation 
     
pTopo-mVKIND-∆aa1059-1235 
PCR: template pSport1- mVKIND-∆aa1059-1235 
                   primer 5´-Topo4delMut 
                  HindIII              TI              Myc → 
  5´- CACC AAG CTT GCC GCC GCC ATG GAG-3´ 
   
  3´-Topo4delMut+E 
                                                                                stop  EcoRI 
  coding sequence        5´- atg aag gct aca ttc cag tag GAA TTC - 3´ 
      start 5209 bp                  5229 bp    
      codon 1737                    codon 1743 
  
  primer sequence 5´- GAA TTC cta ctg gaa tgt agc ctt cat - 3´ 
    
Cloning:  PCR fragment (≈ 4.7 kb) cloned into pcDNA3.1D/V5-His-Topo, named pTopo-mVKIND-∆ aa1059-1235 
 
pSport1-mVKIND-∆aa1238-1364 
PCR: template pSport1-Myc-mVKINDfl 
                   primer 5´-withoutRasGEFN 
        H      P      G       S      G      R       Q      E      R        R      A      D      S       A 
  5´- CAC CCA GGC AGC GGC CGA CAG GAG CGG CGG GCT GAC AGT GCC –3´ 
       start 3691 bp                   end  3711 bp start  4093 bp                   end 4113 bp 
       codon 1231                         codon 1237 codon  1365                          codon 1371 
   
  3´-withoutRasGEFN 
  
  coding sequence        5´- CAC CCA GGC AGC GGC CGA CAG GAG CGG CGG GCT GAC AGT GCC –3´ 
       start 3691 bp                   end  3711 bp start  4093 bp                   end 4113 bp 
       codon 1231                         codon 1237 codon  1365                         codon 1371 
  
  primer sequence 5´- GGC ACT GTC AGC CCG CCG CTC CTG TCG GGC GCT GCC TGG GTG - 3´ 
    
Cloning:  PCR fragment (≈ 9 kb) digested with DpnI followed by bacterial transformation 
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pTopo-mVKIND-∆aa1238-1364 
PCR: template pSport1: mVKIND-∆aa1238-1364 
                   primer 5´-Topo4delMut 
                  HindIII              TI              Myc → 
  5´- CACC AAG CTT GCC GCC GCC ATG GAG-3´ 
   
  3´-Topo4delMut+E 
                                                                                stop   EcoRI 
  coding sequence        5´- atg aag gct aca ttc cag tag GAA TTC - 3´ 
      start 5209 bp                end  5229 bp    
      codon 1737                   codon 1743 
  
  primer sequence 5´- GAA TTC cta ctg gaa tgt agc ctt cat - 3´ 
    
Cloning:  PCR fragment (≈ 4.8 kb) cloned into pcDNA3.1D/V5-His-Topo, named pTopo-mVKIND-∆aa1238-1364 
 
pGEX-6P-1-mVKIND-aa219-453 
PCR: template pcDNA3:Myc-mVKINDfl 
                   primer 5´-vKIND-BamHI-655bp 
             BamHI     P      A      P      R       N      V      G 
  5´- gc GGA TCC CCT GCT CCA AGA AAC GTG GGG - 3´ 
                              codon 219                                    codon 225 
                              start 655 bp                                                   765 bp    
   
  3´-vKIND-1340bp-EcoRI 
                                                  P       G      S      T       A      T      E        EcoRI  
  coding sequence        5´- CCT GGA AGC ACA GCC ACT GAA GAA TTC cg- 3´ 
       start 1339 bp                               bp 1359bp 
       codon 447                                     codon 453 
  
primer sequence 5´- cg GAA TTC TTC AGT GGC TGT GCT TCC AGG - 3´ 
    
Cloning:  
 PCR-fragment (  700 bp, codon 219-453) was digested by BamHI/EcoRI and cloned  into pGEX-6P-1, primary 
digested by BamHI/EcoRI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Anaid Bedrossian Appendix III | Abbreviations 
 
85 
Appendix III | Abbreviations 
 
2-ME ethylene glycol monomethyl ether 
Abi1 Abl-Interactor-1, also E3B1 
ACK  acetate kinase 
ADP adenosine diphosphate 
AF6  ALL-1 fusion partner on chromosome 6 
AKT  also PKB, protein kinase B 
Arp 2/3 actin-related proteins 2 and 3 
ATP adenosine triphosphate  
BGH pA  bovine growth hormone polyadenylation signal 
BLAST Basic Local Alignment Search Tool 
bp base pair 
BPB bromphenol blue 
c complementary 
C57BL/6  C57 black 6 
camr chloramphenicol resistance 
cAPK α cAMP-dependent protein kinase catalytic subunit, also PKA 
Capu  Cappuccino 
CBL  Casitas B-lineage lymphoma 
CC  coiled-coil 
CD1  cluster of differentiation 1 
CDC25 cell division cycle 25 
cDNA  complementary DNA 
CH calponin homology 
CIP calf intestinal phosphatase 
CMV  Cytomegalovirus promotor 
CNB cyclic nucleotide-binding 
CTP cytidine triphosphate 
DAG  diacylglycerol 
DCC deleted in colon cancer 
DH  dibble homology 
DMEM Dulbecco's Modified Eagle Medium 
DMSO Dimethylsulfoxide 
DNA deoxyribonucleic acid 
dNTPs Desoxyribonukleosid-5’-triphosphate  
DRG  dorsal root ganglia 
dsDNA double strand DNA 
dT oligo-dT, thymidine 
e.g. exempli gratia 
ECL enhanced chemiluminescence 
EF-G  elongation factor G  
EF-Tu  elongation factor Tu 
EGF  epidermal growth factor 
Eps8 epidermal growth factor receptor pathway substrate 8 
ERK  extracellular signal-regulated kinase 
EST expressed sequence tag 
FERM  
four point one, Ezrin, Radaxin, and Moesin four point one, 
Ezrin, Radaxin, and Moesin 
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FH1 and FH2  formin homology domains 
G force standard gravity, 9.80665 m/s2 
G proteins  guanine nucleotide binding proteins, GTP-binding proteins 
GAP GTPases-activating protein 
GBP guanylate-binding protein 
GDP guanosine diphosphate  
GEF guanine nucleotide exchange factor 
GNBPs  guanine nucleotide binding proteins 
GPCR  G-protein-coupled receptor 
GRB2  growth factor receptor-bound protein 2 
GTP guanosine triphosphate  
GTPases small guanosine triphosphatases 
HB-EGF heparin-binding EGF 
H-Ras Harvey rat sarcoma  
HRP-linked horseradish peroxidase linked 
i.a. inter alia 
i.e. id est 
IF-2 initiation factor 2 
Inositol-P  inositol monophosphate 
IPTG isopropyl- -D-thiogalactopyranoside 
IS inhibitory switch 
JNK  c-Jun N-terminal kinase 
kb kbp, kilo base pairs 
kD kilo Dalton  
KI kinase inhibitor 
KIND kinase non-catalytic C-lobe domain 
K-Ras Kirsten sarcoma  
KSR  kinase suppressor of Ras 
l liter 
lacI lactose repressor gene 
m murine 
MAP  mitogen-activated protein 
MAPK mitogen-activated protein kinase 
MARK  microtubule affinity regulating kinase 
MEK  mitogen and extracellular regulated kinase 
mg milligram  
min minute 
MKK6 mitogen-activated protein kinase kinase 6 
ml  milliliter  
M-Myc M-Myc epitope peptide 
MP  metalloproteinase 
MPH2O  millipore water 
NaAC sodium acetate 
NF1  neurofibromin 
NORE1  N-Oct-3 responsive element 1 
N-Ras Neuroblastoma sarcoma 
OD optical density  
ori origin 
P loop  phosphate binding site 
PAGE Polyacrylamide gel electrophoresis 
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PAK  p21rac/cdc42-activated kinase 
PCR polymerase chain reaction 
PDK1  phosphatidylinositol-dependent kinase 1 
PDZ  domain present in PSD-95, Dil and Zo-1/2 
PFA paraformaldehyde 
pH potential of hydrogen 
PH  pleckstrin homology 
PI3K  phosphatidylinositol 3-kinase 
PIP  1-phosphatidylinositol phosphate 
PIP2  1-phosphatidylinositol-4,5-bisphosphate 
PIP3  phosphatidylinositol-3,4,5-triphosphate 
PKA cAMP-dependent protein kinase, protein kinase A 
PKC  protein kinase C 
PKCδ  Protein kinase Cδ 
PLCε  phospholipase Cepsilon 
Pol polymerase 
PSI-BLAST Position-Specific Iterative BLAST 
PTP-BAS PTP-Basophil 
PTP-BL  protein-tyrosine phosphatase-BAS-like 
Pyk2  proline-rich tyrosine kinase 2 
Raf  rapidly growing fibrosarcoma 
RalGDS  Ral guanine nucleotide dissociation stimulator 
Rap  Ras-related protein 
Ras  rat sarcoma 
RasGRF guanine nucleotide releasing factor 
RasGRP  guanyl nucleotide releasing protein 
RASSF  Ras association domain family 
RBD Ras binding domain 
Rce1  Ras and a factor converting enzyme 
REM  Ras exchanger motif, also RasGEFN 
RF-3  release factor 3 
Rin1  Ras interference 1 
RNA ribonucleic acid 
RNAse Ribonuclease 
rpm revolutions per minute 
RT room temperature 
RTK  receptor tyrosine kinase  
RT-PCR Reverse Transcription Polymerase Chain Reaction 
s second 
SH2  Src homology 2 
SH3  Src homology 3 
SHC  Src homologous and collagen-like 
SMART Simple Modular Architecture Research Tool 
SOS  Son of sevenless 
SP6 bacteriophage SP6 promotor 
Src  Sarcomatoid renal carcinoma 
SRP  SRP-R signal recognition particle, receptor 
ssDNA single strand DNA 
TGFα  transforming growth factor-α 
Tiam1  T lymphoma invasion and metastasis protein 1 
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Tm  annealing temperature 
U unit 
UV ultra violet 
VKIND very-KIND 
WB western blot 
WH2 Wiskott-Aldrich homology region 2 
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Mees A, Rock R, Ciccarelli FD, Leberfinger CB, Borawski JM, Bork P, Wiese S, Gessler 
M & Kerkhoff E. (2005) Very-KIND is a novel nervous system specific guanine 
nucleotide exchange factor for Ras GTPases. Gene Expr Patterns 6(1): 79-85. 
 
Quinlan ME, Hilgert S, Bedrossian A, Mullins RD & Kerkhoff E. (2007) Regulatory 
interactions between two actin nucleators, Spire and Cappuccino. The Journal of cell 
biology 179(1): 117-28. 
 
Poster: 
Hilgert S, Mees A, Borawski JM, Leberfinger CB, Kerkhoff E (2004) The novel KIND 
motif mediates the interaction of the distinct actin organizers Spir and Cappuccino. 
Symposium on Visualising Cytoskeletal Architecture and Dynamics by Light and 
Electron Microscopy, Dresden, Oktober 2004 
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